ticker,rpa_date_utc,rpa_time_utc,rp_entity_id,entity_name,relevance,event_sentiment_score,group,sub_type,event_text,news_type,source_name,headline
CRL,2021-03-26,11:35:44,104F7A,Creightons PLC,99,0.53,labor-issues,,Creightons PLC: Change of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Change of Director's Role
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.64,earnings,up,Creightons PLC: The profit after tax for the year has increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year ended 31 March 2021
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.3,revenues,,Creightons PLC: Revenue increased by 28.9% to GBP61.6m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year ended 31 March 2021
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.56,earnings,up,Creightons PLC: Operating profit increased by 43.7% to GBP5.4m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year ended 31 March 2021
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,revenues,,Creightons PLC: Operating profit margin of 8.8%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year ended 31 March 2021
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,equity-actions,,Creightons PLC: The additional costs in the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year ended 31 March 2021
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,-0.44,equity-actions,up,"Creightons PLC: Distribution costs have increased by 37.0% to GBP3,353,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year ended 31 March 2021
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,equity-actions,,"Creightons PLC: The Group's tax charge for the year was GBP837,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year ended 31 March 2021
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.61,earnings,positive,Creightons PLC: Profit after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year ended 31 March 2021
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.61,earnings,positive,Creightons PLC: The diluted earnings per share of 5.89p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year ended 31 March 2021
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results - for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -2-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,dividends,,Creightons PLC: Together with the interim dividend of 0.15,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -2-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.65,revenues,up,Creightons PLC: o Sales - increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -2-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.61,earnings,positive,"Creightons PLC: Gross profit 24,982",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -3-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.46,products-services,increase,"Creightons PLC: Increased use of PPE, re-laid out production",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -3-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -3-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.59,earnings,positive,Creightons PLC: Profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -3-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -3-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.61,earnings,positive,Creightons PLC: Profit for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -4-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results - for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -5-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,dividends,,Creightons PLC: Dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -5-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results - for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -6-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: 5 Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -6-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results - for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -7-
CRL,2021-07-21,06:00:10,104F7A,Creightons PLC,100,0.0,investor-relations,,Creightons PLC: the Company's Annual General Meeting.,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Preliminary Results - for year -7-
CRL,2021-07-29,06:00:32,104F7A,Creightons PLC,99,0.62,acquisitions-mergers,,Creightons PLC: Acquisition of Emma Hardie Limited,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Acquisition of Emma Hardie Limited and TVR
CRL,2021-07-29,06:00:32,104F7A,Creightons PLC,99,0.59,earnings,positive,Creightons PLC: The profits before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Acquisition of Emma Hardie Limited and TVR
CRL,2021-07-29,06:00:32,104F7A,Creightons PLC,99,0.0,revenues,,"Creightons PLC: The turnover was GBP3,834,771",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Acquisition of Emma Hardie Limited and TVR
CRL,2021-08-04,12:47:13,104F7A,Creightons PLC,99,0.62,acquisitions-mergers,,Creightons PLC: Acquisition of Emma Hardie Limited,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Emma Hardie Ltd - Q&A video available
CRL,2021-08-25,12:34:11,104F7A,Creightons PLC,100,0.0,dividends,,"Creightons PLC Results of AGM, Final Dividend",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Results of AGM, Final Dividend Declaration"
CRL,2021-08-25,12:34:11,104F7A,Creightons PLC,100,0.0,investor-relations,,Creightons PLC: Results of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Results of AGM, Final Dividend Declaration"
CRL,2021-08-26,10:19:19,104F7A,Creightons PLC,100,0.0,dividends,,Creightons PLC Final Dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Final Dividend Declaration
CRL,2021-09-27,06:00:05,104F7A,Creightons PLC,99,0.62,acquisitions-mergers,,Creightons PLC: Acquisition of Brodie and Stone Holdings Limited and its subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Acquisition of Brodie and Stone
CRL,2021-09-27,08:09:31,104F7A,Creightons PLC,100,0.62,acquisitions-mergers,,Creightons Buys Brodie and Stone Holdings for GBP4.8 Mln,FULL-ARTICLE,Dow Jones Newswires,Creightons Buys Brodie and Stone Holdings for GBP4.8 Mln -- Deal Digest
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,0.0,dividends,,Creightons PLC: The total payment in relation to the dividend paid in October 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,0.0,revenues,,Creightons PLC: The total net sales for the six months were GBP30.00m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,-0.02,equity-actions,,Creightons PLC: Distribution costs have decreased by 2.3% to GBP1.67m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,0.61,earnings,positive,Creightons PLC: Profit after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,0.61,earnings,positive,Creightons PLC: Diluted EPS 2.61p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,0.55,acquisitions-mergers,,Creightons PLC: Successfully completed acquisition of two businesses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,0.65,revenues,up,Creightons PLC: Core sales have increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,0.0,revenues,,Creightons PLC: Overall Group sales were GBP30.00m for the six months ended 30 September 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,99,0.65,revenues,up,Creightons PLC: Contract manufacturing sales have increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,95,0.61,earnings,positive,"Creightons PLC: Gross profit 12,804",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,95,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,95,0.59,earnings,positive,Creightons PLC: Profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,95,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the six months ended 30 September 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the six months ended 31 March 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -4-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the six months ended 30 September 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -4-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,90,-0.65,earnings,negative,Creightons PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -4-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,91,0.62,acquisitions-mergers,,"Creightons PLC: Acquisition of Brodie & Stone (2,807",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -5-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,91,0.0,dividends,,Creightons PLC: Dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -5-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,91,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -5-
CRL,2021-12-30,06:59:52,104F7A,Creightons PLC,97,0.0,dividends,,Creightons PLC: Interim Dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -7-
CRL,2021-12-30,07:19:30,104F7A,Creightons PLC,100,0.59,earnings,positive,Creightons 1H Pretax Profit,FULL-ARTICLE,Dow Jones Newswires,"Creightons 1H Pretax Profit, Revenue Fell"
CRL,2021-12-30,07:19:30,104F7A,Creightons PLC,100,0.59,earnings,positive,Creightons PLC said Thursday that pretax profit,FULL-ARTICLE,Dow Jones Newswires,"Creightons 1H Pretax Profit, Revenue Fell"
CRL,2024-03-07,07:00:18,104F7A,Creightons PLC,99,-0.57,labor-issues,,Creightons PLC: Mr William McIlroy is retiring from his executive,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Directorate Change
CRL,2024-07-08,06:52:09,104F7A,Creightons PLC,100,-0.45,equity-actions,charge,Creightons to Take GBP4.45 Million Impairment,FULL-ARTICLE,Dow Jones Newswires,Creightons to Take GBP4.45 Million Impairment Hit
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.42,earnings,up,Creightons PLC: Gross profit margin increased by 1.3% to 42.9%,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,revenues,,Creightons PLC: Full year operating profit margin,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.58,earnings,positive,Creightons PLC: EBITDA for the year was GBP3.2m,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Adjusted diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,-0.68,revenues,down,Creightons PLC: decreased revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.47,equity-actions,,Creightons PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,-0.44,products-services,cut,Creightons PLC: We are now seeing an easing of supplier price,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: This year's results,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -2-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,-0.49,labor-issues,,Creightons PLC: William McIlroy retired from his Executive,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -2-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.1,revenues,,Creightons PLC: Private label sales have increased sales by 7.9% to GBP23.7m,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -2-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.48,equity-actions,down,Creightons PLC: Key cost reductions,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -2-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.61,earnings,positive,"Creightons PLC: Gross profit 11,632",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -2-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -2-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,-0.65,earnings,negative,Creightons PLC: A GBP1.8m loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -3-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,-0.68,revenues,down,"Creightons PLC: Conversely, the contract sales",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -3-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.7,earnings,up,Creightons PLC: This year has seen an increase,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -3-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.61,earnings,positive,"Creightons PLC: Gross profit 22,830",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -4-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,-0.68,revenues,down,Creightons PLC: The decrease in sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -4-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -4-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.61,earnings,positive,Creightons PLC: Adjusted Diluted EPS - excluding 1.42 pence 1.05 pence,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -4-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,revenues,,Creightons PLC: Overall Group sales were GBP53.2m for the year ended March,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -4-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -5-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.24,equity-actions,down,Creightons PLC: Administrative expenses have decreased by 5.6% to GBP17.8m in the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -5-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -5-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.46,products-services,raise,Creightons PLC: Strategic sales price increases,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -5-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,equity-actions,,Creightons PLC: Redundancy costs of GBP0.02m,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -5-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Adjusted diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -5-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -6-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,-0.49,equity-actions,up,Creightons PLC: Cost increases,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -6-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.61,earnings,positive,"Creightons PLC: Gross profit 22,830",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -7-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -7-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.59,earnings,positive,Creightons PLC: Profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -7-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Adjusted Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -7-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,dividends,,Creightons PLC: Final dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -7-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Profit for the year - - - - - -,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -8-"
CRL,2024-07-18,06:00:12,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -9-"
CRL,2024-07-18,06:00:13,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -10-"
CRL,2024-07-18,06:00:13,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -10-"
CRL,2024-07-18,06:00:13,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Adjusted Earnings,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -11-"
CRL,2024-07-18,06:00:13,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -11-"
CRL,2024-07-18,06:00:13,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Adjusted Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -11-"
CRL,2024-07-18,06:00:13,104F7A,Creightons PLC,100,0.59,equity-actions,,"Creightons PLC: the Company agreed a buy back of 1,600,000 Consideration Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -11-"
CRL,2024-07-18,06:00:13,104F7A,Creightons PLC,100,0.0,investor-relations,,Creightons PLC: the Company's Annual General Meeting.,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -11-"
CRL,2024-07-18,06:00:13,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, Notice of AGM -12-"
CRL,2024-07-29,14:45:11,104F7A,Creightons PLC,100,0.0,dividends,,Creightons PLC Dividend Declaration,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Dividend Declaration
CRL,2024-08-29,15:28:43,104F7A,Creightons PLC,98,0.0,investor-relations,,Creightons PLC: Results of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Result of AGM
CRL,2024-10-28,17:01:53,104F7A,Creightons PLC,99,0.47,labor-issues,,"Director of Creightons, has been appointed a Director",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Notification under UKLR 6.4.9(2)
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,99,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,99,0.61,earnings,positive,Creightons PLC: Diluted EPS was 1.61p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,99,-0.2,revenues,,Creightons PLC: o Branded revenue has decreased by 15.0% to GBP8.9m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,99,-0.68,revenues,down,Creightons PLC: o Contract manufacturing revenue decreased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,99,0.36,equity-actions,down,Creightons PLC: o Distribution costs have decreased by 25.3%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,99,0.46,equity-actions,,"Creightons PLC: we continue to invest in textures, ingredient",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,99,-0.68,revenues,down,Creightons PLC: Contract sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,95,0.36,equity-actions,down,Creightons PLC: Distribution costs have decreased by 25.3% to GBP1.4m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,95,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,95,0.46,products-services,raise,Creightons PLC: S trategic sales price increases,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,95,0.0,earnings,,Creightons PLC: The diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2024-11-28,07:00:12,104F7A,Creightons PLC,95,0.0,dividends,,Creightons PLC: A final dividend for the year ended 31 March 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2024-11-28,07:00:13,104F7A,Creightons PLC,90,0.61,earnings,positive,"Creightons PLC: Gross profit 11,912",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -4-
CRL,2024-11-28,07:00:13,104F7A,Creightons PLC,90,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -4-
CRL,2024-11-28,07:00:13,104F7A,Creightons PLC,90,0.0,earnings,,Creightons PLC: Adjusted Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -4-
CRL,2024-11-28,07:00:13,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the six-month period - - - - - -,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -5-
CRL,2024-11-28,07:00:13,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the six-month period - - - - - -,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -6-
CRL,2024-11-28,07:00:13,104F7A,Creightons PLC,92,0.0,dividends,,Creightons PLC: Dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -7-
CRL,2024-11-28,07:00:13,104F7A,Creightons PLC,92,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -7-
CRL,2024-11-28,07:00:13,104F7A,Creightons PLC,97,0.0,earnings,,Creightons PLC: of basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -8-
CRL,2024-11-28,07:00:13,104F7A,Creightons PLC,97,0.0,equity-actions,,Creightons PLC: Redundancy costs in year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -8-
CRL,2024-12-10,16:10:25,104F7A,Creightons PLC,99,-0.57,labor-issues,,Creightons PLC: Director Resignation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Directorate Change
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.16,revenues,,Creightons PLC: Revenue for the year was GBP58.6m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.58,earnings,positive,Creightons PLC: EBITDA for the year was GBP3.0m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,-0.7,earnings,down,Creightons PLC: Operating profit decreased by 67.5%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.0,revenues,,Creightons PLC: Operating profit margin of 2.4%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.61,earnings,positive,Creightons PLC: Full year Profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.59,earnings,positive,Creightons PLC: Profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.16,revenues,,Creightons PLC: Overall Group sales were GBP58.6m for the year ended March,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -2-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,-0.68,revenues,down,Creightons PLC: Contract manufacturing sales have decreased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -2-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,-0.16,equity-actions,up,Creightons PLC: Administrative expenses have increased by 3.3% to GBP18.9m in the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -2-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.0,equity-actions,,Creightons PLC: The tax charge in the current year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -2-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.61,earnings,positive,Creightons PLC: The diluted earnings per share of 0.65p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -2-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.46,equity-actions,,Creightons PLC: we intend to invest in formulation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -2-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,-0.49,equity-actions,up,Creightons PLC: Cost increases,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -4-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.61,earnings,positive,"Creightons PLC: Gross profit 24,348",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -4-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -4-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.59,earnings,positive,Creightons PLC: Profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -4-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,99,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -4-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the year - - - - - -,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -5-
CRL,2023-07-07,06:00:10,104F7A,Creightons PLC,92,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Audited preliminary results -7-
CRL,2023-07-07,06:40:08,104F7A,Creightons PLC,100,-0.65,earnings,down,Creightons said Friday that pretax profit for fiscal 2023 fell,FULL-ARTICLE,Dow Jones Newswires,Creightons FY 2023 Pretax Profit Fell as Revenue Declined on Lower Sales
CRL,2023-09-14,08:52:43,104F7A,Creightons PLC,99,0.0,investor-relations,,Creightons PLC: Results of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Result of AGM
CRL,2023-12-04,07:00:11,104F7A,Creightons PLC,91,0.61,earnings,positive,"Creightons PLC: Gross profit 11,632",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2023-12-04,07:00:11,104F7A,Creightons PLC,91,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2023-12-04,07:00:11,104F7A,Creightons PLC,91,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2023-12-04,07:00:11,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the six-month period - - - - - -,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -4-
CRL,2023-12-04,07:00:11,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the six-month period - - - - - -,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -5-
CRL,2023-12-04,07:00:11,104F7A,Creightons PLC,91,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -6-
CRL,2023-12-04,07:00:11,104F7A,Creightons PLC,93,0.59,equity-actions,,"Creightons PLC: the Company buy back 800,000 Consideration Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -7-
CRL,2022-07-11,06:00:22,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Preliminary Results, investor/analyst presentation"
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Results for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March 2022
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.38,revenues,,Creightons PLC: Overall Group sales were GBP61.2m for the year ended March,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March 2022
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,-0.38,earnings,down,Creightons PLC: Operating profit decreased by 19.1%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March 2022
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,revenues,,Creightons PLC: Operating profit margin of 7.1%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March 2022
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.46,equity-actions,,"Creightons PLC: We have continued to invest in working capital, product",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March 2022
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.46,revenues,up,Creightons PLC: Contract manufacturing sales increased by 29.3%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March 2022
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.5,acquisitions-mergers,completed,Creightons PLC: Successfully completed acquisition of two businesses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March 2022
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,-0.13,equity-actions,up,Creightons PLC: Administrative expenses have increased by 12.4% to GBP18.3m in the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March 2022
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,equity-actions,,Creightons PLC: Prior year costs included GBP0.8m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March 2022
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Results for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -2-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,equity-actions,,"Creightons PLC: The Group's tax charge for the year was GBP345,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -2-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.61,earnings,positive,Creightons PLC: The diluted earnings per share of 3.98p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -2-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,dividends,,Creightons PLC: The total dividend paid for the year ended 31 March 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -2-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Results for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -3-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,-0.49,equity-actions,up,Creightons PLC: Cost increases,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -3-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Results for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -4-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.61,earnings,positive,"Creightons PLC: Gross profit 26,156",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -4-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -4-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.59,earnings,positive,Creightons PLC: Profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -4-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -4-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,dividends,,Creightons PLC: Total dividend paid in year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -4-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Results for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -5-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.61,earnings,positive,Creightons PLC: Profit for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -5-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,-0.65,earnings,negative,Creightons PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -5-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Results for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -6-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.62,acquisitions-mergers,,"Creightons PLC: Acquisition of Brodie & Stone 8 (3,507",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -6-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Results for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -7-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -7-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Results for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -8-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,earnings,,Creightons PLC Results for year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -9-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.59,earnings,positive,Creightons PLC: Profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -9-
CRL,2022-07-12,06:00:16,104F7A,Creightons PLC,100,0.0,investor-relations,,Creightons PLC: the Company's Annual General Meeting.,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results for year to end 31 March -9-
CRL,2022-08-24,12:01:42,104F7A,Creightons PLC,99,0.0,investor-relations,,Creightons PLC: Results of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Result of AGM
CRL,2022-09-27,06:01:53,104F7A,Creightons PLC,99,0.59,equity-actions,,"Creightons PLC: the Company buy back 800,000 Consideration Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Update on Emma Hardie, Trading in own shares & TVR"
CRL,2022-11-25,07:00:14,104F7A,Creightons PLC,99,0.0,earnings,,Creightons PLC: the Company's Interim results for the 6-month period,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Creightons PLC Interim Results 2022 - announcement, presentations"
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,-0.68,revenues,down,Creightons PLC: Sales for the first,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,0.64,earnings,up,Creightons PLC: our return to profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,-0.28,equity-actions,up,Creightons PLC: Administration costs have increased by 14.2% to GBP9.8m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,-0.65,earnings,negative,Creightons PLC: O perating losses in the first,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,0.61,earnings,positive,Creightons PLC: Diluted EPS was negative 0.48p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,0.47,equity-actions,,Creightons PLC: o Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,0.0,equity-actions,,Creightons PLC: Operating profit before exceptional costs was GBP0.3m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,0.0,earnings,,Creightons PLC: The diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,99,0.61,earnings,positive,"Creightons PLC: Gross profit 11,990",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -2-
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,90,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -3-
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the six-month period,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -4-
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,90,0.62,acquisitions-mergers,,"Creightons PLC: Acquisition of Emma Hardie 7 (1,424) (2,775) (2",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -5-
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,91,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -6-
CRL,2022-12-01,07:00:13,104F7A,Creightons PLC,98,0.59,equity-actions,,"Creightons PLC: the Company buy back 800,000 Consideration Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Half-year Report -7-
CRL,2022-12-01,07:42:24,104F7A,Creightons PLC,100,-0.65,earnings,down,Creightons Swung to 1H Pretax Loss,FULL-ARTICLE,Dow Jones Newswires,Creightons Swung to 1H Pretax Loss
CRL,2025-01-29,12:59:12,104F7A,Creightons PLC,99,0.47,labor-issues,,Creightons PLC: Board Appointment,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Board Appointment
CRL,2025-02-06,14:05:02,104F7A,Creightons PLC,98,0.0,revenues,,Creightons PLC: the company booked revenue of 53.2 million pounds,FULL-ARTICLE,Dow Jones Newswires,Creightons to Switch Listing to London's AIM
CRL,2025-03-25,15:23:13,104F7A,Creightons PLC,99,0.47,labor-issues,,Creightons PLC: Board Appointment,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Board Appointment
CRL,2025-04-30,06:00:21,104F7A,Creightons PLC,100,0.47,labor-issues,,Creightons PLC Promotion of CFO to the Board of Directors,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Promotion of CFO to the Board of Directors
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.0,earnings,,Creightons PLC: Audited results for the year ended 31 March 2025,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of AGM
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.0,investor-relations,,Creightons PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of AGM
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.65,revenues,up,Creightons PLC: Revenue increased by GBP0.9m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of AGM
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.64,earnings,up,Creightons PLC: Gross profit increased by GBP1.3m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of AGM
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.61,earnings,up,Creightons PLC: EBITDA(1) increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of AGM
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.62,earnings,up,Creightons PLC: Operating profit (before exceptional items) increased by GBP2.0m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of AGM
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.0,earnings,,Creightons PLC: Adjusted diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of AGM
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.57,equity-actions,listing,Creightons transitioned to AIM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of AGM
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.47,labor-issues,,"Creightons PLC: the Company name, following the passing of a Board",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -2-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.0,dividends,,Creightons PLC: Ex-Dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -2-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.41,revenues,up,Creightons PLC: Group revenue increased by 1.6% to GBP54.1m (2024: GBP53.2m),PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -2-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.65,revenues,up,Creightons PLC: Revenue increased by GBP0.9m to GBP54.1m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -4-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.42,earnings,up,Creightons PLC: Gross profit margin increased by 180 bps to 44.7%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -4-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,92,0.0,revenues,,Creightons PLC: Overall Group sales were GBP54.1m for the year ended March,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -5-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,92,-0.2,equity-actions,,Creightons PLC: Distribution costs have decreased by 20.8% to GBP2.8m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -5-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,92,0.65,revenues,up,Creightons PLC: This growth in revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -5-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,92,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -5-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,92,0.62,earnings,up,Creightons PLC: Operating profit (before exceptional items) increased by GBP2.0m to GBP3.5m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -5-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,92,0.0,earnings,,Creightons PLC: Adjusted diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -5-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,-0.49,equity-actions,up,Creightons PLC: Cost increases,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -6-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,99,0.61,earnings,positive,"Creightons PLC: Gross profit 24,153",PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -6-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,90,0.6,earnings,positive,Creightons PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -7-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,90,0.59,earnings,positive,Creightons PLC: Profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -7-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,90,0.0,earnings,,Creightons PLC: Adjusted Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -7-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,90,0.0,earnings,,Creightons PLC: Adjusted Earnings,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -7-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,90,0.0,dividends,,Creightons PLC: Final dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -7-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,90,0.61,earnings,positive,Creightons PLC: Profit for the year - - - - - -,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -8-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,90,0.0,dividends,,Creightons PLC: Dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -8-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,92,0.0,dividends,,Creightons PLC: Dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -9-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,94,0.0,earnings,,Creightons PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -10-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,94,0.61,earnings,positive,Creightons PLC: Basic earnings per share - including exceptional items 3.58p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -11-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,94,0.0,earnings,,Creightons PLC: Adjusted Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -11-
CRL,2025-07-16,06:00:15,104F7A,Creightons PLC,94,0.0,earnings,,Creightons PLC: Adjusted Earnings,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC FY25 Audited Results and Notice of -11-
CRL,2025-08-28,14:22:43,104F7A,Creightons PLC,99,0.0,investor-relations,,Creightons PLC: Results of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results of Annual General Meeting
CRL,2025-08-28,14:22:43,104F7A,Creightons PLC,99,0.0,regulatory,,Creightons PLC: To re-appoint Forvis Mazars LLP as auditor,PRESS-RELEASE,LSE Regulatory News Service (RNS),Creightons PLC Results of Annual General Meeting
CRL,2024-01-08,13:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2024-01-08,13:00:31,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2024-01-11,21:11:11,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Coo Girshick Acquires 1,326 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"COO Girshick Acquires 1,326 Of Charles River Labs Intl Inc >CRL"
CRL,2024-01-16,13:00:00,B13B68,Charles River Labs International Inc.,99,-0.47,products-services,decrease,Charles River Labs International Inc.: The reduction in production,PRESS-RELEASE,Business Wire,Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing
CRL,2024-01-16,13:01:01,B13B68,Charles River Labs International Inc.,99,-0.47,products-services,decrease,Charles River Labs International Inc.: The reduction in production,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing
CRL,2024-01-16,21:37:07,B13B68,Charles River Labs International Inc.,100,-0.57,labor-issues,,Charles River Laboratories Chief Commercial Officer William D. Barbo to Retire at End of 2024,RNS-SEC8K,Dow Jones Newswires,Charles River Laboratories Chief Commercial Officer William D. Barbo to Retire at End of 2024
CRL,2024-01-23,21:30:01,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
CRL,2024-01-23,21:30:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2023 financial results and provide 2024 guidance on Wednesday, February 14",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
CRL,2024-01-23,21:30:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2023 financial results and provide 2024 guidance on Wednesday, February 14",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
CRL,2024-01-23,21:31:16,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
CRL,2024-01-23,21:31:16,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2023 financial results and provide 2024 guidance on Wednesday, February 14",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
CRL,2024-01-23,21:31:16,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2023 financial results and provide 2024 guidance on Wednesday, February 14",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
CRL,2024-01-24,21:30:00,B13B68,Charles River Labs International Inc.,100,0.47,labor-issues,,Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors,PRESS-RELEASE,Business Wire,Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
CRL,2024-01-24,21:30:01,B13B68,Charles River Labs International Inc.,100,0.47,labor-issues,,Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
CRL,2024-01-24,21:37:13,B13B68,Charles River Labs International Inc.,100,0.47,labor-issues,,Charles River Laboratories Adds Reshema Kemps-Polanco to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Adds Reshema Kemps-Polanco to Bd of Directors
CRL,2024-01-31,22:04:53,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,"Chmn Foster Surrenders 10,757 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Surrenders 10,757 Of Charles River Labs Intl Inc >CRL"
CRL,2024-01-31,22:24:29,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp Barbo Acquires 2,227 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Acquires 2,227 Of Charles River Labs Intl Inc >CRL"
CRL,2024-01-31,22:27:22,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp Creamer Acquires 2,044 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Creamer Acquires 2,044 Of Charles River Labs Intl Inc >CRL"
CRL,2024-01-31,22:30:39,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp LaPlume Acquires 2,325 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Acquires 2,325 Of Charles River Labs Intl Inc >CRL"
CRL,2024-01-31,22:33:12,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,Vp Knell Acquires 642 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Acquires 642 Of Charles River Labs Intl Inc >CRL
CRL,2024-01-31,22:37:25,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Coo Girshick Acquires 1,299 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"COO Girshick Acquires 1,299 Of Charles River Labs Intl Inc >CRL-Amended"
CRL,2024-02-01,00:16:12,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Coo Girshick Acquires 2,367 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"COO Girshick Acquires 2,367 Of Charles River Labs Intl Inc >CRL"
CRL,2024-02-01,00:36:48,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp Parisotto Acquires 1,560 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Parisotto Acquires 1,560 Of Charles River Labs Intl Inc >CRL"
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q EPS $3.62,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q EPS $3.62 >CRL
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q Adj EPS $2.46,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Adj EPS $2.46 >CRL
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q Net $187.1M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Net $187.1M >CRL
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 4Q Rev $1.01B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Rev $1.01B >CRL
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Fourth-Quarter Segment Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Full-Year Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Fourth-Quarter Revenue of $1.01 Billion,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Fourth-Quarter GAAP Earnings per Share of $3.62,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Full-Year GAAP Earnings per Share of $9.22,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Provides 2024 Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Fourth-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: GAAP earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $127.2 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $195.8 million in the fourth quarter of 2023,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,-0.24,revenues,down,Charles River Labs International Inc.: Organic revenue decreased by 0.4%,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: The GAAP operating margin decrease,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For 2023, Manufacturing revenue was $721.4 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.62,acquisitions-mergers,,Charles River Labs International Inc.: Acquisition of Noveprim Group,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.57,acquisitions-mergers,completed,"On November 30, 2023, Charles River Laboratories completed the acquisition of an additional 41% equity stake of Noveprim",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -2-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.22,acquisitions-mergers,,Charles River Labs International Inc.: the Company had previously acquired a 49% equity stake for $90.0 million,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -2-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: The Company's 2024 guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -2-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 1.0%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -2-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: GAAP EPS estimate $7.90,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -2-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.90 -- $11.40,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -2-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 838,003 $ 900,698",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -3-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -3-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -3-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 8,195,001 $ 7,602,770",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -3-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,92,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -4-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -4-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -5-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,013,476 $1,099,843",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -5-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -5-
CRL,2024-02-14,12:00:01,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth -6-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Fourth-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Full-Year Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Fourth-Quarter Revenue of $1.01 Billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Fourth-Quarter GAAP Earnings per Share of $3.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Full-Year GAAP Earnings per Share of $9.22,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Provides 2024 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Fourth-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: GAAP earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $127.2 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $195.8 million in the fourth quarter of 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,-0.24,revenues,down,Charles River Labs International Inc.: Organic revenue decreased by 0.4%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: The GAAP operating margin decrease,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For 2023, Manufacturing revenue was $721.4 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,100,0.62,acquisitions-mergers,,Charles River Labs International Inc.: Acquisition of Noveprim Group,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.57,acquisitions-mergers,completed,"On November 30, 2023, Charles River Laboratories completed the acquisition of an additional 41% equity stake of Noveprim",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.22,acquisitions-mergers,,Charles River Labs International Inc.: the Company had previously acquired a 49% equity stake for $90.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: The Company's 2024 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 1.0%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: GAAP EPS estimate $7.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.90 -- $11.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 838,003 $ 900,698",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 8,195,001 $ 7,602,770",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,92,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,013,476 $1,099,843",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-02-14,12:01:00,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2024-02-14,12:03:58,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees 2024 EPS $7.90,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2024 EPS $7.90-EPS $8.40 >CRL
CRL,2024-02-14,12:04:40,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees 2024 Adj EPS $10.90,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2024 Adj EPS $10.90-Adj EPS $11.40 >CRL
CRL,2024-02-14,12:31:29,B13B68,Charles River Labs International Inc.,95,0.0,earnings,,"Charles River Laboratories International, Inc. issued a press release providing financial results for the fourth quarter",RNS-SEC8K,Dow Jones Newswires,Charles River Labs Files 8K - Operations And Financial Condition >CRL
CRL,2024-02-14,16:57:17,B13B68,Charles River Labs International Inc.,100,0.72,revenues,up,Charles River also guided for revenue growth,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Shares Rise 8.7% on 2024 Guidance
CRL,2024-02-15,13:12:33,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Neutral From Buy by Guggenheim,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Neutral From Buy by Guggenheim
CRL,2024-02-15,14:49:53,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by JP Morgan
CRL,2024-02-15,14:49:53,B13B68,Charles River Labs International Inc.,100,0.48,price-targets,upgrade,Charles River Labs Price Target Raised to $280.00/Share From $270.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $280.00/Share From $270.00 by JP Morgan
CRL,2024-02-15,15:14:23,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Baird
CRL,2024-02-15,15:14:23,B13B68,Charles River Labs International Inc.,100,0.64,price-targets,upgrade,Charles River Labs Price Target Raised to $268.00/Share From $252.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $268.00/Share From $252.00 by Baird
CRL,2024-02-15,16:06:35,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 838 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 838 Of Charles River Labs Intl Inc >CRL
CRL,2024-02-15,16:28:03,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Citigroup
CRL,2024-02-15,16:28:03,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $250.00/Share From $215.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $250.00/Share From $215.00 by Citigroup
CRL,2024-02-15,17:04:03,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by UBS
CRL,2024-02-15,17:04:03,B13B68,Charles River Labs International Inc.,100,0.68,price-targets,upgrade,Charles River Labs Price Target Raised to $290.00/Share From $270.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $290.00/Share From $270.00 by UBS
CRL,2024-02-15,18:44:13,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Evercore ISI Group
CRL,2024-02-15,18:44:13,B13B68,Charles River Labs International Inc.,100,0.36,price-targets,upgrade,Charles River Labs Price Target Raised to $265.00/Share From $260.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $265.00/Share From $260.00 by Evercore ISI Group
CRL,2024-02-15,21:06:43,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp Parisotto Registers 5,882 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Parisotto Registers 5,882 Of Charles River Labs Intl Inc >CRL"
CRL,2024-02-16,23:45:23,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Coo Girshick Gifts 424 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,COO Girshick Gifts 424 Of Charles River Labs Intl Inc >CRL
CRL,2024-02-20,13:08:00,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River Collaborates with Pluristyx,PRESS-RELEASE,Business Wire,"Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells"
CRL,2024-02-20,13:08:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Collaborates with Pluristyx,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells"
CRL,2024-02-20,13:08:43,B13B68,Charles River Labs International Inc.,100,0.39,products-services,,Charles River Labs Has Entered Into an Agreement With Pluristyx,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Has Entered Into an Agreement With Pluristyx for the Development of Cell Therapies >CRL
CRL,2024-02-20,22:25:35,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 838 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Sells 838 Of Charles River Labs Intl Inc >CRL
CRL,2024-02-20,22:35:55,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp Parisotto Sells 5,882 Of Charles River Labs Intl Inc",FULL-ARTICLE,Dow Jones Newswires,"VP Parisotto Sells 5,882 Of Charles River Labs Intl Inc >CRL"
CRL,2024-02-21,00:27:35,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,"Chmn Foster Gifts 4,000 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Gifts 4,000 Of Charles River Labs Intl Inc >CRL"
CRL,2024-02-21,13:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: our relationship with Charles River and to link with their discovery organization,PRESS-RELEASE,Business Wire,Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
CRL,2024-02-21,13:00:10,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: our relationship with Charles River and to link with their discovery organization,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
CRL,2024-02-22,08:07:05,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 4Q 2023 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 4Q 2023 (CRL)"
CRL,2024-02-23,22:01:05,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp Barbo Sells 4,050 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Sells 4,050 Of Charles River Labs Intl Inc >CRL"
CRL,2024-02-28,14:14:13,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action complaint has been filed against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,DJ Global Press Release Wire,"Grabar Law Office Investigates Claims on Behalf of Shareholders of Charles River Laboratories International, Inc. (CRL)"
CRL,2024-02-29,07:00:43,B13B68,Charles River Labs International Inc.,99,0.39,products-services,,Charles River Labs International Inc.: Wheeler Bio Seals Agreement with Charles River,PRESS-RELEASE,PR Newswire,Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use
CRL,2024-02-29,07:00:43,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: our relationship with Charles River and to link with their discovery organization,PRESS-RELEASE,PR Newswire,Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use
CRL,2024-02-29,07:00:44,B13B68,Charles River Labs International Inc.,99,0.39,products-services,,Charles River Labs International Inc.: Wheeler Bio Seals Agreement with Charles River,PRESS-RELEASE,Dow Jones Newswires,Press Release: Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use
CRL,2024-02-29,07:00:44,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: our relationship with Charles River and to link with their discovery organization,PRESS-RELEASE,Dow Jones Newswires,Press Release: Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use
CRL,2024-02-29,17:45:35,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp Parisotto Registers 3,786 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Parisotto Registers 3,786 Of Charles River Labs Intl Inc >CRL"
CRL,2024-02-29,20:18:30,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp Creamer Registers 5,000 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Creamer Registers 5,000 Of Charles River Labs Intl Inc >CRL"
CRL,2024-03-01,22:39:09,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp Creamer Sells 5,000 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Creamer Sells 5,000 Of Charles River Labs Intl Inc >CRL"
CRL,2024-03-04,12:00:05,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Durect and Charles River Laboratories Enter into Co-Marketing and Collaboration,PRESS-RELEASE,PR Newswire,DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET(R) Product Line in U.S. and Canada
CRL,2024-03-04,12:00:23,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Durect and Charles River Laboratories Enter into Co-Marketing and Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET(R) Product Line in U.S. and Canada
CRL,2024-03-04,12:03:12,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,"Durect, Charles River Labs in Co-Marketing, Collaboration",NEWS-FLASH,Dow Jones Newswires,"Durect, Charles River Labs in Co-Marketing, Collaboration Pact for Alzet Product Line in U.S., Canada"
CRL,2024-03-04,17:51:26,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp Knell Registers 2,750 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Knell Registers 2,750 Of Charles River Labs Intl Inc >CRL"
CRL,2024-03-04,21:13:06,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp Parisotto Sells 3,786 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Parisotto Sells 3,786 Of Charles River Labs Intl Inc >CRL"
CRL,2024-03-05,21:56:07,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp Knell Sells 2,750 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Knell Sells 2,750 Of Charles River Labs Intl Inc >CRL"
CRL,2024-03-08,19:36:27,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Vp Knell Registers 808 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP Knell Registers 808 Of Charles River Labs Intl Inc >CRL
CRL,2024-03-11,20:44:24,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Vp Knell Sells 808 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Sells 808 Of Charles River Labs Intl Inc >CRL
CRL,2024-03-12,12:00:00,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Barclays 26(th) Annual Global Healthcare Conference on Wednesday, March 13",PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL,2024-03-12,12:00:10,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Barclays 26(th) Annual Global Healthcare Conference on Wednesday, March 13",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL,2024-03-18,17:52:56,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by Argus Research
CRL,2024-03-18,17:52:56,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $290.00/Share From $240.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $290.00/Share From $240.00 by Argus Research
CRL,2024-03-25,21:51:55,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,Vp Knell Acquires 635 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Acquires 635 Of Charles River Labs Intl Inc >CRL-Amended
CRL,2024-03-25,21:54:38,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Coo Girshick Acquires 2,316 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"COO Girshick Acquires 2,316 Of Charles River Labs Intl Inc >CRL-Amended"
CRL,2024-03-25,21:58:00,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp LaPlume Acquires 2,285 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Acquires 2,285 Of Charles River Labs Intl Inc >CRL-Amended"
CRL,2024-03-25,22:52:43,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp Barbo Acquires 2,190 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Acquires 2,190 Of Charles River Labs Intl Inc >CRL-Amended"
CRL,2024-03-25,22:54:47,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp Parisotto Acquires 1,535 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Parisotto Acquires 1,535 Of Charles River Labs Intl Inc >CRL-Amended"
CRL,2024-03-25,23:04:21,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Chmn Foster Acquires 13,201 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Acquires 13,201 Of Charles River Labs Intl Inc >CRL-Amended"
CRL,2024-03-25,23:05:18,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp Creamer Acquires 2,010 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Creamer Acquires 2,010 Of Charles River Labs Intl Inc >CRL-Amended"
CRL,2024-03-27,12:00:01,B13B68,Charles River Labs International Inc.,99,0.46,equity-actions,,Charles River Labs International Inc.: Invested more than $4.5 billion in,PRESS-RELEASE,Business Wire,Charles River Laboratories Publishes 2023 Corporate Citizenship Report
CRL,2024-03-27,12:01:20,B13B68,Charles River Labs International Inc.,99,0.46,equity-actions,,Charles River Labs International Inc.: Invested more than $4.5 billion in,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Publishes 2023 Corporate Citizenship Report
CRL,2024-04-01,12:00:01,B13B68,Charles River Labs International Inc.,99,0.52,products-services,,Charles River Launches New Tools & Services,PRESS-RELEASE,Business Wire,Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
CRL,2024-04-01,12:01:30,B13B68,Charles River Labs International Inc.,99,0.52,products-services,,Charles River Launches New Tools & Services,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
CRL,2024-04-02,12:05:06,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,Securities fraud complaint was filed against Charles River,PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Charles River Laboratories International, Inc. (CRL)"
CRL,2024-04-02,12:31:39,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,Securities fraud complaint was filed against Charles River,PRESS-RELEASE,DJ Global Press Release Wire,SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Charles River Laboratories Intl. (CRL) and Encourages Long-Term Investors to Contact the Firm for Additional Information
CRL,2024-04-03,01:00:00,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,GlobeNewswire,"CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm"
CRL,2024-04-04,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Proud to collaborate with Charles River as,PRESS-RELEASE,Business Wire,Charles River to Perform Plasmid Production for Ship of Theseus
CRL,2024-04-04,12:00:02,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Proud to collaborate with Charles River as,PRESS-RELEASE,Business Wire,Charles River to Perform Plasmid Production for Ship of Theseus
CRL,2024-04-04,12:00:31,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Proud to collaborate with Charles River as,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River to Perform Plasmid Production for Ship of Theseus
CRL,2024-04-04,12:00:51,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Proud to collaborate with Charles River as,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River to Perform Plasmid Production for Ship of Theseus
CRL,2024-04-09,12:00:10,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
CRL,2024-04-11,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Collaboration between Charles River and Deciphex,PRESS-RELEASE,Business Wire,"Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology"
CRL,2024-04-11,12:00:50,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Collaboration between Charles River and Deciphex,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology"
CRL,2024-04-12,12:00:00,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
CRL,2024-04-12,12:00:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
CRL,2024-04-12,12:00:29,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
CRL,2024-04-12,12:00:29,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
CRL,2024-04-15,12:10:05,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,Securities fraud complaint was filed against Charles River,PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Charles River Laboratories International, Inc. (CRL)"
CRL,2024-04-15,12:33:57,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,Securities fraud complaint was filed against Charles River,PRESS-RELEASE,DJ Global Press Release Wire,STOCK INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Charles River Laboratories Intl. (CRL) and Encourages Long-Term Investors to Contact the Firm
CRL,2024-04-18,20:11:02,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,Securities fraud class action complaint filed against Charles River,PRESS-RELEASE,DJ Global Press Release Wire,"Notice to Long-Term Charles River Laboratories International, Inc. (CRL) Shareholders: Grabar Law Office Is Investigating Claims on Your Behalf"
CRL,2024-04-22,12:00:02,B13B68,Charles River Labs International Inc.,99,0.39,products-services,,Charles River Labs International Inc.: Executed two critical virtual power purchase agreements,PRESS-RELEASE,Business Wire,Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
CRL,2024-04-22,12:00:02,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: Partnered with leading organizations to,PRESS-RELEASE,Business Wire,Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
CRL,2024-04-22,12:00:02,B13B68,Charles River Labs International Inc.,99,0.46,equity-actions,,Charles River Labs International Inc.: Invested $13.5 million in,PRESS-RELEASE,Business Wire,Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
CRL,2024-04-22,12:11:19,B13B68,Charles River Labs International Inc.,99,0.39,products-services,,Charles River Labs International Inc.: Executed two critical virtual power purchase agreements,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
CRL,2024-04-22,12:11:19,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: Partnered with leading organizations to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
CRL,2024-04-22,12:11:19,B13B68,Charles River Labs International Inc.,99,0.46,equity-actions,,Charles River Labs International Inc.: Invested $13.5 million in,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
CRL,2024-04-25,12:00:04,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Fibrobiologics Plans to Collaborate with Charles River to,PRESS-RELEASE,GlobeNewswire,FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
CRL,2024-04-25,12:00:04,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Fibrobiologics Plans to Collaborate with Charles River to,PRESS-RELEASE,Dow Jones Newswires,Press Release: FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
CRL,2024-05-03,21:04:27,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Cfo Pease Surrenders 893 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,CFO Pease Surrenders 893 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Laboratories Announces First-Quarter 2024 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.04,revenues,,Charles River Labs International Inc.: First-Quarter Revenue of $1.01 Billion --,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: First-Quarter GAAP Earnings per Share of $1.30,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $117.6 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: our financial outlook for the year,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $220.9 million in the first quarter of 2024,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.62,revenues,up,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2024 guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.90 -- $11.40,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,marketing,,"Charles River will present at the Bank of America 2024 Healthcare Conference in Las Vegas, Nevada, on Wednesday",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 816,862 $ 857,366",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 8,152,783 $ 8,195,001",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,99,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,92,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $ 1,011,560 $ 1,029,373",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,99,0.65,revenues,up,Charles River Labs International Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q EPS $1.30,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q EPS $1.30 >CRL
CRL,2024-05-09,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q Adj EPS $2.27,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Adj EPS $2.27 >CRL
CRL,2024-05-09,11:00:03,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q Net $73M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Net $73M >CRL
CRL,2024-05-09,11:00:03,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 1Q Rev $1.01B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Rev $1.01B >CRL
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: First-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.04,revenues,,Charles River Labs International Inc.: First-Quarter Revenue of $1.01 Billion --,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: First-Quarter GAAP Earnings per Share of $1.30,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $117.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: our financial outlook for the year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $220.9 million in the first quarter of 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.62,revenues,up,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2024 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.90 -- $11.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2024 Results
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,99,0.0,marketing,,"Charles River will present at the Bank of America 2024 Healthcare Conference in Las Vegas, Nevada, on Wednesday",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 816,862 $ 857,366",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 8,152,783 $ 8,195,001",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,99,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,92,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $ 1,011,560 $ 1,029,373",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-05-09,11:03:41,B13B68,Charles River Labs International Inc.,99,0.65,revenues,up,Charles River Labs International Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-05-09,11:10:39,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees 2024 EPS $7.60,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2024 EPS $7.60-EPS $8.10 >CRL
CRL,2024-05-09,11:11:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees 2024 Adj EPS $10.90,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2024 Adj EPS $10.90-Adj EPS $11.40 >CRL
CRL,2024-05-09,11:32:03,B13B68,Charles River Labs International Inc.,95,0.0,earnings,,"Charles River Laboratories International, Inc. issued a press release providing financial results for the first quarter ended March 30, 2024",RNS-SEC8K,Dow Jones Newswires,Charles River Labs Files 8K - Operations And Financial Condition >CRL
CRL,2024-05-10,11:31:44,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Baird
CRL,2024-05-10,11:31:44,B13B68,Charles River Labs International Inc.,100,-0.54,price-targets,downgrade,Charles River Labs Price Target Cut to $270.00/Share From $282.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $270.00/Share From $282.00 by Baird
CRL,2024-05-10,15:36:28,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp LaPlume Registers 1,304 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP LaPlume Registers 1,304 Of Charles River Labs Intl Inc >CRL"
CRL,2024-05-13,16:29:21,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Hold by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Hold by TD Cowen
CRL,2024-05-13,16:29:21,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $228.00/Share From $260.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $228.00/Share From $260.00 by TD Cowen
CRL,2024-05-14,20:52:07,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp LaPlume Sells 1,304 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Sells 1,304 Of Charles River Labs Intl Inc >CRL"
CRL,2024-05-15,20:13:01,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Dir Massaro Registers 332 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,Dir Massaro Registers 332 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-16,20:36:47,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Dir Massaro Sells 332 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Massaro Sells 332 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-22,07:05:55,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 1Q 2024 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 1Q 2024 (CRL)"
CRL,2024-05-28,21:27:08,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Coo Girshick Surrenders 750 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,COO Girshick Surrenders 750 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-28,21:31:00,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 552 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Surrenders 552 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-28,21:33:20,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Parisotto Surrenders 343 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Parisotto Surrenders 343 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-28,21:44:53,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 393 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 393 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-29,21:09:24,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 379 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 379 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-29,21:16:48,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Vp Knell Sells 808 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Sells 808 Of Charles River Labs Intl Inc >CRL-Amended
CRL,2024-05-29,21:36:21,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 111 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Surrenders 111 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-29,21:41:39,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Cfo Pease Surrenders 356 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,CFO Pease Surrenders 356 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-29,21:47:05,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Coo Girshick Surrenders 216 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,COO Girshick Surrenders 216 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-29,21:49:40,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 190 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 190 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-29,21:52:18,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 36 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Surrenders 36 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-30,12:00:01,B13B68,Charles River Labs International Inc.,99,0.52,products-services,,Charles River Launches Viral Vector Tech Transfer Program to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
CRL,2024-05-30,22:59:59,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,"Chmn Foster Surrenders 1,274 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Surrenders 1,274 Of Charles River Labs Intl Inc >CRL"
CRL,2024-05-30,23:52:34,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 423 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 423 Of Charles River Labs Intl Inc >CRL-Amended
CRL,2024-05-30,23:59:05,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Cfo Pease Surrenders 406 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,CFO Pease Surrenders 406 Of Charles River Labs Intl Inc >CRL-Amended
CRL,2024-05-31,00:06:11,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 179 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 179 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-31,00:08:52,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 464 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 464 Of Charles River Labs Intl Inc >CRL-Amended
CRL,2024-05-31,00:19:01,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Parisotto Surrenders 110 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Parisotto Surrenders 110 Of Charles River Labs Intl Inc >CRL
CRL,2024-05-31,20:35:01,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 223 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Surrenders 223 Of Charles River Labs Intl Inc >CRL
CRL,2024-06-03,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 44(th) Annual Growth Stock Conference on Tuesday, June 4",PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at William Blair and Jefferies Conferences
CRL,2024-06-03,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 44(th) Annual Growth Stock Conference on Tuesday, June 4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at William Blair and Jefferies Conferences
CRL,2024-06-04,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River and Sanofi are collaborating to,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
CRL,2024-06-04,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River and Sanofi are collaborating to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
CRL,2024-06-04,20:47:29,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp LaPlume Gifts 311 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Gifts 311 Of Charles River Labs Intl Inc >CRL
CRL,2024-06-06,13:07:34,B13B68,Charles River Labs International Inc.,100,0.95,analyst-ratings,positive,Charles River Labs Initiated at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Initiated at Buy by Goldman Sachs
CRL,2024-06-06,13:07:34,B13B68,Charles River Labs International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $290.00/Share by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $290.00/Share by Goldman Sachs
CRL,2024-06-07,10:52:16,B13B68,Charles River Labs International Inc.,100,0.01,analyst-ratings,neutral,Charles River Labs Initiated at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Initiated at Neutral by Mizuho
CRL,2024-06-07,10:52:16,B13B68,Charles River Labs International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $235.00/Share by Mizuho,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $235.00/Share by Mizuho
CRL,2024-06-11,12:00:01,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,"Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives"
CRL,2024-06-11,12:00:01,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,"Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for",PRESS-RELEASE,Business Wire,"Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives"
CRL,2024-06-13,12:00:01,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,Securities fraud complaint was filed against Charles River,PRESS-RELEASE,GlobeNewswire,CHARLES RIVER SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Charles River Laboratories Intl. (NYSE: CRL) and Encourages Long-Term CRL Shareholders to Contact the Firm
CRL,2024-06-25,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,New partnership with Charles River,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
CRL,2024-06-25,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,New partnership with Charles River,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
CRL,2024-06-26,20:14:46,B13B68,Charles River Labs International Inc.,100,-0.03,credit-ratings,stable,"Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable",NEWS-FLASH,Dow Jones Newswires,"Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable"
CRL,2024-06-26,20:14:46,B13B68,Charles River Labs International Inc.,100,-0.03,credit-ratings,stable,"Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable"
CRL,2024-06-26,20:14:46,B13B68,Charles River Labs International Inc.,100,0.01,credit-ratings,confirmation,Fitch has also affirmed the 'BBB' debt rating,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable"
CRL,2024-06-26,20:14:56,B13B68,Charles River Labs International Inc.,100,0.0,credit-ratings,affirmation,Fitch Affirms Charles River,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Charles River -2-
CRL,2024-06-26,21:17:22,B13B68,Charles River Labs International Inc.,100,0.53,credit-ratings,positive,S&PGR Revs Otlk On Charles River Lab Int'l To Pos; Rtgs Affrmd,NEWS-FLASH,Dow Jones Newswires,S&PGR Revs Otlk On Charles River Lab Int'l To Pos; Rtgs Affrmd
CRL,2024-06-26,21:17:22,B13B68,Charles River Labs International Inc.,100,0.53,credit-ratings,positive,S&PGR Revs Otlk On Charles River Lab Int'l To Pos; Rtgs Affrmd,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Revs Otlk On Charles River Lab Int'l To Pos; Rtgs Affrmd
CRL,2024-06-28,12:30:51,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Hold From Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Hold From Buy by Argus Research
CRL,2024-06-28,14:31:11,B13B68,Charles River Labs International Inc.,100,0.01,analyst-ratings,neutral,Charles River Labs Initiated at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Initiated at Equal-Weight by Barclays
CRL,2024-06-28,14:31:11,B13B68,Charles River Labs International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $230.00/Share by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $230.00/Share by Barclays
CRL,2024-07-08,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Charles River Labs International Inc.: By collaborating with Charles River, we are one step closer to",PRESS-RELEASE,Business Wire,Charles River to Perform Plasmid Manufacturing for AAVantgarde
CRL,2024-07-08,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Charles River Labs International Inc.: By collaborating with Charles River, we are one step closer to",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River to Perform Plasmid Manufacturing for AAVantgarde
CRL,2024-07-10,12:25:38,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Baird
CRL,2024-07-10,12:25:38,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $239.00/Share From $271.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $239.00/Share From $271.00 by Baird
CRL,2024-07-16,20:30:00,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
CRL,2024-07-16,20:30:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2024 financial results on Wednesday, August 7",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
CRL,2024-07-16,20:30:52,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
CRL,2024-07-16,20:30:52,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2024 financial results on Wednesday, August 7",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
CRL,2024-07-30,12:00:01,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,"Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to",PRESS-RELEASE,Business Wire,"Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development"
CRL,2024-07-30,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,products-services,,Charles River Labs International Inc.: Clinical trials for,PRESS-RELEASE,Business Wire,"Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development"
CRL,2024-07-30,12:00:03,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development"
CRL,2024-07-30,12:00:03,B13B68,Charles River Labs International Inc.,99,0.0,products-services,,Charles River Labs International Inc.: Clinical trials for,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development"
CRL,2024-08-01,20:12:33,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Chmn Foster Registers 25,000 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Chmn Foster Registers 25,000 Of Charles River Labs Intl Inc >CRL"
CRL,2024-08-05,20:07:13,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 25,000 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Sells 25,000 Of Charles River Labs Intl Inc >CRL"
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q EPS $1.74,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q EPS $1.74 >CRL
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Adj EPS $2.80,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Adj EPS $2.80 >CRL
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Net $94.1M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Net $94.1M >CRL
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 2Q Rev $1.03B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Rev $1.03B >CRL
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Second-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,-0.06,revenues,,Charles River Labs International Inc.: Second-Quarter Revenue of $1.03 Billion --,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Second-Quarter GAAP Earnings per Share of $1.74,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,approved,Charles River Labs International Inc.: Board Approves New Stock Repurchase Authorization of $1.0 Billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Revises 2024 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $144.9 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.64,earnings,up,Charles River Labs International Inc.: The increases in non-GAAP net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Our financial performance through the first half of this year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $206.4 million in the second quarter of 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.90 -- $10.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 842,900 $ 874,891",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,948,283 $ 8,195,001",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,026,117 $1,059,937",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,dividends,,Charles River Labs International Inc.: Incremental dividends,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-08-07,11:00:01,B13B68,Charles River Labs International Inc.,96,0.65,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Second-Quarter 2024 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,-0.06,revenues,,Charles River Labs International Inc.: Second-Quarter Revenue of $1.03 Billion --,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Second-Quarter GAAP Earnings per Share of $1.74,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,approved,Charles River Labs International Inc.: Board Approves New Stock Repurchase Authorization of $1.0 Billion,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Revises 2024 Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $144.9 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.64,earnings,up,Charles River Labs International Inc.: The increases in non-GAAP net income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Our financial performance through the first half of this year,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $206.4 million in the second quarter of 2024,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.90 -- $10.20,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2024 Results
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 842,900 $ 874,891",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,948,283 $ 8,195,001",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,99,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,026,117 $1,059,937",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,dividends,,Charles River Labs International Inc.: Incremental dividends,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-08-07,11:00:02,B13B68,Charles River Labs International Inc.,97,0.65,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2024-08-07,11:01:39,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,approved,Charles River Labs Board Approves New Stock Repurchase Authorization,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Board Approves New Stock Repurchase Authorization of $1.0 >CRL
CRL,2024-08-07,11:02:37,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Labs Cuts 2024 View To EPS $5.65,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cuts 2024 View To EPS $5.65-EPS $5.95 >CRL
CRL,2024-08-07,11:03:01,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Labs Cuts 2024 View To Adj EPS $9.90,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cuts 2024 View To Adj EPS $9.90-Adj EPS $10.20 >CRL
CRL,2024-08-07,11:21:50,B13B68,Charles River Labs International Inc.,95,0.0,earnings,,"Charles River Laboratories International, Inc. issued a press release providing financial results for the second quarter ended June 29, 2024",RNS-SEC8K,Dow Jones Newswires,Charles River Labs Files 8K - Operations And Financial Condition >CRL
CRL,2024-08-07,12:08:38,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Labs International Inc.: the company cut its guidance for 2024,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Shares Fall on Lowered 2024 Outlook
CRL,2024-08-07,13:29:11,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Laboratories slashed its outlook,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024 -- IBD
CRL,2024-08-07,13:29:11,B13B68,Charles River Labs International Inc.,100,-0.27,revenues,down,Charles River expects sales to decline 3% to 5%,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024 -- IBD
CRL,2024-08-07,14:47:09,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Laboratories slashed its outlook,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Plummets 14% On 'Bleaker' Expectations For 2024 -- IBD
CRL,2024-08-07,14:47:09,B13B68,Charles River Labs International Inc.,100,-0.27,revenues,down,Charles River expects sales to decline 3% to 5%,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Plummets 14% On 'Bleaker' Expectations For 2024 -- IBD
CRL,2024-08-07,20:15:39,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Laboratories slashed its outlook,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Plummets 14% On 'Bleaker' Expectations For 2024 -- IBD
CRL,2024-08-07,20:15:39,B13B68,Charles River Labs International Inc.,100,-0.27,revenues,down,Charles River expects sales to decline 3% to 5%,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Plummets 14% On 'Bleaker' Expectations For 2024 -- IBD
CRL,2024-08-08,09:33:37,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Neutral From Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Neutral From Outperform by Baird
CRL,2024-08-08,09:33:37,B13B68,Charles River Labs International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $191.00/Share From $239.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $191.00/Share From $239.00 by Baird
CRL,2024-08-08,11:15:07,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Neutral From Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Neutral From Overweight by JP Morgan
CRL,2024-08-08,11:15:07,B13B68,Charles River Labs International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $205.00/Share From $270.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $205.00/Share From $270.00 by JP Morgan
CRL,2024-08-08,12:16:28,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by Goldman Sachs
CRL,2024-08-08,12:16:28,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $250.00/Share From $290.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $250.00/Share From $290.00 by Goldman Sachs
CRL,2024-08-08,13:13:48,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Evercore ISI Group
CRL,2024-08-08,13:13:48,B13B68,Charles River Labs International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $225.00/Share From $265.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $225.00/Share From $265.00 by Evercore ISI Group
CRL,2024-08-08,14:03:48,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by UBS
CRL,2024-08-08,14:03:48,B13B68,Charles River Labs International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $240.00/Share From $290.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $240.00/Share From $290.00 by UBS
CRL,2024-08-08,17:36:49,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp LaPlume Registers 1,780 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP LaPlume Registers 1,780 Of Charles River Labs Intl Inc >CRL"
CRL,2024-08-08,18:46:38,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Barclays
CRL,2024-08-08,18:46:38,B13B68,Charles River Labs International Inc.,100,-0.74,price-targets,downgrade,Charles River Labs Price Target Cut to $210.00/Share From $230.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $210.00/Share From $230.00 by Barclays
CRL,2024-08-12,15:12:07,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Hold by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Hold by TD Cowen
CRL,2024-08-12,15:12:07,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $203.00/Share From $228.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $203.00/Share From $228.00 by TD Cowen
CRL,2024-08-12,20:14:18,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp LaPlume Sells 1,780 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Sells 1,780 Of Charles River Labs Intl Inc >CRL"
CRL,2024-08-13,20:21:24,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,"Chmn Foster Gifts 2,500 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Gifts 2,500 Of Charles River Labs Intl Inc >CRL"
CRL,2024-08-14,01:00:00,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,GlobeNewswire,"CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm"
CRL,2024-08-22,07:04:04,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 2Q 2024 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 2Q 2024 (CRL)"
CRL,2024-09-03,20:30:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL,2024-09-03,20:30:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL,2024-09-04,12:00:02,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Insightec Announce Strategic Collaboration to Advance,PRESS-RELEASE,Business Wire,Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
CRL,2024-09-04,12:04:01,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Insightec Announce Strategic Collaboration to Advance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
CRL,2024-09-04,13:21:51,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Insightec Announce Strategic Collaboration to Advance,PRESS-RELEASE,PR Newswire,Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
CRL,2024-09-17,12:00:03,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River Laboratories and CEBINA Announce Strategic Collaboration to,PRESS-RELEASE,Business Wire,Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
CRL,2024-09-17,12:00:04,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River Laboratories and CEBINA Announce Strategic Collaboration to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
CRL,2024-09-18,12:30:00,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Biotech and Charles River Laboratories Collaborate to Accelerate,PRESS-RELEASE,GlobeNewswire,Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing
CRL,2024-09-18,12:30:02,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Biotech and Charles River Laboratories Collaborate to Accelerate,PRESS-RELEASE,Dow Jones Newswires,Press Release: Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing
CRL,2024-09-18,12:30:02,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Biotech and Charles River Laboratories Collaborate to Accelerate,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing
CRL,2024-09-20,11:18:15,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Baird
CRL,2024-09-20,11:18:15,B13B68,Charles River Labs International Inc.,100,-0.17,price-targets,downgrade,Charles River Labs Price Target Cut to $190.00/Share From $191.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $190.00/Share From $191.00 by Baird
CRL,2024-10-01,13:39:48,B13B68,Charles River Labs International Inc.,100,-0.98,analyst-ratings,negative,Charles River Labs Cut to Sell From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Sell From Neutral by Citigroup
CRL,2024-10-01,13:39:48,B13B68,Charles River Labs International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $175.00/Share From $215.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $175.00/Share From $215.00 by Citigroup
CRL,2024-10-02,11:32:00,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Neutral From Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Neutral From Buy by B of A Securities
CRL,2024-10-02,11:32:00,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $215.00/Share From $250.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $215.00/Share From $250.00 by B of A Securities
CRL,2024-10-02,12:00:03,B13B68,Charles River Labs International Inc.,100,0.39,products-services,,"Charles River Laboratories International, Inc. (NYSE: CRL) today announced an agreement with H. Lundbeck A/S",PRESS-RELEASE,Business Wire,Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica(R) to Advance the Discovery of Novel Drugs for Neurological Disease
CRL,2024-10-02,12:00:03,B13B68,Charles River Labs International Inc.,100,0.39,products-services,,"Charles River Laboratories International, Inc. (NYSE: CRL) today announced an agreement with H. Lundbeck A/S",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica(R) to Advance the Discovery of Novel Drugs for Neurological Disease
CRL,2024-10-07,11:51:22,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to In-Line From Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to In-Line From Outperform by Evercore ISI Group
CRL,2024-10-07,11:51:22,B13B68,Charles River Labs International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $190.00/Share From $225.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $190.00/Share From $225.00 by Evercore ISI Group
CRL,2024-10-14,16:24:08,B13B68,Charles River Labs International Inc.,100,-0.99,analyst-ratings,negative,Charles River Labs Initiated at Sell,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Initiated at Sell by Redburn Atlantic
CRL,2024-10-14,16:24:08,B13B68,Charles River Labs International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $151.00/Share by Redburn Atlantic,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $151.00/Share by Redburn Atlantic
CRL,2024-10-16,20:30:01,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
CRL,2024-10-16,20:30:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2024 financial results on Wednesday, November 6",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
CRL,2024-10-16,21:27:47,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
CRL,2024-10-16,21:27:47,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2024 financial results on Wednesday, November 6",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
CRL,2024-10-18,12:30:00,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Fibrobiologics and Charles River Announce Collaboration to,PRESS-RELEASE,GlobeNewswire,FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
CRL,2024-10-18,12:30:01,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Fibrobiologics and Charles River Announce Collaboration to,PRESS-RELEASE,Dow Jones Newswires,Press Release: FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
CRL,2024-10-23,10:56:38,B13B68,Charles River Labs International Inc.,100,-0.99,analyst-ratings,negative,Charles River Labs Initiated at Underperform by CLSA,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Initiated at Underperform by CLSA
CRL,2024-10-23,10:56:38,B13B68,Charles River Labs International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $167.00/Share by CLSA,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $167.00/Share by CLSA
CRL,2024-11-05,13:00:02,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Bio and Charles River Announce a Strategic Alliance to Advance,PRESS-RELEASE,Business Wire,NJ Bio and Charles River Announce a Strategic Alliance to Advance ADC Development and Manufacturing Services
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q EPS $1.33,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q EPS $1.33 >CRL
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q Adj EPS $2.59,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Adj EPS $2.59 >CRL
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 3Q Rev $1.01B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Rev $1.01B >CRL
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Third-Quarter 2024 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.02,revenues,,Charles River Labs International Inc.: Third-Quarter Revenue of $1.01 Billion --,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Third-Quarter GAAP Earnings per Share of $1.33,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Third-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $133.7 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $197.8 million in the third quarter of 2024,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,-0.65,revenues,down,Charles River Labs International Inc.: The GAAP operating margin decline,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.62,revenues,up,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,,"Charles River Labs International Inc.: the Company repurchased 500,000 shares during the third quarter of 2024",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,approved,Charles River Labs International Inc.: the Company's Board of Directors approved a new stock repurchase authorization,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2024 guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.10 -- $10.30,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,91,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,009,763 $1,026,623",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,dividends,,Charles River Labs International Inc.: Incremental dividends,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,96,0.65,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Third-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.02,revenues,,Charles River Labs International Inc.: Third-Quarter Revenue of $1.01 Billion --,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Third-Quarter GAAP Earnings per Share of $1.33,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Third-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $133.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $197.8 million in the third quarter of 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,-0.65,revenues,down,Charles River Labs International Inc.: The GAAP operating margin decline,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.62,revenues,up,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,,"Charles River Labs International Inc.: the Company repurchased 500,000 shares during the third quarter of 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,approved,Charles River Labs International Inc.: the Company's Board of Directors approved a new stock repurchase authorization,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2024 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.10 -- $10.30,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2024 Results
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 832,463 $ 869,759",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Earnings per common share Basic $ 1.34 $ 1.70 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 8,003,842 $ 8,195,001",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,91,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,009,763 $1,026,623",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,dividends,,Charles River Labs International Inc.: Incremental dividends,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2024-11-06,12:00:02,B13B68,Charles River Labs International Inc.,96,0.65,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2024-11-06,12:03:47,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees 2024 EPS $5.30,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2024 EPS $5.30-EPS $5.50 >CRL
CRL,2024-11-06,12:04:14,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees 2024 Adj EPS $10.10,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2024 Adj EPS $10.10-Adj EPS $10.30 >CRL
CRL,2024-11-06,12:22:18,B13B68,Charles River Labs International Inc.,95,0.0,earnings,,"Charles River Laboratories International, Inc. issued a press release providing financial results for the third quarter ended September 28, 2024",RNS-SEC8K,Dow Jones Newswires,Charles River Labs Files 8K - Operations And Financial Condition >CRL
CRL,2024-11-07,13:55:33,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at In-Line by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at In-Line by Evercore ISI Group
CRL,2024-11-07,13:55:33,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $225.00/Share From $190.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $225.00/Share From $190.00 by Evercore ISI Group
CRL,2024-11-07,16:09:33,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by UBS
CRL,2024-11-07,16:09:34,B13B68,Charles River Labs International Inc.,100,0.5,price-targets,upgrade,Charles River Labs Price Target Raised to $250.00/Share From $240.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $250.00/Share From $240.00 by UBS
CRL,2024-11-07,21:27:40,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Dir Wallman Registers 12,161 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Dir Wallman Registers 12,161 Of Charles River Labs Intl Inc >CRL"
CRL,2024-11-08,23:23:13,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Barbo Gifts 470 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,VP Barbo Gifts 470 Of Charles River Labs Intl Inc >CRL
CRL,2024-11-11,13:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the UBS Global Healthcare Conference on Tuesday, November 12",PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at UBS and Jefferies Conferences
CRL,2024-11-11,13:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the UBS Global Healthcare Conference on Tuesday, November 12",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at UBS and Jefferies Conferences
CRL,2024-11-11,16:00:13,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Hold by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Hold by TD Cowen
CRL,2024-11-11,16:00:13,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $227.00/Share From $203.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $227.00/Share From $203.00 by TD Cowen
CRL,2024-11-12,21:41:26,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Dir Wallman Sells 7,621 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Wallman Sells 7,621 Of Charles River Labs Intl Inc >CRL"
CRL,2024-11-12,22:26:15,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,"Chmn Foster Gifts 4,500 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Gifts 4,500 Of Charles River Labs Intl Inc >CRL"
CRL,2024-11-22,08:02:53,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 3Q 2024 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 3Q 2024 (CRL)"
CRL,2024-12-02,13:00:00,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Evercore ISI Investor Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Evercore ISI Investor Conference
CRL,2024-12-02,13:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Evercore ISI Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Evercore ISI Investor Conference
CRL,2024-12-05,13:00:01,B13B68,Charles River Labs International Inc.,99,0.41,assets,open,Charles River Introduces Global Biotech Incubator,PRESS-RELEASE,Business Wire,Charles River Introduces Global Biotech Incubator Program
CRL,2024-12-05,13:00:01,B13B68,Charles River Labs International Inc.,99,0.41,assets,open,Charles River Introduces Global Biotech Incubator,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Introduces Global Biotech Incubator Program
CRL,2024-12-13,16:21:14,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by B of A Securities
CRL,2024-12-13,16:21:14,B13B68,Charles River Labs International Inc.,100,-0.56,price-targets,downgrade,Charles River Labs Price Target Cut to $210.00/Share From $220.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $210.00/Share From $220.00 by B of A Securities
CRL,2024-12-13,21:46:30,B13B68,Charles River Labs International Inc.,100,0.38,credit,,Charles River Laboratories International Amends Credit,RNS-SEC8K,Dow Jones Newswires,"Charles River Laboratories International Amends Credit Agreement, Extending Maturity to Dec. 2029 and Reducing Revolving Commitments to $2B From $3B"
CRL,2021-01-04,12:00:06,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories Acquires Distributed Bio >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Acquires Distributed Bio >CRL
CRL,2021-01-04,12:00:08,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Distributed Bio expands Charles River,PRESS-RELEASE,Business Wire,Charles River Laboratories Acquires Distributed Bio
CRL,2021-01-04,12:00:08,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Distributed Bio expands Charles River,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Acquires Distributed Bio
CRL,2021-01-04,12:06:07,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories Buys Distributed Bio for $83 Million,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Buys Distributed Bio for $83 Million >CRL
CRL,2021-01-04,13:59:40,B13B68,Charles River Laboratories International Inc.,94,0.62,acquisitions-mergers,,Charles River Laboratories International Inc. on Monday said it has acquired antibody-discovery company Distributed Bio Inc. for $,FULL-ARTICLE,Dow Jones Newswires,Charles River Buys Distributed Bio for Initial $83 Million >CRL
CRL,2021-01-04,13:59:40,B13B68,Charles River Laboratories International Inc.,94,0.49,partnerships,,"Charles River formed an exclusive partnership with Distributed Bio, based in South San Francisco, Calif",FULL-ARTICLE,Dow Jones Newswires,Charles River Buys Distributed Bio for Initial $83 Million >CRL
CRL,2021-01-05,22:23:38,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Cfo Smith Sells 5,000 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Sells 5,000 Of Charles River Labs Intl Inc >CRL"
CRL,2021-01-05,23:11:12,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Cfo Smith Registers 16,516 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"CFO Smith Registers 16,516 Of Charles River Labs Intl Inc >CRL"
CRL,2021-01-11,13:00:24,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2021-01-11,13:06:48,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2021-01-12,16:48:26,B13B68,Charles River Laboratories International Inc.,91,0.46,equity-actions,,Charles River Laboratories International Inc.: 9 Investing in North America,PRESS-RELEASE,Business Wire,"North American CDMO Industry to 2030 - Players Include Aenova Group, Baxter BioPharma Solutions and Charles River Laboratories Among Others - ResearchAndMarkets.com"
CRL,2021-01-14,13:00:29,B13B68,Charles River Laboratories International Inc.,99,0.41,assets,open,Charles River Laboratories International Inc.: The new facility,PRESS-RELEASE,Business Wire,Charles River Partners with JADE Biomedical to Expand Biologics Capabilities
CRL,2021-01-14,13:04:51,B13B68,Charles River Laboratories International Inc.,99,0.41,assets,open,Charles River Laboratories International Inc.: The new facility,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Partners with JADE Biomedical to Expand Biologics Capabilities
CRL,2021-01-20,13:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
CRL,2021-01-20,13:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2020 financial results and provide 2021 guidance on Wednesday, February 17",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
CRL,2021-01-20,13:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2020 financial results and provide 2021 guidance on Wednesday, February 17",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
CRL,2021-01-20,13:33:09,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
CRL,2021-01-20,13:33:09,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2020 financial results and provide 2021 guidance on Wednesday, February 17",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
CRL,2021-01-20,13:33:09,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2020 financial results and provide 2021 guidance on Wednesday, February 17",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
CRL,2021-01-21,09:05:40,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 4Q 2020 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 4Q 2020 (CRL)"
CRL,2021-01-28,13:00:03,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,"Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for",PRESS-RELEASE,Business Wire,"Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening"
CRL,2021-01-28,13:00:16,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,"Charles River Announces Strategic Partnership With Cypre, Expanding 3D in Vitro Services for",NEWS-FLASH,Dow Jones Newswires,"Charles River Announces Strategic Partnership With Cypre, Expanding 3D in Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening"
CRL,2021-01-28,13:07:50,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,"Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening"
CRL,2021-02-02,15:51:25,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Barbo Acquires 7,154 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Acquires 7,154 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-02,15:53:36,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Cfo Smith Acquires 10,439 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Acquires 10,439 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-02,16:10:00,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Chmn Foster Acquires 42,376 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Acquires 42,376 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-02,16:19:12,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Girshick Acquires 7,153 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Girshick Acquires 7,153 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-02,16:36:23,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Knell Acquires 2,209 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Knell Acquires 2,209 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-02,16:42:22,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 251 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 251 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-02,16:47:07,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp LaPlume Acquires 7,154 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Acquires 7,154 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-02,16:58:11,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Dir Massaro Gifts 700 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,Dir Massaro Gifts 700 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-05,22:00:30,B13B68,Charles River Laboratories International Inc.,100,0.0,credit-ratings,action,"Moody's Announces Completion Of A Periodic Review Of Ratings Of Charles River Laboratories Int'l, Inc.",NEWS-FLASH,Dow Jones Newswires,"Moody's Announces Completion Of A Periodic Review Of Ratings Of Charles River Laboratories Int'l, Inc."
CRL,2021-02-08,13:05:13,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,Algernon Pharmaceuticals Signs Agreement with Charles River Laboratories,PRESS-RELEASE,GlobeNewswire,Algernon Pharmaceuticals Signs Agreement with Charles River Laboratories for DMT Preclinical Studies
CRL,2021-02-08,13:05:14,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,Algernon Pharmaceuticals Signs Agreement with Charles River Laboratories,PRESS-RELEASE,Dow Jones Newswires,Press Release: Algernon Pharmaceuticals Signs Agreement with Charles River Laboratories for DMT Preclinical Studies
CRL,2021-02-08,13:05:24,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,Algernon Pharmaceuticals Signs Agreement With Charles River Laboratories,NEWS-FLASH,Dow Jones Newswires,Algernon Pharmaceuticals Signs Agreement With Charles River Laboratories for DMT Preclinical Studies
CRL,2021-02-12,22:36:08,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Chmn Foster Registers 30,000 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Chmn Foster Registers 30,000 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-16,16:59:59,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 30,000 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Sells 30,000 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-17,12:06:00,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories To Acquire Cognate BioServices To Create,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories To Acquire Cognate BioServices To Create A Premier Scientific Partner For Cell And Gene Therapy Development >CRL
CRL,2021-02-17,12:06:00,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories to Acquire Cognate BioServices to Create,PRESS-RELEASE,Business Wire,Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development
CRL,2021-02-17,12:06:00,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories to Acquire Cognate,PRESS-RELEASE,Business Wire,Charles River Laboratories to Acquire Cognate -2-
CRL,2021-02-17,12:06:01,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Press Release: Charles River Laboratories to Acquire Cognate BioServices,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development
CRL,2021-02-17,12:07:34,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Labs To Acquire Cognate BioServices for $875M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs To Acquire Cognate BioServices for $875M in Cash >CRL
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q EPS $2.81,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q EPS $2.81 >CRL
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q Net $143.2M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Net $143.2M >CRL
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $791.0 million, an increase of 14.4%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Fourth-Quarter GAAP Earnings per Share of $2.81,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Full-Year GAAP Earnings per Share of $7.20,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Provides 2021 Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: Announces Definitive Agreement to Acquire Cognate BioServices,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Fourth-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,90,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: GAAP earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $156.7 million in the fourth quarter of 2020,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For 2020, Manufacturing revenue was $515.4 million, an increase of 10.8%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,100,-0.24,revenues,down,Charles River Laboratories International Inc.: Organic revenue growth declined by 3.3%,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: 2021 GUIDANCE,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 12%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: GAAP EPS estimate (3) $7.10,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $9.00,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $ 618,229 $ 549,380 $",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,91,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 5,490,831 $ 4,692,790",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,91,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2021-02-17,12:08:00,B13B68,Charles River Laboratories International Inc.,90,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $ 790,990 $ 691,138 $",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -7-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 14.4 %",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -7-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,96,0.0,revenues,,Charles River Laboratories International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -8-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $791.0 million, an increase of 14.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Fourth-Quarter GAAP Earnings per Share of $2.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Full-Year GAAP Earnings per Share of $7.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Provides 2021 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: Announces Definitive Agreement to Acquire Cognate BioServices,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Fourth-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: GAAP earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $156.7 million in the fourth quarter of 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For 2020, Manufacturing revenue was $515.4 million, an increase of 10.8%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,100,-0.24,revenues,down,Charles River Laboratories International Inc.: Organic revenue growth declined by 3.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: 2021 GUIDANCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 12%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: GAAP EPS estimate (3) $7.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $9.00,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $ 618,229 $ 549,380 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,91,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 5,490,831 $ 4,692,790",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,91,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,90,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,90,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $ 790,990 $ 691,138 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -7-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 14.4 %",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -7-
CRL,2021-02-17,12:08:01,B13B68,Charles River Laboratories International Inc.,95,0.0,revenues,,Charles River Laboratories International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -8-
CRL,2021-02-17,12:08:15,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 4Q Rev $791M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Rev $791M >CRL
CRL,2021-02-17,12:08:40,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q Adj EPS $2.39,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Adj EPS $2.39 >CRL
CRL,2021-02-17,12:09:51,B13B68,Charles River Laboratories International Inc.,100,0.48,revenues,up,Charles River Labs Sees 2021 Revenue Growth of 12%-14%,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2021 Revenue Growth of 12%-14% >CRL
CRL,2021-02-17,12:10:20,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Labs Sees 2021 EPS $7.10,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2021 EPS $7.10-EPS $7.35 >CRL
CRL,2021-02-17,12:10:40,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Labs Sees 2021 Adj EPS $9,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2021 Adj EPS $9-Adj EPS $9.25 >CRL
CRL,2021-02-17,12:21:16,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories to Buy Cognate BioServices for About $875M,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories to Buy Cognate BioServices for About $875M
CRL,2021-02-17,12:33:08,B13B68,Charles River Laboratories International Inc.,100,0.7,earnings,above-expectations,Charles River Laboratories' 4Q Results Top Estimates,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories' 4Q Results Top Estimates
CRL,2021-02-17,12:43:13,B13B68,Charles River Laboratories International Inc.,100,0.48,revenues,up,Charles River Laboratories Sees 2021 Revenue Growth Between 12%,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Sees 2021 Revenue Growth Between 12% and 14%
CRL,2021-02-17,12:43:13,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,Charles River also said it expects revenue to increase between 12% and 14%,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Sees 2021 Revenue Growth Between 12% and 14%
CRL,2021-02-17,12:43:13,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River expects 2021 adjusted earnings,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Sees 2021 Revenue Growth Between 12% and 14%
CRL,2021-02-17,15:54:06,B13B68,Charles River Laboratories International Inc.,99,0.41,assets,open,Charles River Laboratories International Inc.: The new facility,PRESS-RELEASE,GlobeNewswire,Dresner Partners Advised JADE Biomedical (China) on Investment by and Partnership with Charles River Labs
CRL,2021-02-17,18:15:05,B13B68,Charles River Laboratories International Inc.,97,0.0,products-services,,Charles River Laboratories International Inc.: CELL LINE DEVELOPMENT SERVICE,PRESS-RELEASE,PR Newswire,"Worldwide Cell Line Development and Characterization Services Industry to 2030 - Featuring BioReliance, Charles River Laboratories & Molecular Diagnostic Services Among Many More"
CRL,2021-02-17,20:27:39,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories International, Inc. CEO Jim Foster on Q4 2020 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO Jim Foster on Q4 2020 Results -- Earnings Call Transcript >CRL"
CRL,2021-02-17,20:27:39,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles-river-laboratories-international-inc-crl-ceo-jim-foster-on-q4-2020-results-earnings,NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO Jim Foster on Q4 2020 Results -- Earnings Call Transcript >CRL"
CRL,2021-02-18,16:06:19,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by Deutsche Bank
CRL,2021-02-18,16:06:19,B13B68,Charles River Laboratories International Inc.,100,0.8,price-targets,upgrade,Charles River Labs Price Target Raised to $334.00/Share From $250.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $334.00/Share From $250.00 by Deutsche Bank
CRL,2021-02-18,16:22:59,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by Truist Securities
CRL,2021-02-18,16:22:59,B13B68,Charles River Laboratories International Inc.,100,0.8,price-targets,upgrade,Charles River Labs Price Target Raised to $324.00/Share From $256.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $324.00/Share From $256.00 by Truist Securities
CRL,2021-02-19,14:30:43,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Morgan Stanley
CRL,2021-02-19,14:30:43,B13B68,Charles River Laboratories International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $350.00/Share From $280.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $350.00/Share From $280.00 by Morgan Stanley
CRL,2021-02-22,14:06:50,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Morgan Stanley
CRL,2021-02-22,14:06:50,B13B68,Charles River Laboratories International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $350.00/Share From $280.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $350.00/Share From $280.00 by Morgan Stanley
CRL,2021-02-23,16:18:07,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Girshick Registers 14,916 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Girshick Registers 14,916 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-23,16:18:27,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Cfo Smith Sells 8,656 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Sells 8,656 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-23,16:20:31,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Officer Smith Registers 8,656 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 8,656 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-23,16:29:45,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Vp Knell Registers 410 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP Knell Registers 410 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-23,16:33:53,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,Vp Knell Sells 410 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Sells 410 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-23,16:42:35,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Girshick Sells 1,675 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Girshick Sells 1,675 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-24,15:34:52,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 121 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 121 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-24,15:42:49,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 632 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Surrenders 632 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-24,16:05:51,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,Dir Chubb Sells 658 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Chubb Sells 658 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-24,16:14:12,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 37,731 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Sells 37,731 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-24,16:21:35,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Cfo Smith Surrenders 399 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,CFO Smith Surrenders 399 Of Charles River Labs Intl Inc >CRL-Amended
CRL,2021-02-24,16:36:51,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 602 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 602 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-24,18:09:15,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Chmn Foster Registers 61,740 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Chmn Foster Registers 61,740 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-24,23:39:15,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Dir Chubb Registers 658 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,Dir Chubb Registers 658 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-25,13:00:00,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River Laboratories Announces Strategic Partnership with Kibur Medical to,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies
CRL,2021-02-25,13:00:01,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River Laboratories Announces Strategic Partnership with Kibur Medical to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies
CRL,2021-02-25,13:00:39,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River Laboratories Announces Strategic Partnership With Kibur Medical to,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Announces Strategic Partnership With Kibur Medical to Advance Preclinical Oncology Studies
CRL,2021-02-25,20:26:15,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Cfo Smith Surrenders 289 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,CFO Smith Surrenders 289 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-25,20:28:01,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 322 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Surrenders 322 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-25,21:15:57,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 322 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 322 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-25,21:24:27,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 24,009 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Sells 24,009 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-25,22:25:17,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Girshick Surrenders 322 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Girshick Surrenders 322 Of Charles River Labs Intl Inc >CRL
CRL,2021-02-26,21:05:46,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp LaPlume Registers 8,735 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP LaPlume Registers 8,735 Of Charles River Labs Intl Inc >CRL"
CRL,2021-02-26,22:05:54,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp LaPlume Sells 8,735 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Sells 8,735 Of Charles River Labs Intl Inc >CRL"
CRL,2021-03-02,21:38:43,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Barbo Sells 4,650 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Sells 4,650 Of Charles River Labs Intl Inc >CRL"
CRL,2021-03-02,21:42:43,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Cfo Smith Sells 4,366 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Sells 4,366 Of Charles River Labs Intl Inc >CRL"
CRL,2021-03-02,21:48:09,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Dir Milne Jr Sells 3,530 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Milne Jr Sells 3,530 Of Charles River Labs Intl Inc >CRL"
CRL,2021-03-02,23:59:27,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Barbo Registers 4,650 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Barbo Registers 4,650 Of Charles River Labs Intl Inc >CRL"
CRL,2021-03-02,23:59:47,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Cfo Smith Registers 4,366 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"CFO Smith Registers 4,366 Of Charles River Labs Intl Inc >CRL"
CRL,2021-03-03,00:30:08,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Dir Milne Jr Registers 3,530 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Dir Milne Jr Registers 3,530 Of Charles River Labs Intl Inc >CRL"
CRL,2021-03-08,13:30:00,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Barclays Global Healthcare Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL,2021-03-08,13:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL,2021-03-08,14:15:01,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes
CRL,2021-03-08,14:15:01,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes
CRL,2021-03-08,14:15:10,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes
CRL,2021-03-08,14:33:30,B13B68,Charles River Laboratories International Inc.,100,-0.16,credit-ratings,set,S&PGR Rates Charles River Laboratories' Proposed Notes 'BB,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Charles River Laboratories' Proposed Notes 'BB'
CRL,2021-03-08,14:33:30,B13B68,Charles River Laboratories International Inc.,100,-0.16,credit-ratings,set,S&PGR Rates Charles River Laboratories' Proposed Notes 'BB,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Charles River Laboratories' Proposed Notes 'BB'
CRL,2021-03-08,16:08:08,B13B68,Charles River Laboratories International Inc.,100,-0.16,credit-ratings,set,Moody's Assigns Ba2 Ratings To Charles River's New Senior Unsecured Notes,NEWS-FLASH,Dow Jones Newswires,Moody's Assigns Ba2 Ratings To Charles River's New Senior Unsecured Notes
CRL,2021-03-09,13:00:04,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Laboratories Prices $1 Billion of Senior Notes,PRESS-RELEASE,Business Wire,Charles River Laboratories Prices $1 Billion of Senior Notes
CRL,2021-03-09,13:00:04,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Laboratories Prices $1 Billion of Senior Notes,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Prices $1 Billion of Senior Notes
CRL,2021-03-09,13:02:31,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Laboratories Prices $1B of Senior Notes,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Prices $1B of Senior Notes
CRL,2021-03-09,13:03:04,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Labs Offering $500M of 3.750% Senior Notes Due 2029,NEWS-FLASH,Dow Jones Newswires,"Charles River Labs Offering $500M of 3.750% Senior Notes Due 2029, $500M of 4.000% Senior Notes Due 2031 >CRL"
CRL,2021-03-23,20:30:00,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Laboratories Announces Closing of Senior Notes Offering,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Closing of Senior Notes Offering
CRL,2021-03-23,20:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Laboratories Announces Closing of Senior Notes Offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Closing of Senior Notes Offering
CRL,2021-03-23,20:30:48,B13B68,Charles River Laboratories International Inc.,100,0.0,credit,,Charles River Laboratories Announces Closing of Senior Notes Offering,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Announces Closing of Senior Notes Offering
CRL,2021-03-29,20:15:00,B13B68,Charles River Laboratories International Inc.,100,0.57,acquisitions-mergers,completed,Charles River Laboratories Completes The Acquisition Of Cognate BioServices,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Completes The Acquisition Of Cognate BioServices >CRL
CRL,2021-03-29,20:15:00,B13B68,Charles River Laboratories International Inc.,100,0.57,acquisitions-mergers,completed,Charles River Laboratories Completes the Acquisition of Cognate BioServices,PRESS-RELEASE,Business Wire,Charles River Laboratories Completes the Acquisition of Cognate BioServices
CRL,2021-03-29,20:15:01,B13B68,Charles River Laboratories International Inc.,100,0.57,acquisitions-mergers,completed,Charles River Laboratories Completes the Acquisition of Cognate BioServices,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Completes the Acquisition of Cognate BioServices
CRL,2021-03-29,20:15:54,B13B68,Charles River Laboratories International Inc.,100,0.57,acquisitions-mergers,completed,Charles River Laboratories Completes Acquisition of Cognate BioServices,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Completes Acquisition of Cognate BioServices for About $875M >CRL
CRL,2021-03-31,11:00:00,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories Acquires Retrogenix >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Acquires Retrogenix >CRL
CRL,2021-03-31,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.76,products-services,,"Charles River Laboratories International Inc.: uncover novel, high-quality and exploitable drug",PRESS-RELEASE,Business Wire,Charles River Laboratories Acquires Retrogenix
CRL,2021-03-31,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Retrogenix enhances Charles River,PRESS-RELEASE,Business Wire,Charles River Laboratories Acquires Retrogenix
CRL,2021-03-31,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.76,products-services,,"Charles River Laboratories International Inc.: uncover novel, high-quality and exploitable drug",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Acquires Retrogenix
CRL,2021-03-31,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Retrogenix enhances Charles River,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Acquires Retrogenix
CRL,2021-03-31,11:01:34,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Labs Buys Retrogenix for About $48 Million,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Buys Retrogenix for About $48 Million >CRL
CRL,2021-04-06,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,"Charles River Laboratories International, Inc. (NYSE: CRL) and Valence Discovery today announced the formation of a strategic partnership to",PRESS-RELEASE,Business Wire,Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities
CRL,2021-04-06,12:00:45,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Valence Discovery Announce Strategic Partnership to,NEWS-FLASH,Dow Jones Newswires,Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients With AI-Enabled Drug Design Capabilities
CRL,2021-04-06,12:08:42,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,"Charles River Laboratories International, Inc. (NYSE: CRL) and Valence Discovery today announced the formation of a strategic partnership to",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities
CRL,2021-04-06,18:47:53,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Girshick Registers 6,985 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Girshick Registers 6,985 Of Charles River Labs Intl Inc >CRL"
CRL,2021-04-07,15:27:41,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Girshick Sells 19,310 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Girshick Sells 19,310 Of Charles River Labs Intl Inc >CRL"
CRL,2021-04-07,18:29:42,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Girshick Registers 12,325 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Girshick Registers 12,325 Of Charles River Labs Intl Inc >CRL"
CRL,2021-04-13,12:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
CRL,2021-04-13,12:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2021 financial results on Tuesday, May 4",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
CRL,2021-04-13,12:31:29,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
CRL,2021-04-13,12:31:29,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2021 financial results on Tuesday, May 4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
CRL,2021-04-16,19:24:40,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Cfo Smith Sells 2,000 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Sells 2,000 Of Charles River Labs Intl Inc >CRL"
CRL,2021-04-16,21:03:08,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Cfo Smith Registers 2,000 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"CFO Smith Registers 2,000 Of Charles River Labs Intl Inc >CRL"
CRL,2021-04-22,07:05:20,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 1Q 2021 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 1Q 2021 (CRL)"
CRL,2021-04-23,16:59:50,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Cfo Smith Registers 7,150 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"CFO Smith Registers 7,150 Of Charles River Labs Intl Inc >CRL"
CRL,2021-04-26,17:10:27,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Cfo Smith Sells 3,845 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Sells 3,845 Of Charles River Labs Intl Inc >CRL"
CRL,2021-05-04,11:00:00,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q EPS $1.20,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q EPS $1.20 >CRL
CRL,2021-05-04,11:00:00,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q Net $61.5M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Net $61.5M >CRL
CRL,2021-05-04,11:00:00,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 1Q Rev $824.6M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Rev $824.6M >CRL
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces First-Quarter 2021 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.63,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $824.6 million, an increase of 16.6%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: First-Quarter GAAP Earnings per Share of $1.20,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $176.9 million in the first quarter of 2021,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: the Company provided 2021 financial guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Cognate,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $9.75,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,marketing,,Charles River will virtually present at the Bank of America 2021 Health Care Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $ 626,581 $ 546,592",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 5,808,963 $ 5,490,831",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $ 824,566 $ 707,059",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2021-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 16.6 %",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.63,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $824.6 million, an increase of 16.6%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: First-Quarter GAAP Earnings per Share of $1.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $176.9 million in the first quarter of 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: the Company provided 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Cognate,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $9.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2021 Results
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,marketing,,Charles River will virtually present at the Bank of America 2021 Health Care Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,98,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $ 626,581 $ 546,592",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,98,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 5,808,963 $ 5,490,831",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,92,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $ 824,566 $ 707,059",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2021-05-04,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 16.6 %",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2021-05-04,11:03:18,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Labs Sees 2021 EPS $5.95,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2021 EPS $5.95-EPS $6.20 >CRL
CRL,2021-05-04,11:03:44,B13B68,Charles River Laboratories International Inc.,100,0.7,earnings,up,Charles River Labs Raises 2021 View To Adj EPS $9.75,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raises 2021 View To Adj EPS $9.75-Adj EPS $10 >CRL
CRL,2021-05-04,11:04:22,B13B68,Charles River Laboratories International Inc.,100,0.48,revenues,up,Charles River Labs Expects 2021 Revenue Growth 19%-21%,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Expects 2021 Revenue Growth 19%-21% Vs $16%-18% Previously >CRL
CRL,2021-05-04,20:00:15,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 93 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Surrenders 93 Of Charles River Labs Intl Inc >CRL
CRL,2021-05-04,20:52:10,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories International, Inc. CEO Jim Foster on Q1 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO Jim Foster on Q1 2021 Results -- Earnings Call Transcript >CRL"
CRL,2021-05-04,20:52:10,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles-river-laboratories-international-inc-crl-ceo-jim-foster-on-q1-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO Jim Foster on Q1 2021 Results -- Earnings Call Transcript >CRL"
CRL,2021-05-06,17:22:58,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Cfo Smith Sells 3,305 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Sells 3,305 Of Charles River Labs Intl Inc >CRL"
CRL,2021-05-07,17:23:51,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Dir Massaro Sells 3,370 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Massaro Sells 3,370 Of Charles River Labs Intl Inc >CRL"
CRL,2021-05-07,21:32:40,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Dir Massaro Registers 3,370 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Dir Massaro Registers 3,370 Of Charles River Labs Intl Inc >CRL"
CRL,2021-05-10,21:14:56,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 7,500 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Sells 7,500 Of Charles River Labs Intl Inc >CRL"
CRL,2021-05-10,21:30:18,B13B68,Charles River Laboratories International Inc.,100,0.58,indexes,,Charles River Laboratories to Join S&P 500,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories to Join S&P 500
CRL,2021-05-10,21:41:50,B13B68,Charles River Laboratories International Inc.,100,0.58,indexes,,Charles River Laboratories International Inc. will replace Flir Systems Inc. in the S&P 500,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories International to Join S&P 500
CRL,2021-05-10,22:37:39,B13B68,Charles River Laboratories International Inc.,100,0.58,indexes,,Charles River Laboratories International (NYSE:CRL) will replace FLIR Systems Inc. (NASD:FLIR) in the S&P 500,PRESS-RELEASE,PR Newswire,Charles River Laboratories International Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
CRL,2021-05-10,22:37:39,B13B68,Charles River Laboratories International Inc.,100,0.58,indexes,,Charles River Laboratories International (NYSE:CRL) will replace FLIR Systems Inc. (NASD:FLIR) in the S&P 500,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories International Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
CRL,2021-05-10,23:23:36,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Chmn Foster Registers 7,500 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Chmn Foster Registers 7,500 Of Charles River Labs Intl Inc >CRL"
CRL,2021-05-12,18:44:47,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Dir Massaro Registers 371 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,Dir Massaro Registers 371 Of Charles River Labs Intl Inc >CRL
CRL,2021-05-12,20:47:06,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,Dir Massaro Sells 371 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Massaro Sells 371 Of Charles River Labs Intl Inc >CRL
CRL,2021-05-14,09:49:54,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Keybanc
CRL,2021-05-14,09:49:54,B13B68,Charles River Laboratories International Inc.,100,0.62,price-targets,upgrade,Charles River Labs Price Target Raised to $360.00/Share From $340.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $360.00/Share From $340.00 by Keybanc
CRL,2021-05-17,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.84,acquisitions-mergers,,Charles River Laboratories to Acquire Vigene Biosciences to Enhance,PRESS-RELEASE,Business Wire,Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
CRL,2021-05-17,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.84,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Vigene Biosciences will enhance,PRESS-RELEASE,Business Wire,Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
CRL,2021-05-17,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.65,revenues,up,Charles River's reported revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
CRL,2021-05-17,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.84,acquisitions-mergers,,Charles River Laboratories to Acquire Vigene Biosciences to Enhance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
CRL,2021-05-17,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.84,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Vigene Biosciences will enhance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
CRL,2021-05-17,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.65,revenues,up,Charles River's reported revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
CRL,2021-05-17,11:00:13,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories to Acquire Vigene Biosciences to Enhance,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
CRL,2021-05-17,11:36:17,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River to Buy Vigene Biosciences for $292.5 Million,FULL-ARTICLE,Dow Jones Newswires,Charles River to Buy Vigene Biosciences for $292.5 Million >CRL
CRL,2021-05-17,11:36:17,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River said Vigene expects revenue of $30 million to $35 million,FULL-ARTICLE,Dow Jones Newswires,Charles River to Buy Vigene Biosciences for $292.5 Million >CRL
CRL,2021-05-17,20:20:54,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Dir Chubb Registers 1,269 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Dir Chubb Registers 1,269 Of Charles River Labs Intl Inc >CRL"
CRL,2021-05-25,11:31:02,B13B68,Charles River Laboratories International Inc.,100,0.78,price-targets,upgrade,Charles River Laboratories stock price target raised to $369 from $324,NEWS-FLASH,MarketWatch,MW Charles River Laboratories stock price target raised to $369 from $324 at Truist
CRL,2021-05-25,13:34:18,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by Truist Securities
CRL,2021-05-25,13:34:18,B13B68,Charles River Laboratories International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $369.00/Share From $324.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $369.00/Share From $324.00 by Truist Securities
CRL,2021-05-28,12:00:00,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Participate in June Investor Conferences,PRESS-RELEASE,Business Wire,Charles River Laboratories to Participate in June Investor Conferences
CRL,2021-05-28,12:02:14,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Participate in June Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Participate in June Investor Conferences
CRL,2021-05-28,13:11:44,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by JP Morgan
CRL,2021-05-28,13:11:44,B13B68,Charles River Laboratories International Inc.,100,0.5,price-targets,upgrade,Charles River Labs Price Target Raised to $390.00/Share From $375.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $390.00/Share From $375.00 by JP Morgan
CRL,2021-05-28,13:24:44,B13B68,Charles River Laboratories International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Credit Suisse
CRL,2021-05-28,13:24:45,B13B68,Charles River Laboratories International Inc.,100,0.44,price-targets,upgrade,Charles River Labs Price Target Raised to $352.00/Share From $342.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $352.00/Share From $342.00 by Credit Suisse
CRL,2021-05-28,14:27:35,B13B68,Charles River Laboratories International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Citigroup
CRL,2021-05-28,14:27:35,B13B68,Charles River Laboratories International Inc.,100,0.3,price-targets,upgrade,Charles River Labs Price Target Raised to $355.00/Share From $350.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $355.00/Share From $350.00 by Citigroup
CRL,2021-06-01,21:54:52,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 201 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 201 Of Charles River Labs Intl Inc >CRL
CRL,2021-06-01,21:57:35,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 127 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 127 Of Charles River Labs Intl Inc >CRL
CRL,2021-06-01,21:59:22,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Girshick Surrenders 216 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Girshick Surrenders 216 Of Charles River Labs Intl Inc >CRL
CRL,2021-06-01,22:03:27,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 54 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Surrenders 54 Of Charles River Labs Intl Inc >CRL
CRL,2021-06-01,22:04:44,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 223 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Surrenders 223 Of Charles River Labs Intl Inc >CRL
CRL,2021-06-02,14:36:19,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,"Chmn Foster Surrenders 1,273 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Surrenders 1,273 Of Charles River Labs Intl Inc >CRL"
CRL,2021-06-02,18:44:31,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Chmn Foster Registers 9,577 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Chmn Foster Registers 9,577 Of Charles River Labs Intl Inc >CRL"
CRL,2021-06-03,16:49:38,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 9,577 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Sells 9,577 Of Charles River Labs Intl Inc >CRL"
CRL,2021-06-04,13:35:28,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,Vp Knell Sells 800 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Sells 800 Of Charles River Labs Intl Inc >CRL
CRL,2021-06-04,19:08:40,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Knell Registers 1,923 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Knell Registers 1,923 Of Charles River Labs Intl Inc >CRL"
CRL,2021-06-07,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.34,products-services,,Charles River has chosen Duke Energy Sustainable Solutions,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Long-Term Solar Contract for North American Operations
CRL,2021-06-07,12:05:21,B13B68,Charles River Laboratories International Inc.,99,0.34,products-services,,Charles River has chosen Duke Energy Sustainable Solutions,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Long-Term Solar Contract for North American Operations
CRL,2021-06-07,20:05:30,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Vp Knell Registers 404 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP Knell Registers 404 Of Charles River Labs Intl Inc >CRL
CRL,2021-06-07,22:24:28,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Knell Sells 1,527 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Knell Sells 1,527 Of Charles River Labs Intl Inc >CRL"
CRL,2021-06-29,11:00:00,B13B68,Charles River Laboratories International Inc.,100,0.57,acquisitions-mergers,completed,Charles River Laboratories Completes Acquisition Of Vigene Biosciences >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Completes Acquisition Of Vigene Biosciences >CRL
CRL,2021-06-29,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.57,acquisitions-mergers,completed,Charles River Laboratories Completes Acquisition of Vigene Biosciences,PRESS-RELEASE,Business Wire,Charles River Laboratories Completes Acquisition of Vigene Biosciences
CRL,2021-06-29,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.57,acquisitions-mergers,completed,Charles River Laboratories Completes Acquisition of Vigene Biosciences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Completes Acquisition of Vigene Biosciences
CRL,2021-07-13,12:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call
CRL,2021-07-13,12:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2021 financial results on Wednesday, August 4",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call
CRL,2021-07-13,12:32:26,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call
CRL,2021-07-13,12:32:26,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2021 financial results on Wednesday, August 4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call
CRL,2021-07-20,12:33:12,B13B68,Charles River Laboratories International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Credit Suisse
CRL,2021-07-20,12:33:12,B13B68,Charles River Laboratories International Inc.,100,0.76,price-targets,upgrade,Charles River Labs Price Target Raised to $385.00/Share From $352.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $385.00/Share From $352.00 by Credit Suisse
CRL,2021-07-22,07:24:58,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 2Q 2021 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 2Q 2021 (CRL)"
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q EPS $1.72,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q EPS $1.72 >CRL
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Net $88.4M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Net $88.4M >CRL
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 2Q Rev $914.6M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Rev $914.6M >CRL
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Second-Quarter 2021 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.5,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $914.6 million, an increase of 34.0%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Second-Quarter GAAP Earnings per Share of $1.72,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.7,earnings,up,Charles River Laboratories International Inc.: Increases 2021 Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $133.8 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $176.7 million in the second quarter of 2021,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Laboratories International Inc.: The Company's increased guidance for revenue,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $10.10,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,revenues,,Charles River Laboratories International Inc.: estimated revenue,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $715,320 $550,561",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 6,720,352 $ 5,490,831",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,91,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,91,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $914,607 $682,584",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2021-08-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.5,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 34.0%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.5,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $914.6 million, an increase of 34.0%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Second-Quarter GAAP Earnings per Share of $1.72,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.7,earnings,up,Charles River Laboratories International Inc.: Increases 2021 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $133.8 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $176.7 million in the second quarter of 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Laboratories International Inc.: The Company's increased guidance for revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $10.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2021 Results
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,98,0.0,revenues,,Charles River Laboratories International Inc.: estimated revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,98,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $715,320 $550,561",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,98,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 6,720,352 $ 5,490,831",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,91,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,91,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $914,607 $682,584",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2021-08-04,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.5,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 34.0%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2021-08-04,11:00:38,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Adj EPS $2.61,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Adj EPS $2.61 >CRL
CRL,2021-08-04,11:01:27,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Labs Sees 2021 EPS $6.55,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2021 EPS $6.55-EPS $6.80 >CRL
CRL,2021-08-04,11:01:48,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Labs Sees 2021 Adj EPS $10.10,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2021 Adj EPS $10.10-Adj EPS $10.35 >CRL
CRL,2021-08-05,03:16:24,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories International, Inc. CEO Jim Foster on Q2 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO Jim Foster on Q2 2021 Results -- Earnings Call Transcript >CRL"
CRL,2021-08-05,03:16:24,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles-river-laboratories-international-inc-crl-ceo-jim-foster-on-q2-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO Jim Foster on Q2 2021 Results -- Earnings Call Transcript >CRL"
CRL,2021-08-09,20:18:04,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Chmn Foster Registers 10,000 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Chmn Foster Registers 10,000 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-09,20:18:14,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Dir Kochevar Registers 3,526 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Dir Kochevar Registers 3,526 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-09,20:20:52,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp LaPlume Registers 3,700 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP LaPlume Registers 3,700 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-09,20:29:38,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Barbo Registers 12,387 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Barbo Registers 12,387 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-10,15:44:03,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 10,000 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Sells 10,000 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-10,15:48:02,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Dir Kochevar Sells 3,526 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Kochevar Sells 3,526 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-10,15:54:07,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Barbo Sells 12,387 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Sells 12,387 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-10,15:57:28,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp LaPlume Sells 3,700 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Sells 3,700 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-10,16:00:07,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Cfo Smith Sells 1,750 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Sells 1,750 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-10,18:33:06,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Cfo Smith Registers 1,750 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"CFO Smith Registers 1,750 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-17,13:46:50,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by UBS
CRL,2021-08-17,13:46:50,B13B68,Charles River Laboratories International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $465.00/Share From $390.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $465.00/Share From $390.00 by UBS
CRL,2021-08-17,15:10:25,B13B68,Charles River Laboratories International Inc.,100,0.78,price-targets,upgrade,Charles River Laboratories stock price target raised to $465 from $390 at UBS,NEWS-FLASH,MarketWatch,MW Charles River Laboratories stock price target raised to $465 from $390 at UBS
CRL,2021-08-17,19:02:43,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Creamer Sells 6,917 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Creamer Sells 6,917 Of Charles River Labs Intl Inc >CRL"
CRL,2021-08-17,21:23:46,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Creamer Registers 6,917 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Creamer Registers 6,917 Of Charles River Labs Intl Inc >CRL"
CRL,2021-09-01,18:30:47,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Dir Massaro Sells 2,539 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Massaro Sells 2,539 Of Charles River Labs Intl Inc >CRL"
CRL,2021-09-01,20:14:50,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Dir Massaro Registers 2,539 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Dir Massaro Registers 2,539 Of Charles River Labs Intl Inc >CRL"
CRL,2021-09-07,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Participate in September Investor Conferences,PRESS-RELEASE,Business Wire,Charles River Laboratories to Participate in September Investor Conferences
CRL,2021-09-14,18:14:35,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Girshick Registers 2,425 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Girshick Registers 2,425 Of Charles River Labs Intl Inc >CRL"
CRL,2021-09-15,15:12:19,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Girshick Sells 2,425 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Girshick Sells 2,425 Of Charles River Labs Intl Inc >CRL"
CRL,2021-09-20,12:04:10,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) today released the results from its first annual",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Launches First Annual Healthcare Collaboration Report
CRL,2021-09-20,12:04:10,B13B68,Charles River Laboratories International Inc.,99,-0.44,products-services,cut,"Charles River Laboratories International Inc.: Pandemic prevention, lowering drug prices",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Launches First Annual Healthcare Collaboration Report
CRL,2021-10-12,23:00:00,B13B68,Charles River Laboratories International Inc.,99,-0.42,assets,,Charles River Laboratories International Inc.: the Company completed the sale of its RMS Japan operations,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Two Divestitures
CRL,2021-10-12,23:00:00,B13B68,Charles River Laboratories International Inc.,99,-0.44,assets,sale,Charles River Laboratories International Inc.: the Company completed the sale of its gene therapy CDMO site in Sweden,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Two Divestitures
CRL,2021-10-12,23:00:00,B13B68,Charles River Laboratories International Inc.,100,0.65,acquisitions-mergers,,Laboratory Announces Acquisition of Charles River Laboratories,PRESS-RELEASE,Business Wire,The Jackson Laboratory Announces Acquisition of Charles River Laboratories Japan
CRL,2021-10-12,23:00:01,B13B68,Charles River Laboratories International Inc.,99,-0.42,assets,,Charles River Laboratories International Inc.: the Company completed the sale of its RMS Japan operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Two Divestitures
CRL,2021-10-12,23:00:01,B13B68,Charles River Laboratories International Inc.,99,-0.44,assets,sale,Charles River Laboratories International Inc.: the Company completed the sale of its gene therapy CDMO site in Sweden,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Two Divestitures
CRL,2021-10-12,23:01:14,B13B68,Charles River Laboratories International Inc.,100,0.58,acquisitions-mergers,,Charles River Labs Sells RMS Japan Ops to Jackson Laboratory for About $63M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sells RMS Japan Ops to Jackson Laboratory for About $63M in Cash >CRL
CRL,2021-10-12,23:37:09,B13B68,Charles River Laboratories International Inc.,100,0.65,acquisitions-mergers,,Laboratory Announces Acquisition of Charles River Laboratories,PRESS-RELEASE,Dow Jones Newswires,Press Release: The Jackson Laboratory Announces Acquisition of Charles River Laboratories Japan
CRL,2021-10-13,20:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call
CRL,2021-10-13,20:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2021 financial results on Wednesday, November 3",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call
CRL,2021-10-13,20:38:04,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call
CRL,2021-10-13,20:38:04,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2021 financial results on Wednesday, November 3",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call
CRL,2021-10-18,13:07:00,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and ATEM Structural Discovery Announce Strategic Partnership to,PRESS-RELEASE,Business Wire,Charles River and ATEM Structural Discovery Announce Strategic Partnership to Provide Clients with Cryo-EM Capabilities
CRL,2021-10-18,13:07:01,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and ATEM Structural Discovery Announce Strategic Partnership to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and ATEM Structural Discovery Announce Strategic Partnership to Provide Clients with Cryo-EM Capabilities
CRL,2021-10-18,13:07:17,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and ATEM Structural Discovery Announce Strategic Partnership to,NEWS-FLASH,Dow Jones Newswires,Charles River and ATEM Structural Discovery Announce Strategic Partnership to Provide Clients With Cryo-EM Capabilities
CRL,2021-10-20,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.53,products-services,complete,Charles River's complete portfolio of integrated drug discovery and non-clinical development,PRESS-RELEASE,Business Wire,Charles River Laboratories Plans to Increase CRADL Capacity in Cambridge
CRL,2021-10-20,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.52,products-services,,Charles River Laboratories International Inc.: the Company offers access to discovery services,PRESS-RELEASE,Business Wire,Charles River Laboratories Plans to Increase CRADL Capacity in Cambridge
CRL,2021-10-20,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.53,products-services,complete,Charles River's complete portfolio of integrated drug discovery and non-clinical development,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Plans to Increase CRADL Capacity in Cambridge
CRL,2021-10-20,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.52,products-services,,Charles River Laboratories International Inc.: the Company offers access to discovery services,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Plans to Increase CRADL Capacity in Cambridge
CRL,2021-10-22,07:18:14,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 3Q 2021 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 3Q 2021 (CRL)"
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q EPS $2.01,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q EPS $2.01 >CRL
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q Net $103.4M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Net $103.4M >CRL
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 3Q Rev $895.9M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Rev $895.9M >CRL
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Third-Quarter 2021 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $895.9 million, an increase of 20.5%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Third-Quarter GAAP Earnings per Share of $2.01,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Third-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $139.1 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $171.3 million in the third quarter of 2021,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,-0.65,revenues,down,Charles River Laboratories International Inc.: The GAAP operating margin also declined,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Laboratories International Inc.: The Company's guidance for revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: 2021 GUIDANCE,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $10.20,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,marketing,,Charles River will virtually present at the Credit Suisse 30(th) Annual Healthcare Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $703,859 $580,774",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,058,437 $ 5,490,831",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,-0.4,earnings,negative,Charles River Laboratories International Inc.: comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $895,937 $743,300",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,97,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 20.5 %",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $895.9 million, an increase of 20.5%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Third-Quarter GAAP Earnings per Share of $2.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Third-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $139.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $171.3 million in the third quarter of 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,-0.65,revenues,down,Charles River Laboratories International Inc.: The GAAP operating margin also declined,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Laboratories International Inc.: The Company's guidance for revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: 2021 GUIDANCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $10.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2021 Results
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,marketing,,Charles River will virtually present at the Credit Suisse 30(th) Annual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $703,859 $580,774",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,058,437 $ 5,490,831",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,-0.4,earnings,negative,Charles River Laboratories International Inc.: comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $895,937 $743,300",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2021-11-03,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 20.5 %",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2021-11-03,11:04:53,B13B68,Charles River Laboratories International Inc.,100,-0.75,revenues,down,Charles River Labs Cuts View to 2021 Revenue,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cuts View to 2021 Revenue Up 19.5%-20.5% >CRL
CRL,2021-11-03,11:05:37,B13B68,Charles River Laboratories International Inc.,100,0.7,earnings,up,Charles River Labs Raises 2021 View To EPS $7.05,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raises 2021 View To EPS $7.05-EPS $7.15 >CRL
CRL,2021-11-03,11:06:14,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Labs Narrows 2021 View To Adj EPS $10.20,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Narrows 2021 View To Adj EPS $10.20-Adj EPS $10.30 >CRL
CRL,2021-11-03,11:06:33,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q Adj EPS $2.70,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Adj EPS $2.70 >CRL
CRL,2021-11-03,17:10:21,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories International, Inc.'s CEO Jim Foster on Q3 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc.'s CEO Jim Foster on Q3 2021 Results -- Earnings Call Transcript >CRL"
CRL,2021-11-03,17:10:21,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles-river-laboratories-international-inc-s-crl-ceo-jim-foster-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc.'s CEO Jim Foster on Q3 2021 Results -- Earnings Call Transcript >CRL"
CRL,2021-11-04,13:54:41,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Morgan Stanley
CRL,2021-11-04,13:54:41,B13B68,Charles River Laboratories International Inc.,100,-0.46,price-targets,downgrade,Charles River Labs Price Target Cut to $465.00/Share From $480.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $465.00/Share From $480.00 by Morgan Stanley
CRL,2021-11-10,12:30:03,B13B68,Charles River Laboratories International Inc.,99,0.0,products-services,,Charles River Laboratories International Inc.: the Company is dedicated to developing technologies,PRESS-RELEASE,GlobeNewswire,Charles River Laboratories Reinforces Commitment to South Carolina
CRL,2021-11-10,12:30:23,B13B68,Charles River Laboratories International Inc.,99,0.0,products-services,,Charles River Laboratories International Inc.: the Company is dedicated to developing technologies,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Reinforces Commitment to South Carolina
CRL,2021-11-11,12:00:00,B13B68,Charles River Laboratories International Inc.,100,0.53,labor-issues,,Charles River Laboratories Promotes Birgit Girshick To Chief Operating Officer >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Promotes Birgit Girshick To Chief Operating Officer >CRL
CRL,2021-11-11,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.53,labor-issues,,Charles River Laboratories Promotes Birgit Girshick to Chief Operating Officer,PRESS-RELEASE,Business Wire,Charles River Laboratories Promotes Birgit Girshick to Chief Operating Officer
CRL,2021-11-11,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.53,labor-issues,,Charles River Laboratories Promotes Birgit Girshick to Chief Operating Officer,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Promotes Birgit Girshick to Chief Operating Officer
CRL,2021-11-16,13:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,Charles River Laboratories to Participate in Upcoming Investor Conferences
CRL,2021-11-16,13:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Participate in Upcoming Investor Conferences
CRL,2021-12-13,13:57:30,B13B68,Charles River Laboratories International Inc.,100,0.0,credit-ratings,action,"Moody's Announces Completion Of A Periodic Review Of Ratings Of Charles River Laboratories Int'l, Inc.",NEWS-FLASH,Dow Jones Newswires,"Moody's Announces Completion Of A Periodic Review Of Ratings Of Charles River Laboratories Int'l, Inc."
CRL,2021-12-27,20:46:12,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp LaPlume Gifts 182 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Gifts 182 Of Charles River Labs Intl Inc >CRL
CRL,2022-01-06,13:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2022-01-06,13:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2022-01-11,12:00:00,B13B68,Charles River Laboratories International Inc.,100,-0.49,labor-issues,,Charles River Laboratories Announces Chief Financial Officer Retirement,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Announces Chief Financial Officer Retirement And Transition Plan >CRL
CRL,2022-01-11,12:00:00,B13B68,Charles River Laboratories International Inc.,100,-0.49,labor-issues,,Charles River Laboratories Announces Chief Financial Officer Retirement,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:00,B13B68,Charles River Laboratories International Inc.,100,-0.38,earnings,,Charles River Laboratories International Inc.: Issues 2022 Financial Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:00,B13B68,Charles River Laboratories International Inc.,100,0.53,labor-issues,,Charles River Laboratories International Inc.: As Chief Financial Officer,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:00,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 13.0%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:00,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: GAAP EPS estimate $9.20,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:00,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $11.50,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:00,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River will virtually present at the 40(th) Annual J.P. Morgan Healthcare Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:01,B13B68,Charles River Laboratories International Inc.,100,-0.49,labor-issues,,Charles River Laboratories Announces Chief Financial Officer Retirement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:01,B13B68,Charles River Laboratories International Inc.,100,-0.38,earnings,,Charles River Laboratories International Inc.: Issues 2022 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.53,labor-issues,,Charles River Laboratories International Inc.: As Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 13.0%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: GAAP EPS estimate $9.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $11.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River will virtually present at the 40(th) Annual J.P. Morgan Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
CRL,2022-01-11,12:02:22,B13B68,Charles River Laboratories International Inc.,100,0.52,products-services,,Charles River Labs: Commencing Global Search,NEWS-FLASH,Dow Jones Newswires,Charles River Labs: Commencing Global Search to Identify Its Next Chief Fincl Officer >CRL
CRL,2022-01-11,12:09:35,B13B68,Charles River Laboratories International Inc.,100,-0.49,labor-issues,,Charles River Labs Financial Chief David Smith to Retire,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Financial Chief David Smith to Retire
CRL,2022-01-19,14:00:04,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Valo Health Announce Strategic Partnership to,PRESS-RELEASE,Business Wire,Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
CRL,2022-01-19,14:00:04,B13B68,Charles River Laboratories International Inc.,100,0.0,products-services,,And Charles River have joined forces to create enhanced drug,PRESS-RELEASE,Business Wire,Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
CRL,2022-01-19,14:03:00,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Valo Health in Strategic Partnership to,NEWS-FLASH,Dow Jones Newswires,Charles River and Valo Health in Strategic Partnership to Provide Clients With Access to AI-Enabled Drug Discovery Solutions
CRL,2022-01-19,14:07:10,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Valo Health Announce Strategic Partnership to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
CRL,2022-01-19,14:07:10,B13B68,Charles River Laboratories International Inc.,100,0.0,products-services,,And Charles River have joined forces to create enhanced drug,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
CRL,2022-01-20,13:30:00,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
CRL,2022-01-20,13:30:00,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2021 financial results on Wednesday, February 16",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
CRL,2022-01-20,13:30:00,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2021 financial results on Wednesday, February 16",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
CRL,2022-01-22,08:28:38,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 4Q 2021 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 4Q 2021 (CRL)"
CRL,2022-01-27,13:00:02,B13B68,Charles River Laboratories International Inc.,99,0.49,partnerships,,Charles River Expands Strategic Partnership,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Expands Strategic Partnership With SAMDI Tech
CRL,2022-01-31,21:56:07,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,"Dir Wallman Gifts 13,460 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Wallman Gifts 13,460 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-01,21:49:07,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Cfo Smith Acquires 6,957 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Acquires 6,957 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-01,22:23:34,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,"Chmn Foster Surrenders 25,108 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Surrenders 25,108 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-01,22:33:30,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Knell Acquires 1,915 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Knell Acquires 1,915 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-01,22:36:44,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Barbo Acquires 6,178 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Acquires 6,178 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-01,22:39:35,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Girshick Acquires 7,152 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Girshick Acquires 7,152 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-01,22:41:01,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp LaPlume Acquires 6,774 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Acquires 6,774 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-01,22:48:23,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Creamer Acquires 3,564 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Creamer Acquires 3,564 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-03,13:00:02,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,Charles River Laboratories Announces Wind Contract with Repsol for European,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Wind Contract with Repsol for European Operations
CRL,2022-02-03,13:00:14,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,Charles River Laboratories Announces Wind Contract With Repsol for European,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Announces Wind Contract With Repsol for European Ops
CRL,2022-02-03,13:07:37,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,Charles River Labs Entered Into Virtual Power Purchase Agreement With Repsol,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Entered Into Virtual Power Purchase Agreement With Repsol for Wind Energy in Spain >CRL
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q EPS $2.67,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q EPS $2.67 >CRL
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $905.1 million, an increase of 14.4%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Fourth-Quarter GAAP Earnings per Share of $2.67,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Full-Year GAAP Earnings per Share of $7.60,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,unchanged,Charles River Laboratories International Inc.: Reaffirms 2022 Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Fourth quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $128.4 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $165.6 million in the fourth quarter of 2021,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisitions of Cognate BioServices,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,-0.65,revenues,down,Charles River Laboratories International Inc.: The non-GAAP operating margin decreased,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For 2021, DSA revenue was $2.11 billion, an increase of 14.7%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: The Company's 2022 guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 13.0%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: GAAP EPS estimate $9.20,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $11.50,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,marketing,,"Charles River will virtually present at Citi's 2022 Virtual Healthcare Conference, on Wednesday, February 23",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $709,819 $618,229",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,024,292 $ 5,490,831",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q Adj EPS $2.49,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Adj EPS $2.49 >CRL
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $905,050 $790,990",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 14.4 %",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q Net $137.6M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Net $137.6M >CRL
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 4Q Rev $905.1M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Rev $905.1M >CRL
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: The Company's 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 13.0%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: GAAP EPS estimate $9.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $11.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,marketing,,"Charles River will virtually present at Citi's 2022 Virtual Healthcare Conference, on Wednesday, February 23",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $709,819 $618,229",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,024,292 $ 5,490,831",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,98,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $905,050 $790,990",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2022-02-16,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 14.4 %",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2022-02-16,12:00:34,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,unchanged,Charles River Labs Reaffirms 2022 Guidance,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Reaffirms 2022 Guidance >CRL
CRL,2022-02-16,20:20:31,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Chmn Foster Registers 20,000 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Chmn Foster Registers 20,000 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-17,02:53:13,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories International, Inc. CEO James Foster on Q4 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO James Foster on Q4 2021 Results -- Earnings Call Transcript >CRL"
CRL,2022-02-17,02:53:13,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles-river-laboratories-international-inc-crl-ceo-james-foster-on-q4-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO James Foster on Q4 2021 Results -- Earnings Call Transcript >CRL"
CRL,2022-02-17,09:50:35,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Keybanc
CRL,2022-02-17,09:50:35,B13B68,Charles River Laboratories International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $390.00/Share From $450.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $390.00/Share From $450.00 by Keybanc
CRL,2022-02-17,13:42:26,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Morgan Stanley
CRL,2022-02-17,13:42:26,B13B68,Charles River Laboratories International Inc.,100,-0.7,price-targets,downgrade,Charles River Labs Price Target Cut to $430.00/Share From $465.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $430.00/Share From $465.00 by Morgan Stanley
CRL,2022-02-17,15:48:07,B13B68,Charles River Laboratories International Inc.,100,0.94,analyst-ratings,positive,Charles River Labs Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raised to Buy From Neutral by Citigroup
CRL,2022-02-17,15:48:07,B13B68,Charles River Laboratories International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $400.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $400.00/Share by Citigroup
CRL,2022-02-17,21:43:03,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 20,000 Of Charles River Labs Intl Inc",FULL-ARTICLE,Dow Jones Newswires,"Chmn Foster Sells 20,000 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-23,21:00:06,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp LaPlume Registers 1,143 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP LaPlume Registers 1,143 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-23,21:12:10,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Dir Wallman Sells 7,200 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Wallman Sells 7,200 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-23,21:21:20,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 602 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 602 Of Charles River Labs Intl Inc >CRL
CRL,2022-02-23,21:24:51,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 180 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,VP Creamer Surrenders 180 Of Charles River Labs Intl Inc >CRL
CRL,2022-02-23,21:37:45,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Girshick Surrenders 554 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,VP Girshick Surrenders 554 Of Charles River Labs Intl Inc >CRL
CRL,2022-02-23,21:50:45,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 107 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,VP Knell Surrenders 107 Of Charles River Labs Intl Inc >CRL
CRL,2022-02-23,21:56:15,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 17,436 Of Charles River Labs Intl Inc",FULL-ARTICLE,Dow Jones Newswires,"Chmn Foster Sells 17,436 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-23,21:56:45,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp LaPlume Sells 1,539 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Sells 1,539 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-23,22:56:38,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 396 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 396 Of Charles River Labs Intl Inc >CRL
CRL,2022-02-23,22:59:29,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Chmn Foster Registers 37,732 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Chmn Foster Registers 37,732 Of Charles River Labs Intl Inc >CRL"
CRL,2022-02-24,19:59:25,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 395 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 395 Of Charles River Labs Intl Inc >CRL
CRL,2022-02-24,23:40:44,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Cfo Smith Surrenders 715 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,CFO Smith Surrenders 715 Of Charles River Labs Intl Inc >CRL
CRL,2022-02-24,23:45:35,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 395 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Sells 395 Of Charles River Labs Intl Inc >CRL
CRL,2022-02-25,21:31:10,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 20,296 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Sells 20,296 Of Charles River Labs Intl Inc >CRL"
CRL,2022-03-04,21:00:05,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Cfo Smith Registers 8,965 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"CFO Smith Registers 8,965 Of Charles River Labs Intl Inc >CRL"
CRL,2022-03-04,21:19:13,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Cfo Smith Sells 8,965 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Smith Sells 8,965 Of Charles River Labs Intl Inc >CRL"
CRL,2022-03-17,13:30:01,B13B68,Charles River Laboratories International Inc.,91,0.0,products-services,,Charles River Laboratories International Inc.: Proliferation of clinical trials across,PRESS-RELEASE,Business Wire,"Insights on the Healthcare Analytical Testing Services Global Market to 2027 - Featuring Anacura, CD Biosciences and Charles River Laboratories Among Others - ResearchAndMarkets.com"
CRL,2022-03-28,12:00:00,B13B68,Charles River Laboratories International Inc.,100,0.53,labor-issues,,Charles River Laboratories To Appoint Flavia H. Pease As Chief Financial Officer >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories To Appoint Flavia H. Pease As Chief Financial Officer >CRL
CRL,2022-03-28,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.53,labor-issues,,Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer,PRESS-RELEASE,Business Wire,Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
CRL,2022-03-28,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: the Company's Quarterly Report on Form 10-Q in early May,PRESS-RELEASE,Business Wire,Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
CRL,2022-03-28,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.53,labor-issues,,Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
CRL,2022-03-28,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: the Company's Quarterly Report on Form 10-Q in early May,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
CRL,2022-03-28,12:18:37,B13B68,Charles River Laboratories International Inc.,100,0.53,labor-issues,,Charles River Laboratories Names Flavia Pease as CFO,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Names Flavia Pease as CFO
CRL,2022-04-06,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Explora BioLabs complements and expands the Charles River,PRESS-RELEASE,Business Wire,Charles River Laboratories Acquires Explora BioLabs
CRL,2022-04-06,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Explora BioLabs complements and expands the Charles River,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Acquires Explora BioLabs
CRL,2022-04-06,12:24:12,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories Buys Explora BioLabs for $295M,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Buys Explora BioLabs for $295M
CRL,2022-04-07,11:03:34,B13B68,Charles River Laboratories International Inc.,100,0.95,analyst-ratings,positive,Charles River Labs Initiated at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Initiated at Overweight by Stephens & Co.
CRL,2022-04-07,11:03:34,B13B68,Charles River Laboratories International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $377.00/Share by Stephens,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $377.00/Share by Stephens & Co.
CRL,2022-04-07,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.52,products-services,,Charles River Laboratories International Inc.: The company also launched a new enterprise learning management system,PRESS-RELEASE,Business Wire,Charles River Laboratories Publishes 2021 Corporate Citizenship Report
CRL,2022-04-07,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.52,products-services,,Charles River Laboratories International Inc.: The company also launched a new enterprise learning management system,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Publishes 2021 Corporate Citizenship Report
CRL,2022-04-13,20:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
CRL,2022-04-13,20:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2022 financial results on Wednesday, May 4",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
CRL,2022-04-13,20:45:26,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
CRL,2022-04-13,20:45:26,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2022 financial results on Wednesday, May 4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
CRL,2022-04-22,07:25:47,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 1Q 2022 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 1Q 2022 (CRL)"
CRL,2022-04-25,10:23:17,B13B68,Charles River Laboratories International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Hold From Buy by Jefferies,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Hold From Buy by Jefferies
CRL,2022-04-25,10:23:17,B13B68,Charles River Laboratories International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $280.00/Share From $370.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $280.00/Share From $370.00 by Jefferies
CRL,2022-04-25,13:13:58,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Wells Fargo
CRL,2022-04-25,13:13:58,B13B68,Charles River Laboratories International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $325.00/Share From $390.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $325.00/Share From $390.00 by Wells Fargo
CRL,2022-04-27,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.49,partnerships,,Thrilled to partner with Charles River on,PRESS-RELEASE,Business Wire,"Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets"
CRL,2022-05-04,11:00:00,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q EPS $1.81,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q EPS $1.81 >CRL
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q Adj EPS $2.75,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Adj EPS $2.75 >CRL
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q Net $93M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Net $93M >CRL
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 1Q Rev $913.9M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Rev $913.9M >CRL
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces First-Quarter 2022 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.63,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $913.9 million, an increase of 10.8%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: First-Quarter GAAP Earnings per Share of $1.81,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: our financial guidance for the year,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $176.5 million in the first quarter of 2022,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.62,revenues,up,Charles River Laboratories International Inc.: The GAAP operating margin increase,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisitions of the Cognate BioServices,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: 2022 GUIDANCE,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS $11.50,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,marketing,,"Charles River will present at the Bank of America 2022 Healthcare Conference in Las Vegas, Nevada, on Wednesday",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $ 720,485 $ 626,581",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,075,049 $ 7,024,292",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $ 913,929 $ 824,566",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 10.8 %",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.63,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $913.9 million, an increase of 10.8%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: First-Quarter GAAP Earnings per Share of $1.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: our financial guidance for the year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $176.5 million in the first quarter of 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.62,revenues,up,Charles River Laboratories International Inc.: The GAAP operating margin increase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisitions of the Cognate BioServices,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: 2022 GUIDANCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS $11.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2022 Results
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,marketing,,"Charles River will present at the Bank of America 2022 Healthcare Conference in Las Vegas, Nevada, on Wednesday",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $ 720,485 $ 626,581",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,075,049 $ 7,024,292",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,96,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $ 913,929 $ 824,566",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-05-04,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 10.8 %",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-05-04,11:01:46,B13B68,Charles River Laboratories International Inc.,100,0.48,revenues,up,Charles River Labs Sees 2022 Revenue Growth of 13.5%-15.5%,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2022 Revenue Growth of 13.5%-15.5% >CRL
CRL,2022-05-04,11:02:15,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Labs Sees 2022 EPS $8.70,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2022 EPS $8.70-EPS $8.95 >CRL
CRL,2022-05-04,11:02:36,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Labs Sees 2022 Adj EPS $11.50,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2022 Adj EPS $11.50-Adj EPS $11.75 >CRL
CRL,2022-05-04,18:26:03,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories International, Inc. CEO James Foster on Q1 2022 Earnings Call",NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO James Foster on Q1 2022 Earnings Call Transcript >CRL"
CRL,2022-05-05,08:44:59,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Keybanc
CRL,2022-05-05,08:44:59,B13B68,Charles River Laboratories International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $300.00/Share From $390.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $300.00/Share From $390.00 by Keybanc
CRL,2022-05-05,09:59:48,B13B68,Charles River Laboratories International Inc.,100,-0.82,price-targets,downgrade,Charles River Laboratories stock price target cut to $300 from $390 at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Charles River Laboratories stock price target cut to $300 from $390 at KeyBanc Capital
CRL,2022-05-05,12:33:20,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Morgan Stanley
CRL,2022-05-05,12:33:20,B13B68,Charles River Laboratories International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $350.00/Share From $430.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $350.00/Share From $430.00 by Morgan Stanley
CRL,2022-05-05,13:30:00,B13B68,Charles River Laboratories International Inc.,99,0.49,partnerships,,Cytiva is collaborating with Multiply Labs to,PRESS-RELEASE,Business Wire,Multiply Labs Adds Thermo Fisher Scientific and Charles River Laboratories to Its Robotic Manufacturing Consortium
CRL,2022-05-10,18:29:52,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Dir Massaro Registers 178 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,Dir Massaro Registers 178 Of Charles River Labs Intl Inc >CRL
CRL,2022-05-11,19:54:03,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,Dir Massaro Sells 178 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Massaro Sells 178 Of Charles River Labs Intl Inc >CRL
CRL,2022-05-24,10:00:19,B13B68,Charles River Laboratories International Inc.,100,0.01,analyst-ratings,neutral,Charles River Labs Initiated at Neutral by Guggenheim,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Initiated at Neutral by Guggenheim
CRL,2022-05-31,22:09:27,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 304 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 304 Of Charles River Labs Intl Inc >CRL
CRL,2022-05-31,22:14:07,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 91 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Surrenders 91 Of Charles River Labs Intl Inc >CRL
CRL,2022-05-31,22:16:35,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Coo Girshick Surrenders 368 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,COO Girshick Surrenders 368 Of Charles River Labs Intl Inc >CRL
CRL,2022-05-31,23:10:10,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 348 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Surrenders 348 Of Charles River Labs Intl Inc >CRL
CRL,2022-06-01,21:17:27,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 314 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 314 Of Charles River Labs Intl Inc >CRL
CRL,2022-06-01,21:20:31,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,"Chmn Foster Surrenders 1,311 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Surrenders 1,311 Of Charles River Labs Intl Inc >CRL"
CRL,2022-06-08,11:05:54,B13B68,Charles River Laboratories International Inc.,100,-0.75,revenues,down,"Charles River Labs Cuts 2Q Revenue, Adjusted EPS Growth Views",RNS-SEC8K,Dow Jones Newswires,"Charles River Labs Cuts 2Q Revenue, Adjusted EPS Growth Views >CRL"
CRL,2022-06-08,11:07:16,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Labs Now Sees 2Q Revenue Up,RNS-SEC8K,Dow Jones Newswires,Charles River Labs Now Sees 2Q Revenue Up High-Single Digits >CRL
CRL,2022-06-08,11:07:31,B13B68,Charles River Laboratories International Inc.,100,0.84,revenues,up,Charles River Labs Had Seen 2Q Revenue Up Low-Double,RNS-SEC8K,Dow Jones Newswires,Charles River Labs Had Seen 2Q Revenue Up Low-Double Digits >CRL
CRL,2022-06-08,11:08:47,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Labs Sees 2Q Manufacturing Rev Growth,RNS-SEC8K,Dow Jones Newswires,Charles River Labs Sees 2Q Manufacturing Rev Growth Rate Below 1Q Due Mainly to CDMO Business >CRL
CRL,2022-06-08,11:09:55,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Labs Still Sees FY22 Organic Revenue Growth,RNS-SEC8K,Dow Jones Newswires,"Charles River Labs Still Sees FY22 Organic Revenue Growth, Adjusted EPS Within Prior Guidance >CRL"
CRL,2022-06-08,11:12:08,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Labs issues profit warning for Q2,NEWS-FLASH,MarketWatch,MW Charles River Labs issues profit warning for Q2
CRL,2022-06-08,11:13:43,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Labs now sees Q2 reveneu up,NEWS-FLASH,MarketWatch,MW Charles River Labs now sees Q2 reveneu up in high single digits vs. prior guidance of low-double-digits
CRL,2022-06-21,14:52:26,B13B68,Charles River Laboratories International Inc.,95,0.0,credit-ratings,set,Fitch Assigns First-Time 'BBB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Assigns First-Time 'BBB-' IDR to Charles River Laboratories International; Outlook Stable
CRL,2022-06-23,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Ziphius Vaccines Collaborate to,PRESS-RELEASE,Business Wire,Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
CRL,2022-06-23,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.49,partnerships,,Charles River and Ziphius Vaccines Collaborate to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
CRL,2022-06-23,12:00:53,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Ziphius Vaccines Collaborate to,NEWS-FLASH,Dow Jones Newswires,Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
CRL,2022-06-24,15:00:00,B13B68,Charles River Laboratories International Inc.,99,0.49,partnerships,,"Charles River Laboratories International Inc.: In collaboration with Canadian Forest Service, a Sustainable Forest Management Plan",PRESS-RELEASE,GlobeNewswire,Wildlife Habitat Council Awards CNL Gold Certification for Chalk River Laboratories Campus
CRL,2022-06-28,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.41,assets,open,Charles River Laboratories Announces Opening of U.K. Manufacturing Facility,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
CRL,2022-06-28,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,"Charles River's acquisition of Cognate BioServices and Cobra Biologics, a pioneering plasmid DNA, viral vector",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
CRL,2022-06-28,12:01:06,B13B68,Charles River Laboratories International Inc.,100,0.41,assets,open,Charles River Laboratories Announces Opening of U.K. Manufacturing Facility,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
CRL,2022-06-28,12:06:21,B13B68,Charles River Laboratories International Inc.,100,0.41,assets,open,Charles River Laboratories Announces Opening of U.K. Manufacturing Facility,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
CRL,2022-06-28,12:06:21,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,"Charles River's acquisition of Cognate BioServices and Cobra Biologics, a pioneering plasmid DNA, viral vector",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
CRL,2022-07-11,12:30:00,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
CRL,2022-07-11,12:30:00,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2022 financial results on Wednesday, August 3",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
CRL,2022-07-14,12:24:56,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by Deutsche Bank
CRL,2022-07-14,12:24:56,B13B68,Charles River Laboratories International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $290.00/Share From $350.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $290.00/Share From $350.00 by Deutsche Bank
CRL,2022-07-18,19:47:58,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Dir Milne Jr Registers 2,735 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Dir Milne Jr Registers 2,735 Of Charles River Labs Intl Inc >CRL"
CRL,2022-07-22,07:22:27,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 2Q 2022 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 2Q 2022 (CRL)"
CRL,2022-07-26,13:00:53,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,Gempharmatech and Charles River Laboratories Sign Exclusive Agreement,PRESS-RELEASE,PR Newswire,GemPharmatech and Charles River Laboratories Sign Exclusive Agreement to Distribute Next Generation NCG Portfolio
CRL,2022-07-26,13:00:59,B13B68,Charles River Laboratories International Inc.,100,0.39,products-services,,Gempharmatech and Charles River Laboratories Sign Exclusive Agreement,PRESS-RELEASE,PR Newswire,GemPharmatech and Charles River Laboratories Sign Exclusive Agreement to Distribute Next Generation NCG Portfolio
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q EPS $2.13,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q EPS $2.13 >CRL
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Adj EPS $2.77,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Adj EPS $2.77 >CRL
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Net $109.3M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Net $109.3M >CRL
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 2Q Rev $973.1M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Rev $973.1M >CRL
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Second-Quarter 2022 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $973.1 million, an increase of 6.4%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Second-Quarter GAAP Earnings per Share of $2.13,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Laboratories International Inc.: Reduces 2022 Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $141.9 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: our initial outlook for the year.,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $186.4 million in the second quarter of 2022,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.86,revenues,up,Charles River Laboratories International Inc.: Organic revenue growth guidance for 2022,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Laboratories International Inc.: The Company continues to expect the organic revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS $10.70,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $782,827 $715,320",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,revenues,,Charles River Laboratories International Inc.: Total revenue,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,529,361 $ 7,024,292",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,91,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,91,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $973,131 $914,607",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 6.4 %",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $973.1 million, an increase of 6.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Second-Quarter GAAP Earnings per Share of $2.13,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Laboratories International Inc.: Reduces 2022 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $141.9 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: our initial outlook for the year.,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $186.4 million in the second quarter of 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.86,revenues,up,Charles River Laboratories International Inc.: Organic revenue growth guidance for 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.72,revenues,up,Charles River Laboratories International Inc.: The Company continues to expect the organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS $10.70,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2022 Results
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $782,827 $715,320",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,revenues,,Charles River Laboratories International Inc.: Total revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,92,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,529,361 $ 7,024,292",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,91,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,91,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $973,131 $914,607",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-08-03,11:00:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 6.4 %",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-08-03,11:02:28,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q EPS $2.13,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q EPS $2.13 >CRL
CRL,2022-08-03,11:02:39,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 2Q Rev $973.1M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Rev $973.1M >CRL
CRL,2022-08-03,11:03:27,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Labs Cuts 2022 View to,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cuts 2022 View to Revenue Up 9%-11% >CRL
CRL,2022-08-03,11:03:51,B13B68,Charles River Laboratories International Inc.,100,-0.75,revenues,down,Charles River Labs Cuts 2022 View to Organic Revenue,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cuts 2022 View to Organic Revenue Up 10%-12% >CRL
CRL,2022-08-03,11:04:09,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Labs Cuts 2022 View To EPS $7.90,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cuts 2022 View To EPS $7.90-EPS $8.15 >CRL
CRL,2022-08-03,11:04:27,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Labs Cuts 2022 View To Adj EPS $10.70,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cuts 2022 View To Adj EPS $10.70-Adj EPS $10.95 >CRL
CRL,2022-08-03,11:05:35,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Adj EPS $2.77,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Adj EPS $2.77 >CRL
CRL,2022-08-03,11:25:06,B13B68,Charles River Laboratories International Inc.,100,0.64,earnings,up,"Charles River Laboratories 2Q Profit, Revenue Rise",FULL-ARTICLE,Dow Jones Newswires,"Charles River Laboratories 2Q Profit, Revenue Rise"
CRL,2022-08-03,11:34:26,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Laboratories Reduces Full-Year Guidance,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Reduces Full-Year Guidance
CRL,2022-08-03,11:34:26,B13B68,Charles River Laboratories International Inc.,100,0.48,revenues,up,Charles River Laboratories International Inc.: The company expects revenue growth for the year to be between 9%,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Reduces Full-Year Guidance
CRL,2022-08-03,11:34:26,B13B68,Charles River Laboratories International Inc.,100,-0.75,revenues,down,Charles River Laboratories International Inc.: The company reduced its organic growth revenue forecast,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Reduces Full-Year Guidance
CRL,2022-08-03,15:01:39,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Laboratories International Inc.: the company lowered its full-year guidance,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Shares Down 10% Following Lowered Guidance
CRL,2022-08-03,15:01:39,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,Charles River Laboratories International Inc.: The company said it expects revenue growth for the year of 9% to 11%,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Shares Down 10% Following Lowered Guidance
CRL,2022-08-03,15:01:39,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: the company said its second-quarter profit,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Shares Down 10% Following Lowered Guidance
CRL,2022-08-03,18:19:54,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories International, Inc. CEO James Foster on Q2 2022 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO James Foster on Q2 2022 Results -- Earnings Call Transcript >CRL"
CRL,2022-08-03,18:19:54,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles-river-laboratories-international-inc-crl-ceo-james-foster-on-q2-2022-results-earnings,NEWS-FLASH,Dow Jones Newswires,"Charles River Laboratories International, Inc. CEO James Foster on Q2 2022 Results -- Earnings Call Transcript >CRL"
CRL,2022-08-04,10:30:58,B13B68,Charles River Laboratories International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Equal-Weight From Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Equal-Weight From Overweight by Morgan Stanley
CRL,2022-08-04,10:30:58,B13B68,Charles River Laboratories International Inc.,100,-0.84,price-targets,downgrade,Charles River Labs Price Target Cut to $250.00/Share From $350.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $250.00/Share From $350.00 by Morgan Stanley
CRL,2022-08-08,19:04:44,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 200 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Sells 200 Of Charles River Labs Intl Inc >CRL
CRL,2022-08-08,22:00:04,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 200 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 200 Of Charles River Labs Intl Inc >CRL
CRL,2022-08-16,11:45:54,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Wells Fargo
CRL,2022-08-16,11:45:54,B13B68,Charles River Laboratories International Inc.,100,-0.7,price-targets,downgrade,Charles River Labs Price Target Cut to $300.00/Share From $325.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $300.00/Share From $325.00 by Wells Fargo
CRL,2022-08-23,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.53,products-services,complete,Charles River's complete portfolio of integrated drug discovery and non-clinical development,PRESS-RELEASE,Business Wire,Charles River Laboratories Expands Contract Vivarium Space on West Coast
CRL,2022-08-23,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,Charles River company since Explora was acquired by Charles River in April 2022,PRESS-RELEASE,Business Wire,Charles River Laboratories Expands Contract Vivarium Space on West Coast
CRL,2022-08-23,12:01:30,B13B68,Charles River Laboratories International Inc.,99,0.53,products-services,complete,Charles River's complete portfolio of integrated drug discovery and non-clinical development,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Expands Contract Vivarium Space on West Coast
CRL,2022-08-23,12:01:30,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,Charles River company since Explora was acquired by Charles River in April 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Expands Contract Vivarium Space on West Coast
CRL,2022-08-25,09:27:49,B13B68,Charles River Laboratories International Inc.,100,0.95,analyst-ratings,positive,Charles River Labs Initiated at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Initiated at Outperform by Credit Suisse
CRL,2022-08-25,09:27:49,B13B68,Charles River Laboratories International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $285.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $285.00/Share by Credit Suisse
CRL,2022-09-06,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration,PRESS-RELEASE,Business Wire,Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
CRL,2022-09-06,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.84,products-services,positive,Charles River Laboratories International Inc.: Company will perform HQ plasmid production in support of Phase I/II clinical trials,PRESS-RELEASE,Business Wire,Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
CRL,2022-09-06,12:02:20,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
CRL,2022-09-06,12:02:20,B13B68,Charles River Laboratories International Inc.,100,0.84,products-services,positive,Charles River Laboratories International Inc.: Company will perform HQ plasmid production in support of Phase I/II clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
CRL,2022-09-08,20:30:00,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL,2022-09-08,20:30:10,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL,2022-09-30,09:19:29,B13B68,Charles River Laboratories International Inc.,100,0.94,analyst-ratings,positive,Charles River Labs Raised to Buy From Hold by Jefferies,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raised to Buy From Hold by Jefferies
CRL,2022-09-30,09:19:29,B13B68,Charles River Laboratories International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $240.00/Share by Jefferies,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $240.00/Share by Jefferies
CRL,2022-10-10,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.52,products-services,,Charles River Launches nAAVigation Vector Platform to,PRESS-RELEASE,Business Wire,Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs
CRL,2022-10-10,12:00:02,B13B68,Charles River Laboratories International Inc.,100,-0.51,labor-issues,,Charles River Laboratories International Inc.: The significant turnaround time reduction for viral vector therapy developers,PRESS-RELEASE,Business Wire,Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs
CRL,2022-10-10,12:01:10,B13B68,Charles River Laboratories International Inc.,100,0.44,products-services,,Charles River Launches nAAVigation Vector Platform to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs
CRL,2022-10-10,12:01:10,B13B68,Charles River Laboratories International Inc.,100,-0.51,labor-issues,,Charles River Laboratories International Inc.: The significant turnaround time reduction for viral vector therapy developers,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs
CRL,2022-10-11,20:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
CRL,2022-10-11,20:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2022 financial results on Wednesday, November 2",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
CRL,2022-10-11,20:42:33,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
CRL,2022-10-11,20:42:33,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2022 financial results on Wednesday, November 2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
CRL,2022-10-18,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership,PRESS-RELEASE,Business Wire,Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
CRL,2022-10-18,12:00:14,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership,PRESS-RELEASE,PR Newswire,(PR) Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
CRL,2022-10-18,12:00:15,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership,NEWS-FLASH,Dow Jones Newswires,Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
CRL,2022-10-18,12:04:56,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
CRL,2022-10-19,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.52,products-services,,Charles River Launches HemaCare Donor App to,PRESS-RELEASE,Business Wire,Charles River Launches HemaCare Donor App to Engage Diverse Donors and Source Cell Solutions for Critical Cell and Gene Therapy Research
CRL,2022-10-19,12:00:10,B13B68,Charles River Laboratories International Inc.,99,0.52,products-services,,Charles River Launches HemaCare Donor App to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Launches HemaCare Donor App to Engage Diverse Donors and Source Cell Solutions for Critical Cell and Gene Therapy Research
CRL,2022-10-22,07:19:23,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 3Q 2022 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 3Q 2022 (CRL)"
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Third-Quarter 2022 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $989.2 million, an increase of 10.4%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Third-Quarter GAAP Earnings per Share of $1.88,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,Charles River Laboratories International Inc.: Narrows 2022 Revenue Growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Third-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $134.7 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $180.1 million in the third quarter of 2022,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: GAAP earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: our 2022 financial guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS $10.80,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,equity-actions,,Charles River Laboratories International Inc.: Capital expenditures $340 million $340 million,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $812,894 $703,859",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,382,769 $ 7,024,292",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,99,-0.65,earnings,negative,Charles River Laboratories International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,91,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 10.4%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,97,0.0,revenues,,Charles River Laboratories International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q EPS $1.88,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q EPS $1.88 >CRL
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q Adj EPS $2.63,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Adj EPS $2.63 >CRL
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q Net $96.5M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Net $96.5M >CRL
CRL,2022-11-02,11:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 3Q Rev $989.2M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Rev $989.2M >CRL
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $989.2 million, an increase of 10.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Third-Quarter GAAP Earnings per Share of $1.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,Charles River Laboratories International Inc.: Narrows 2022 Revenue Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Third-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $134.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $180.1 million in the third quarter of 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: GAAP earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: our 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS $10.80 -- $10.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2022 Results
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $812,894 $703,859",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,99,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,382,769 $ 7,024,292",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,99,-0.65,earnings,negative,Charles River Laboratories International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,91,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 10.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2022-11-02,11:02:30,B13B68,Charles River Laboratories International Inc.,96,0.0,revenues,,Charles River Laboratories International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2022-11-02,11:07:58,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International 3Q EPS $1.88,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories International 3Q EPS $1.88 >CRL
CRL,2022-11-02,11:08:09,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International 3Q Rev $989.2M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories International 3Q Rev $989.2M >CRL
CRL,2022-11-02,11:08:56,B13B68,Charles River Laboratories International Inc.,100,-0.75,revenues,down,Charles River Laboratories International Narrows FY22 View to Reported Revenue,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories International Narrows FY22 View to Reported Revenue Up 10%-11% >CRL
CRL,2022-11-02,11:09:15,B13B68,Charles River Laboratories International Inc.,100,-0.75,revenues,down,Charles River Laboratories International Narrows FY22 View to Organic Revenue,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories International Narrows FY22 View to Organic Revenue Up 11%-12% >CRL
CRL,2022-11-02,11:09:38,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Laboratories International Narrows FY22 View To EPS $7.90,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories International Narrows FY22 View To EPS $7.90-EPS $8.05 >CRL
CRL,2022-11-02,11:09:59,B13B68,Charles River Laboratories International Inc.,100,-0.74,earnings,down,Charles River Laboratories International Narrows FY22 View To Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories International Narrows FY22 View To Adj EPS $10.80-Adj EPS $10.95 >CRL
CRL,2022-11-02,11:10:25,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International 3Q Adj EPS $2.63,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories International 3Q Adj EPS $2.63 >CRL
CRL,2022-11-03,12:51:06,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Credit Suisse
CRL,2022-11-03,12:51:06,B13B68,Charles River Laboratories International Inc.,100,-0.34,price-targets,downgrade,Charles River Labs Price Target Cut to $280.00/Share From $285.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $280.00/Share From $285.00 by Credit Suisse
CRL,2022-11-03,14:35:47,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by JP Morgan
CRL,2022-11-03,14:35:47,B13B68,Charles River Laboratories International Inc.,100,-0.34,price-targets,downgrade,Charles River Labs Price Target Cut to $275.00/Share From $280.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $275.00/Share From $280.00 by JP Morgan
CRL,2022-11-07,21:51:59,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 534 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 534 Of Charles River Labs Intl Inc >CRL
CRL,2022-11-07,23:56:02,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 534 Of Charles River Labs Intl Inc,FULL-ARTICLE,Dow Jones Newswires,VP LaPlume Sells 534 Of Charles River Labs Intl Inc >CRL
CRL,2022-11-14,13:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at November Investor Conferences,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at November Investor Conferences
CRL,2022-11-14,13:00:20,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at November Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at November Investor Conferences
CRL,2022-11-16,21:03:33,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Parisotto Registers 2,279 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Parisotto Registers 2,279 Of Charles River Labs Intl Inc >CRL"
CRL,2022-11-17,22:12:47,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,Vp Knell Registers 855 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP Knell Registers 855 Of Charles River Labs Intl Inc >CRL
CRL,2022-11-17,22:25:11,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Parisotto Sells 2,279 Of Charles River Labs Intl Inc",FULL-ARTICLE,Dow Jones Newswires,"VP Parisotto Sells 2,279 Of Charles River Labs Intl Inc >CRL"
CRL,2022-11-17,22:29:35,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,Vp Knell Sells 855 Of Charles River Labs Intl Inc,FULL-ARTICLE,Dow Jones Newswires,VP Knell Sells 855 Of Charles River Labs Intl Inc >CRL
CRL,2022-11-30,14:55:31,B13B68,Charles River Laboratories International Inc.,100,-0.65,equity-actions,halt,Charles River Laboratories International Inc. (CRL) Halted due to news,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories International Inc. (CRL) Halted due to news pending
CRL,2022-11-30,15:28:30,B13B68,Charles River Laboratories International Inc.,100,0.48,equity-actions,resumed,Charles River Laboratories International Inc. (CRL) Resumed Trading,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories International Inc. (CRL) Resumed Trading
CRL,2022-12-05,19:27:28,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp LaPlume Registers 6,409 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP LaPlume Registers 6,409 Of Charles River Labs Intl Inc >CRL"
CRL,2022-12-05,21:56:09,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp LaPlume Sells 6,409 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Sells 6,409 Of Charles River Labs Intl Inc >CRL"
CRL,2022-12-05,22:16:26,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Barbo Registers 3,205 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Barbo Registers 3,205 Of Charles River Labs Intl Inc >CRL"
CRL,2022-12-06,21:13:23,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Dir Wallman Buys 1,500 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Wallman Buys 1,500 Of Charles River Labs Intl Inc >CRL"
CRL,2022-12-06,21:42:44,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Barbo Sells 3,205 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Sells 3,205 Of Charles River Labs Intl Inc >CRL"
CRL,2024-09-05,13:08:00,E686E5,CCR Technologies Ltd.,99,0.44,products-services,,CCR Technologies Ltd.: Transforming technology as,PRESS-RELEASE,Business Wire,"Circle Computer Resources Launches Holding Company Model, as CCR Technologies"
CRL,2024-09-05,13:08:00,E686E5,CCR Technologies Ltd.,99,0.44,products-services,,CCR Technologies Ltd.: Transforming technology as,PRESS-RELEASE,Business Wire,"Circle Computer Resources Launches Holding Company Model, as CCR Technologies"
CRL,2023-01-09,21:15:00,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2023-01-09,21:15:20,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2023-01-11,14:52:31,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Baird
CRL,2023-01-11,14:52:31,B13B68,Charles River Laboratories International Inc.,100,0.48,price-targets,upgrade,Charles River Labs Price Target Raised to $285.00/Share From $275.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $285.00/Share From $275.00 by Baird
CRL,2023-01-12,13:00:02,B13B68,Charles River Laboratories International Inc.,99,0.52,products-services,,Charles River will officially launch the eXpDNA platform during,PRESS-RELEASE,Business Wire,Charles River Establishes eXpDNA(TM) Plasmid Manufacturing Platform to Expedite DNA Programs
CRL,2023-01-12,13:00:11,B13B68,Charles River Laboratories International Inc.,99,0.52,products-services,,Charles River will officially launch the eXpDNA platform during,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Establishes eXpDNA(TM) Plasmid Manufacturing Platform to Expedite DNA Programs
CRL,2023-01-18,13:00:00,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance,PRESS-RELEASE,Business Wire,Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
CRL,2023-01-18,13:00:00,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
CRL,2023-01-18,13:01:15,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance,NEWS-FLASH,Dow Jones Newswires,Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
CRL,2023-01-22,08:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 4Q 2022 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 4Q 2022 (CRL)"
CRL,2023-01-30,12:00:00,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,"Chief Executive Officer of Charles River Laboratories, commented, ""The acquisition of SAMDI Tech's cutting-edge, high-throughput screening technology",PRESS-RELEASE,Business Wire,Charles River Laboratories Acquires SAMDI Tech
CRL,2023-01-30,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.62,acquisitions-mergers,,"Chief Executive Officer of Charles River Laboratories, commented, ""The acquisition of SAMDI Tech's cutting-edge, high-throughput screening technology",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Acquires SAMDI Tech
CRL,2023-01-30,21:38:15,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Knell Acquires 1,451 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Knell Acquires 1,451 Of Charles River Labs Intl Inc >CRL"
CRL,2023-01-30,21:44:35,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp LaPlume Acquires 5,415 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Acquires 5,415 Of Charles River Labs Intl Inc >CRL"
CRL,2023-01-30,21:45:02,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Coo Girshick Acquires 5,282 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"COO Girshick Acquires 5,282 Of Charles River Labs Intl Inc >CRL"
CRL,2023-01-30,21:50:19,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Barbo Acquires 4,960 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Acquires 4,960 Of Charles River Labs Intl Inc >CRL"
CRL,2023-01-30,23:04:46,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Creamer Acquires 4,537 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Creamer Acquires 4,537 Of Charles River Labs Intl Inc >CRL"
CRL,2023-01-30,23:08:10,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Vp Parisotto Acquires 3,511 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"VP Parisotto Acquires 3,511 Of Charles River Labs Intl Inc >CRL"
CRL,2023-01-31,22:59:13,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,"Chmn Foster Surrenders 21,453 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Surrenders 21,453 Of Charles River Labs Intl Inc >CRL"
CRL,2023-02-09,13:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call
CRL,2023-02-09,13:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2022 financial results and provide 2023 guidance on Wednesday, February 22",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call
CRL,2023-02-09,13:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2022 financial results and provide 2023 guidance on Wednesday, February 22",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call
CRL,2023-02-09,13:34:34,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call
CRL,2023-02-09,13:34:34,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2022 financial results and provide 2023 guidance on Wednesday, February 22",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call
CRL,2023-02-09,13:34:34,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2022 financial results and provide 2023 guidance on Wednesday, February 22",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call
CRL,2023-02-13,13:00:01,B13B68,Charles River Laboratories International Inc.,100,0.52,products-services,,"Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its first Enzyme-Linked Immunosorbent Assay",PRESS-RELEASE,Business Wire,Charles River Launches Novel IgY-based ELISA Kit for the Detection and Quantitation of Residual Host Cell Protein
CRL,2023-02-13,13:01:00,B13B68,Charles River Laboratories International Inc.,100,0.52,products-services,,"Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its first Enzyme-Linked Immunosorbent Assay",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Launches Novel IgY-based ELISA Kit for the Detection and Quantitation of Residual Host Cell Protein
CRL,2023-02-15,21:31:00,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration,PRESS-RELEASE,Business Wire,Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
CRL,2023-02-15,21:31:10,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
CRL,2023-02-15,21:40:50,B13B68,Charles River Laboratories International Inc.,100,0.49,partnerships,,Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration,NEWS-FLASH,Dow Jones Newswires,Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
CRL,2023-02-16,20:15:38,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Chmn Foster Registers 37,436 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"Chmn Foster Registers 37,436 Of Charles River Labs Intl Inc >CRL"
CRL,2023-02-17,21:05:46,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Chmn Foster Sells 20,000 Of Charles River Labs Intl Inc",FULL-ARTICLE,Dow Jones Newswires,"Chmn Foster Sells 20,000 Of Charles River Labs Intl Inc >CRL"
CRL,2023-02-17,22:30:42,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Coo Girshick Sells 3,205 Of Charles River Labs Intl Inc",FULL-ARTICLE,Dow Jones Newswires,"COO Girshick Sells 3,205 Of Charles River Labs Intl Inc >CRL"
CRL,2023-02-21,21:28:56,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Vp Parisotto Registers 4,558 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Parisotto Registers 4,558 Of Charles River Labs Intl Inc >CRL"
CRL,2023-02-21,22:00:59,B13B68,Charles River Laboratories International Inc.,100,-0.48,insider-trading,,"Coo Girshick Registers 3,205 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"COO Girshick Registers 3,205 Of Charles River Labs Intl Inc >CRL"
CRL,2023-02-21,22:41:04,B13B68,Charles River Laboratories International Inc.,100,-0.49,insider-trading,,"Vp Parisotto Sells 4,558 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Parisotto Sells 4,558 Of Charles River Labs Intl Inc >CRL"
CRL,2023-02-22,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q EPS $3.65,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q EPS $3.65 >CRL
CRL,2023-02-22,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q Adj EPS $2.98,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Adj EPS $2.98 >CRL
CRL,2023-02-22,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Labs 4Q Net $187.4M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Net $187.4M >CRL
CRL,2023-02-22,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Labs 4Q Rev $1.1B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Rev $1.1B >CRL
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Fourth-Quarter Segment Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Full-Year Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $1.10 billion, an increase of 21.5%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Fourth-Quarter GAAP Earnings per Share of $3.65,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Full-Year GAAP Earnings per Share of $9.48,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Provides 2023 Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Explora BioLabs in April 2022 contributed 1.8,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Fourth-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.64,earnings,up,Charles River Laboratories International Inc.: The increases in GAAP net income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $152.9 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.64,earnings,up,Charles River Laboratories International Inc.: The increases in non-GAAP net income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $196.1 million in the fourth quarter of 2022,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.65,revenues,up,Charles River Laboratories International Inc.: The Discovery Services revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,-0.65,revenues,down,Charles River Laboratories International Inc.: The GAAP operating margin also decreased,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For 2022, DSA revenue was $2.45 billion, an increase of 16.1%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,100,-0.47,regulatory,,Charles River Laboratories International Inc.: U.S. Department of Justice Investigation into,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share in 2023,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: The Company's 2023 guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 1.5%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: GAAP EPS estimate (2) $7.40,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $9.70 -- $10.90,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $ 900,698 $ 709,819",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,602,770 $ 7,024,292",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,92,-0.65,earnings,negative,Charles River Laboratories International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,97,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,97,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $1,099,843 $ 905,050",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,97,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-02-22,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 21.5%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For the quarter, revenue was $1.10 billion, an increase of 21.5%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Fourth-Quarter GAAP Earnings per Share of $3.65,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River Laboratories International Inc.: Full-Year GAAP Earnings per Share of $9.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Provides 2023 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.62,acquisitions-mergers,,Charles River Laboratories International Inc.: The acquisition of Explora BioLabs in April 2022 contributed 1.8,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: Fourth-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,"Charles River Laboratories International Inc.: On a non-GAAP basis, net income was $152.9 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.0,revenues,,Charles River Laboratories International Inc.: Revenue for the RMS segment was $196.1 million in the fourth quarter of 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.65,revenues,up,Charles River Laboratories International Inc.: The Discovery Services revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,-0.65,revenues,down,Charles River Laboratories International Inc.: The GAAP operating margin also decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,0.41,revenues,up,"Charles River Laboratories International Inc.: For 2022, DSA revenue was $2.45 billion, an increase of 16.1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,100,-0.47,regulatory,,Charles River Laboratories International Inc.: U.S. Department of Justice Investigation into,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share in 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: The Company's 2023 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 1.5%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: GAAP EPS estimate (2) $7.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River Laboratories International Inc.: Non-GAAP EPS estimate $9.70 -- $10.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.0,revenues,,"Charles River Laboratories International Inc.: Service revenue $ 900,698 $ 709,819",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.0,assets,,"Charles River Laboratories International Inc.: Total assets $ 7,602,770 $ 7,024,292",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,92,-0.65,earnings,negative,Charles River Laboratories International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,92,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,97,0.0,earnings,,Charles River Laboratories International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,97,0.0,revenues,,"Charles River Laboratories International Inc.: Total Revenue $1,099,843 $ 905,050",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,97,0.0,earnings,,Charles River Laboratories International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-02-22,12:01:01,B13B68,Charles River Laboratories International Inc.,99,0.41,revenues,up,"Charles River Laboratories International Inc.: Revenue growth, reported 21.5%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2023-02-22,12:01:03,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Labs Sees 2023 EPS $7.40,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2023 EPS $7.40-EPS $8.60 >CRL
CRL,2023-02-22,12:01:24,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Labs Sees 2023 Adj EPS $9.70,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2023 Adj EPS $9.70-Adj EPS $10.90 >CRL
CRL,2023-02-22,12:01:40,B13B68,Charles River Laboratories International Inc.,100,0.48,revenues,up,Charles River Labs Sees 2023 Revenue Growth of 1.5%-4.5%,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2023 Revenue Growth of 1.5%-4.5% >CRL
CRL,2023-02-22,12:24:17,B13B68,Charles River Laboratories International Inc.,100,0.42,revenues,up,Charles River Laboratories International Inc.'s fourth-quarter revenue climbed almost 22%,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Posts Higher 4Q Revenue
CRL,2023-02-22,12:55:29,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: The company reported fourth-quarter net income,FULL-ARTICLE,MarketWatch,"MW Charles River Labs stock tumbles after DOJ subpoena disclosed, downbeat profit outlook"
CRL,2023-02-22,12:55:29,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: The company reported fourth-quarter net income,FULL-ARTICLE,Dow Jones Newswires,"Charles River Labs Stock Tumbles After DOJ Subpoena Disclosed, Downbeat Profit Outlook -- MarketWatch"
CRL,2023-02-22,14:39:52,B13B68,Charles River Laboratories International Inc.,99,-0.8,earnings,below-expectations,Charles River's profit guidance also missed,FULL-ARTICLE,Dow Jones Newswires,Charles River Dives As Monkey Investigation Hamstrings 2023 Outlook -- IBD
CRL,2023-02-22,14:39:52,B13B68,Charles River Laboratories International Inc.,99,0.61,earnings,positive,Charles River earned $2.98 per share,FULL-ARTICLE,Dow Jones Newswires,Charles River Dives As Monkey Investigation Hamstrings 2023 Outlook -- IBD
CRL,2023-02-22,14:39:52,B13B68,Charles River Laboratories International Inc.,99,0.65,revenues,up,Charles River noted sales grew,FULL-ARTICLE,Dow Jones Newswires,Charles River Dives As Monkey Investigation Hamstrings 2023 Outlook -- IBD
CRL,2023-02-22,14:39:52,B13B68,Charles River Laboratories International Inc.,99,0.48,revenues,up,Charles River expects organic sales growth of 4.5% to 7.5% in 2023,FULL-ARTICLE,Dow Jones Newswires,Charles River Dives As Monkey Investigation Hamstrings 2023 Outlook -- IBD
CRL,2023-02-22,16:56:34,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: The company also reported fourth-quarter results,FULL-ARTICLE,MarketWatch,"MW Charles River Labs stock tumbles after Justice Department subpoena disclosed, downbeat profit outlook"
CRL,2023-02-22,18:00:12,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: The company also reported fourth-quarter results,FULL-ARTICLE,Dow Jones Newswires,"Charles River Labs stock tumbles after Justice Department subpoena disclosed, downbeat profit outlook"
CRL,2023-02-22,18:48:00,B13B68,Charles River Laboratories International Inc.,99,-0.52,legal,,"Cruz announces an investigation of Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,Business Wire,"The Law Offices of Frank R. Cruz Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors"
CRL,2023-02-22,19:31:59,B13B68,Charles River Laboratories International Inc.,100,-0.8,earnings,below-expectations,Charles River's profit outlook also missed,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-02-22,19:31:59,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River earned $2.98 per share,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-02-22,19:31:59,B13B68,Charles River Laboratories International Inc.,100,0.65,revenues,up,Charles River noted sales grew,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-02-22,19:31:59,B13B68,Charles River Laboratories International Inc.,100,0.48,revenues,up,Charles River expects organic sales growth of 4.5% to 7.5% in 2023,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-02-22,20:21:06,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-02-22,21:06:15,B13B68,Charles River Laboratories International Inc.,100,-0.8,earnings,below-expectations,Charles River's profit outlook also missed,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-02-22,21:06:15,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River earned $2.98 per share,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-02-22,21:06:15,B13B68,Charles River Laboratories International Inc.,100,0.65,revenues,up,Charles River noted sales grew,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-02-22,21:06:15,B13B68,Charles River Laboratories International Inc.,100,0.48,revenues,up,Charles River expects organic sales growth of 4.5% to 7.5% in 2023,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-02-22,21:27:51,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Coo Girshick Surrenders 308 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,COO Girshick Surrenders 308 Of Charles River Labs Intl Inc >CRL
CRL,2023-02-22,21:30:05,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 317 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Surrenders 317 Of Charles River Labs Intl Inc >CRL
CRL,2023-02-22,21:56:51,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 287 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 287 Of Charles River Labs Intl Inc >CRL
CRL,2023-02-22,22:08:39,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 51 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Surrenders 51 Of Charles River Labs Intl Inc >CRL
CRL,2023-02-22,22:15:08,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,"Chmn Foster Surrenders 1,814 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Surrenders 1,814 Of Charles River Labs Intl Inc >CRL"
CRL,2023-02-22,22:24:39,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Parisotto Surrenders 136 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Parisotto Surrenders 136 Of Charles River Labs Intl Inc >CRL
CRL,2023-02-22,22:33:36,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 524 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 524 Of Charles River Labs Intl Inc >CRL
CRL,2023-02-23,12:02:39,B13B68,Charles River Laboratories International Inc.,100,0.94,analyst-ratings,positive,Charles River Labs Raised to Buy From Neutral by Guggenheim,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raised to Buy From Neutral by Guggenheim
CRL,2023-02-23,12:02:39,B13B68,Charles River Laboratories International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $255.00/Share by Guggenheim,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $255.00/Share by Guggenheim
CRL,2023-02-23,12:21:48,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,Charles River Laboratories International Inc.: The company also reported fourth-quarter results,FULL-ARTICLE,MarketWatch,"MW Charles River Labs stock tumbles after Justice Department subpoena disclosed, downbeat profit outlook"
CRL,2023-02-23,12:51:30,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by Citigroup
CRL,2023-02-23,12:51:30,B13B68,Charles River Laboratories International Inc.,100,-0.68,price-targets,downgrade,Charles River Labs Price Target Cut to $260.00/Share From $280.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $260.00/Share From $280.00 by Citigroup
CRL,2023-02-23,13:28:30,B13B68,Charles River Laboratories International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley
CRL,2023-02-23,13:28:30,B13B68,Charles River Laboratories International Inc.,100,-0.56,price-targets,downgrade,Charles River Labs Price Target Cut to $230.00/Share From $241.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $230.00/Share From $241.00 by Morgan Stanley
CRL,2023-02-23,14:20:10,B13B68,Charles River Laboratories International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Credit Suisse
CRL,2023-02-23,14:20:10,B13B68,Charles River Laboratories International Inc.,100,-0.68,price-targets,downgrade,Charles River Labs Price Target Cut to $260.00/Share From $280.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $260.00/Share From $280.00 by Credit Suisse
CRL,2023-02-24,00:32:27,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-02-24,21:25:14,B13B68,Charles River Laboratories International Inc.,100,0.52,insider-trading,,"Dir Wallman Buys 1,750 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Wallman Buys 1,750 Of Charles River Labs Intl Inc >CRL"
CRL,2023-02-25,02:00:00,B13B68,Charles River Laboratories International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,Business Wire,"CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Charles River Stockholders and Encourages Investors to Contact the Firm"
CRL,2023-02-27,00:27:24,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-02-28,00:12:25,B13B68,Charles River Laboratories International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-03-01,20:42:11,B13B68,Charles River Laboratories International Inc.,100,-0.8,earnings,below-expectations,Charles River's profit outlook also missed,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-03-01,20:42:11,B13B68,Charles River Laboratories International Inc.,100,0.61,earnings,positive,Charles River earned $2.98 per share,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-03-01,20:42:11,B13B68,Charles River Laboratories International Inc.,100,0.65,revenues,up,Charles River noted sales grew,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-03-01,20:42:11,B13B68,Charles River Laboratories International Inc.,100,0.48,revenues,up,Charles River expects organic sales growth of 4.5% to 7.5% in 2023,FULL-ARTICLE,Dow Jones Newswires,"Charles River Tumbles As DOJ, PETA Zero In On Monkey Shipments -- IBD"
CRL,2023-03-02,00:15:26,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-03-03,00:32:28,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-03-04,01:25:28,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-03-05,12:27:24,B13B68,Charles River Laboratories International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-03-07,00:12:26,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-03-08,21:21:14,B13B68,Charles River Laboratories International Inc.,100,0.0,insider-trading,,Coo Girshick Gifts 475 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,COO Girshick Gifts 475 Of Charles River Labs Intl Inc >CRL
CRL,2023-03-09,00:15:25,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-03-11,01:26:07,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-03-13,12:00:01,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Barclays Global Healthcare Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL,2023-03-13,12:00:01,B13B68,Charles River Laboratories International Inc.,99,0.52,products-services,,"Charles River Laboratories International, Inc. (NYSE: CRL) today launched Apollo(TM), an industry-leading, secure, cloud-based platform for drug",PRESS-RELEASE,Business Wire,"Charles River Launches Apollo(TM), an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data"
CRL,2023-03-13,12:00:40,B13B68,Charles River Laboratories International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL,2023-03-13,12:01:10,B13B68,Charles River Laboratories International Inc.,99,0.52,products-services,,"Charles River Laboratories International, Inc. (NYSE: CRL) today launched Apollo(TM), an industry-leading, secure, cloud-based platform for drug",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Launches Apollo(TM), an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data"
CRL,2023-03-13,23:12:28,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-03-14,23:12:24,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-03-15,23:15:26,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-03-18,00:25:26,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-03-19,11:27:25,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-03-20,23:12:25,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-03-22,23:15:27,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-03-25,00:25:47,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-03-25,13:31:37,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-03-28,14:21:16,B13B68,Charles River Laboratories International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Hold by Jefferies,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Hold by Jefferies
CRL,2023-03-28,14:21:16,B13B68,Charles River Laboratories International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $203.00/Share From $233.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $203.00/Share From $233.00 by Jefferies
CRL,2023-03-29,23:15:49,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-04-01,00:25:46,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-04-02,23:27:45,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-04-03,23:32:47,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-04-05,23:15:49,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-04-08,00:25:48,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-04-09,23:27:45,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-04-10,12:00:02,B13B68,Charles River Laboratories International Inc.,99,0.49,partnerships,,Charles River announced a strategic partnership with Kibur Medical to,PRESS-RELEASE,Business Wire,Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
CRL,2023-04-10,12:00:40,B13B68,Charles River Laboratories International Inc.,99,0.49,partnerships,,Charles River announced a strategic partnership with Kibur Medical to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
CRL,2023-04-10,23:32:46,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-04-11,12:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
CRL,2023-04-11,12:30:01,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2023 financial results on Thursday, May 11",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
CRL,2023-04-11,12:36:13,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
CRL,2023-04-11,12:36:13,B13B68,Charles River Laboratories International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2023 financial results on Thursday, May 11",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
CRL,2023-04-12,23:15:50,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-04-15,00:25:46,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-04-17,23:32:45,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-04-19,23:15:45,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-04-22,00:25:45,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-04-22,07:27:54,B13B68,Charles River Laboratories International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 1Q 2023 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 1Q 2023 (CRL)"
CRL,2023-04-23,11:27:48,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-04-24,23:32:45,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-04-26,23:15:51,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-04-29,00:25:47,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-04-30,11:27:49,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-05-01,12:00:04,B13B68,Charles River Laboratories International Inc.,100,0.52,products-services,,Charles River Laboratories Launches Next Generation Sequencing Services,PRESS-RELEASE,Business Wire,Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
CRL,2023-05-01,12:02:30,B13B68,Charles River Laboratories International Inc.,100,0.52,products-services,,Charles River Laboratories Launches Next Generation Sequencing Services,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
CRL,2023-05-01,12:03:26,B13B68,Charles River Laboratories International Inc.,100,0.52,products-services,,Charles River Laboratories Launches Next Generation Sequencing Services,NEWS-FLASH,Dow Jones Newswires,Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
CRL,2023-05-01,23:32:50,B13B68,Charles River Laboratories International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-05-03,23:15:52,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-05-06,00:25:50,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-05-07,11:27:47,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-05-08,23:32:47,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-05-10,23:15:49,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q EPS $2.01,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q EPS $2.01 >CRL
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q Adj EPS $2.78,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Adj EPS $2.78 >CRL
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q Net $103.1M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Net $103.1M >CRL
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 1Q Rev $1.03B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Rev $1.03B >CRL
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Laboratories Announces First-Quarter 2023 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For the quarter, revenue was $1.03 billion, an increase of 12.6%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: First-Quarter GAAP Earnings per Share of $2.01,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: GAAP earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $143.0 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: our financial guidance for 2023,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $199.8 million in the first quarter of 2023,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.90 -- $10.90,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 857,366 $ 720,485",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,92,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,699,439 $ 7,602,770",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,92,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,98,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,98,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $ 1,029,373 $ 913,929",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-05-11,11:00:00,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 12.6 %",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: First-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For the quarter, revenue was $1.03 billion, an increase of 12.6%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: First-Quarter GAAP Earnings per Share of $2.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: GAAP earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $143.0 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: our financial guidance for 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $199.8 million in the first quarter of 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.90 -- $10.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2023 Results
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 857,366 $ 720,485",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,92,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,699,439 $ 7,602,770",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,92,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,98,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,98,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $ 1,029,373 $ 913,929",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-05-11,11:00:40,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 12.6 %",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-05-11,11:01:49,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Labs Narrows 2023 View To Adj EPS $9.90,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Narrows 2023 View To Adj EPS $9.90-Adj EPS $10.90 >CRL
CRL,2023-05-11,11:02:16,B13B68,Charles River Labs International Inc.,100,-0.75,revenues,down,Charles River Labs Narrows 2023 Revenue Growth View to 2.0%-4.5%,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Narrows 2023 Revenue Growth View to 2.0%-4.5% >CRL
CRL,2023-05-11,11:02:48,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Labs Narrows 2023 View To EPS $7.45,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Narrows 2023 View To EPS $7.45-EPS $8.45 >CRL
CRL,2023-05-11,11:48:56,B13B68,Charles River Labs International Inc.,100,0.64,earnings,up,"Charles River Laboratories 1Q Sales, Earnings Rise",FULL-ARTICLE,Dow Jones Newswires,"Charles River Laboratories 1Q Sales, Earnings Rise"
CRL,2023-05-11,20:15:41,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Dir Massaro Registers 288 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,Dir Massaro Registers 288 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-12,11:24:54,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Wells Fargo
CRL,2023-05-12,11:24:54,B13B68,Charles River Labs International Inc.,100,-0.48,price-targets,downgrade,Charles River Labs Price Target Cut to $280.00/Share From $290.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $280.00/Share From $290.00 by Wells Fargo
CRL,2023-05-12,12:43:55,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Credit Suisse
CRL,2023-05-12,12:43:55,B13B68,Charles River Labs International Inc.,100,-0.36,price-targets,downgrade,Charles River Labs Price Target Cut to $255.00/Share From $260.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $255.00/Share From $260.00 by Credit Suisse
CRL,2023-05-12,18:54:32,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 959 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 959 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-13,00:25:51,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-05-14,11:27:48,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-05-15,18:24:36,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 345 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 345 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-15,18:43:47,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Dir Massaro Sells 288 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Massaro Sells 288 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-15,18:50:58,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 959 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Sells 959 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-15,23:32:51,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Investor Alert
CRL,2023-05-16,18:20:10,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 345 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Sells 345 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-17,21:37:31,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,"Chmn Foster Gifts 7,623 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Gifts 7,623 Of Charles River Labs Intl Inc >CRL"
CRL,2023-05-17,23:15:46,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-05-19,22:28:00,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.",PRESS-RELEASE,Business Wire,"CRL CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc."
CRL,2023-05-20,12:14:41,B13B68,Charles River Labs International Inc.,100,-0.52,legal,,Charles River Faces Shareholder Class Action Lawsuit,PRESS-RELEASE,GlobeNewswire,Charles River Faces Shareholder Class Action Lawsuit: Johnson Fistel Encourages Investors to Seek Compensation for Alleged Wrongdoings -- CRL
CRL,2023-05-21,11:27:48,B13B68,Charles River Labs International Inc.,98,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-05-21,16:00:00,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Cruz Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.",PRESS-RELEASE,Business Wire,"CRL CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc."
CRL,2023-05-22,01:00:00,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,Business Wire,"CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc. and Encourages Investors to Contact the Firm"
CRL,2023-05-22,17:42:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,GlobeNewswire,"Class Action Lawsuit Filed on Behalf of Charles River Laboratories International, Inc. (CRL) Investors - Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm"
CRL,2023-05-22,18:52:40,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-05-22,20:25:40,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Grabar Law Office Investigates Claims on Behalf of Shareholders of Charles River Laboratories International, Inc. (CRL)"
CRL,2023-05-22,22:00:32,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc. (CRL)",PRESS-RELEASE,GlobeNewswire,"Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc. (CRL)"
CRL,2023-05-22,22:03:50,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-05-23,12:15:01,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc.",PRESS-RELEASE,GlobeNewswire,"CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc."
CRL,2023-05-23,15:01:38,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-05-23,18:25:07,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE: CRL",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023"
CRL,2023-05-23,22:06:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River issued a press release announcing its fourth quarter and full year 2022 financial results,PRESS-RELEASE,Business Wire,"Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors"
CRL,2023-05-23,22:36:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-05-24,12:15:03,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc."
CRL,2023-05-24,12:46:49,B13B68,Charles River Labs International Inc.,100,-0.52,legal,,"Lawsuits FILED AGAINST TGT, MARA and CRL",PRESS-RELEASE,DJ Global Press Release Wire,"LAWSUITS FILED AGAINST TGT, MARA and CRL - Jakubowitz Law Pursues Shareholders Claims"
CRL,2023-05-24,14:00:10,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,PR Newswire,"Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-05-24,22:49:45,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-05-25,01:00:02,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River",PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River and Encourages Investors to Contact the Firm"
CRL,2023-05-25,20:10:30,B13B68,Charles River Labs International Inc.,100,-0.52,legal,,"Lawsuits FILED AGAINST MPW, VIRT and CRL",PRESS-RELEASE,DJ Global Press Release Wire,"LAWSUITS FILED AGAINST MPW, VIRT and CRL - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS"
CRL,2023-05-26,12:30:43,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Grabar Law Office Investigates Claims on Behalf of Shareholders of Charles River Laboratories International, Inc. (CRL)"
CRL,2023-05-26,17:28:24,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Charles River Laboratories International, Inc. (CRL)",PRESS-RELEASE,GlobeNewswire,"Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Charles River Laboratories International, Inc. (CRL)"
CRL,2023-05-26,22:27:51,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-05-27,01:03:12,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (CRL)",PRESS-RELEASE,DJ Global Press Release Wire,"Attention CRL Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (CRL) and Encourages Investors to Contact the Firm"
CRL,2023-05-27,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-05-27,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-05-27,15:00:54,B13B68,Charles River Labs International Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"CRL CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Charles River Laboratories International, Inc."
CRL,2023-05-28,11:27:47,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-05-29,23:03:48,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-05-30,13:45:02,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Kessler Topaz Meltzer & Check, LLP: Announces Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,PR Newswire,"Kessler Topaz Meltzer & Check, LLP: Announces Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (NYSE: CRL)"
CRL,2023-05-30,13:45:02,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Kessler Topaz Meltzer & Check, LLP: Announces Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Kessler Topaz Meltzer & Check, LLP: Announces Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (NYSE: CRL)"
CRL,2023-05-30,14:12:47,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action complaint has been filed against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Grabar Law Office Investigates Claims on Behalf of Shareholders of Charles River Laboratories International, Inc. (CRL)"
CRL,2023-05-30,15:00:00,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,Business Wire,"Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-05-30,23:04:45,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-05-31,01:00:01,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class Action Lawsuits Have Been Filed Against Disney, Charles River, and TD",PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Disney, Charles River, and TD and Encourages Investors to Contact the Firm"
CRL,2023-05-31,12:00:01,B13B68,Charles River Labs International Inc.,99,0.52,products-services,,Charles River Labs International Inc.: Deployed on-site at,PRESS-RELEASE,Business Wire,Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSource(SM) Laboratory
CRL,2023-05-31,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Charles River, in close collaboration with Wheeler, will set up a CGMP testing lab",PRESS-RELEASE,Business Wire,Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSource(SM) Laboratory
CRL,2023-05-31,12:00:30,B13B68,Charles River Labs International Inc.,99,0.52,products-services,,Charles River Labs International Inc.: Deployed on-site at,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSourceSM Laboratory
CRL,2023-05-31,12:00:30,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Charles River, in close collaboration with Wheeler, will set up a CGMP testing lab",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSourceSM Laboratory
CRL,2023-05-31,14:30:03,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-05-31,14:30:03,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-05-31,15:00:00,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,Business Wire,"Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-05-31,15:35:21,B13B68,Charles River Labs International Inc.,100,0.39,products-services,,Bio and Charles River Laboratories Announce Agreement,PRESS-RELEASE,PR Newswire,Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource(SM) Laboratory
CRL,2023-05-31,15:35:21,B13B68,Charles River Labs International Inc.,100,0.52,products-services,,Charles River Labs International Inc.: Deployed on-site at,PRESS-RELEASE,PR Newswire,Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource(SM) Laboratory
CRL,2023-05-31,15:35:21,B13B68,Charles River Labs International Inc.,100,0.39,products-services,,Bio and Charles River Laboratories Announce Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource(SM) Laboratory
CRL,2023-05-31,15:35:21,B13B68,Charles River Labs International Inc.,100,0.52,products-services,,Charles River Labs International Inc.: Deployed on-site at,PRESS-RELEASE,Dow Jones Newswires,Press Release: Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource(SM) Laboratory
CRL,2023-05-31,15:36:04,B13B68,Charles River Labs International Inc.,100,0.39,products-services,,Bio and Charles River Laboratories Announce Agreement,NEWS-FLASH,Dow Jones Newswires,Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource Laboratory
CRL,2023-05-31,17:31:53,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Parisotto Surrenders 286 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Parisotto Surrenders 286 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-31,17:32:03,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 475 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 475 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-31,17:32:12,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Coo Girshick Surrenders 590 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,COO Girshick Surrenders 590 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-31,17:32:22,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Barbo Surrenders 480 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Barbo Surrenders 480 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-31,17:38:54,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,"Chmn Foster Surrenders 1,274 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Surrenders 1,274 Of Charles River Labs Intl Inc >CRL"
CRL,2023-05-31,18:40:52,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Pease Surrenders 137 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Pease Surrenders 137 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-31,20:19:52,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 96 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Surrenders 96 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-31,22:02:00,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Shareholder filed a class action against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,Business Wire,"Charles River Laboratories International, Inc. (CRL) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Charles River Laboratories International, Inc. Class Action"
CRL,2023-05-31,22:11:20,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 532 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Surrenders 532 Of Charles River Labs Intl Inc >CRL
CRL,2023-05-31,22:45:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River issued a press release announcing its fourth quarter and full year 2022 financial results,PRESS-RELEASE,Business Wire,"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Charles River Laboratories International, Inc. (CRL) Investors and Encourages Investors to Contact the Firm Before July 18, 2023"
CRL,2023-05-31,23:05:53,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-06-01,18:51:58,B13B68,Charles River Labs International Inc.,100,-0.03,credit-ratings,stable,"Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable",NEWS-FLASH,Dow Jones Newswires,"Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable"
CRL,2023-06-01,18:51:58,B13B68,Charles River Labs International Inc.,100,-0.03,credit-ratings,stable,"Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable"
CRL,2023-06-01,18:51:58,B13B68,Charles River Labs International Inc.,100,-0.04,credit-ratings,set,"Fitch's 'BBB-' rating for Charles River Laboratories International, Inc. (CRL)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable"
CRL,2023-06-01,18:52:08,B13B68,Charles River Labs International Inc.,100,0.0,credit-ratings,affirmation,Fitch Affirms Charles River,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Charles River -2-
CRL,2023-06-02,03:01:16,B13B68,Charles River Labs International Inc.,100,-0.52,legal,,"Lawsuits FILED AGAINST HBNC, IEP and CRL",PRESS-RELEASE,DJ Global Press Release Wire,"LAWSUITS FILED AGAINST HBNC, IEP and CRL - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS"
CRL,2023-06-02,15:33:41,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE: CRL",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023"
CRL,2023-06-02,17:00:38,B13B68,Charles River Labs International Inc.,100,-0.52,legal,,"Lawsuits FILED AGAINST STEM, VIRT and CRL",PRESS-RELEASE,DJ Global Press Release Wire,"LAWSUITS FILED AGAINST STEM, VIRT and CRL - Jakubowitz Law Pursues Shareholders Claims"
CRL,2023-06-02,21:08:46,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River issued a press release announcing its fourth quarter and full year 2022 financial results,PRESS-RELEASE,GlobeNewswire,"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Charles River Laboratories International, Inc. (CRL) Investors and Encourages Investors to Contact the Firm Before July 18, 2023"
CRL,2023-06-02,22:27:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-06-03,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-06-03,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-06-03,19:04:33,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE:CRL",PRESS-RELEASE,DJ Global Press Release Wire,"CRL Investor Notification: Kessler Topaz Meltzer & Check, LLP Announces July 18, 2023 Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (CRL)"
CRL,2023-06-04,11:27:43,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-06-05,01:00:01,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River",PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River and Encourages Investors to Contact the Firm"
CRL,2023-06-05,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at William Blair and Jefferies Conferences,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at William Blair and Jefferies Conferences
CRL,2023-06-05,12:00:30,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at William Blair and Jefferies Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at William Blair and Jefferies Conferences
CRL,2023-06-05,19:12:33,B13B68,Charles River Labs International Inc.,100,-0.52,legal,,"Lawsuits FILED AGAINST HSAI, BYND and CRL",PRESS-RELEASE,DJ Global Press Release Wire,"LAWSUITS FILED AGAINST HSAI, BYND and CRL - Jakubowitz Law Pursues Shareholders Claims"
CRL,2023-06-05,22:03:45,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-06-06,22:53:41,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-06-06,23:17:42,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-06-07,20:28:39,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE: CRL",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR REMINDER: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023"
CRL,2023-06-07,23:22:45,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-06-08,20:30:00,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration,PRESS-RELEASE,Business Wire,Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration
CRL,2023-06-08,20:30:00,B13B68,Charles River Labs International Inc.,100,0.84,products-services,positive,Charles River Labs International Inc.: CDMO will perform HQ plasmid production in support of Phase I/II clinical trials,PRESS-RELEASE,Business Wire,Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration
CRL,2023-06-08,20:30:00,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration
CRL,2023-06-08,20:30:00,B13B68,Charles River Labs International Inc.,100,0.84,products-services,positive,Charles River Labs International Inc.: CDMO will perform HQ plasmid production in support of Phase I/II clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration
CRL,2023-06-08,20:32:15,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and INADcure: Announce Gene Therapy Manufacturing Collaboration,NEWS-FLASH,Dow Jones Newswires,Charles River and INADcure: Announce Gene Therapy Manufacturing Collaboration
CRL,2023-06-08,20:45:08,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE:CRL",PRESS-RELEASE,DJ Global Press Release Wire,"Charles River Laboratories International, Inc. Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds CRL Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf"
CRL,2023-06-09,11:31:29,B13B68,Charles River Labs International Inc.,100,-0.52,legal,,"Lawsuits FILED AGAINST LPSN, IEP and CRL",PRESS-RELEASE,DJ Global Press Release Wire,"LAWSUITS FILED AGAINST LPSN, IEP and CRL - Jakubowitz Law Pursues Shareholders Claims"
CRL,2023-06-09,16:16:11,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Shareholder filed a class action against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,GlobeNewswire,"Charles River Laboratories International, Inc. (CRL) Equity Alert: Robbins LLP Urges Charles River Laboratories International, Inc. Investors to Contact the Firm"
CRL,2023-06-09,22:27:45,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-06-10,01:00:01,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class Action Lawsuits Have Been Filed Against Charles River, Virtu, and Cutera",PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Charles River, Virtu, and Cutera and Encourages Investors to Contact the Firm"
CRL,2023-06-10,11:59:47,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CHARLES RIVER SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-06-10,11:59:57,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CHARLES RIVER SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-06-11,11:27:44,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-06-12,13:00:03,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-06-12,13:00:20,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-06-12,21:19:27,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River issued a press release announcing its fourth quarter and full year 2022 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Charles River Laboratories International, Inc. (CRL) Investors and Encourages Investors to Contact the Firm Before July 18, 2023"
CRL,2023-06-13,18:49:06,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE: CRL",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR REMINDER: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023"
CRL,2023-06-13,22:36:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-06-14,13:30:52,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River issued a press release announcing its fourth quarter and full year 2022 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Charles River Laboratories International, Inc. (CRL) Investors and Encourages Investors to Contact the Firm Before July 18, 2023"
CRL,2023-06-14,22:13:01,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Shareholder filed a class action against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,GlobeNewswire,"Charles River Laboratories (CRL) Equity Notice: Contact Robbins LLP if you are a Shareholder Who Suffered Significant Losses in Charles River Laboratories International, Inc."
CRL,2023-06-14,22:49:47,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-06-15,00:08:08,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"")(NYSE:CRL",PRESS-RELEASE,DJ Global Press Release Wire,"Charles River Laboratories International, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on July 18, 2023 in Securities Fraud Class Action Lawsuit"
CRL,2023-06-15,01:00:01,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class Action Lawsuits Have Been Filed Against Charles River, Virtu, and Cutera",PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Charles River, Virtu, and Cutera and Encourages Investors to Contact the Firm"
CRL,2023-06-15,14:32:04,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE: CRL",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR REMINDER: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023"
CRL,2023-06-16,21:01:15,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River issued a press release announcing its fourth quarter and full year 2022 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Charles River Laboratories International, Inc. (CRL) Investors and Encourages Investors to Contact the Firm Before July 18, 2023"
CRL,2023-06-16,22:27:47,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-06-17,11:59:38,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CHARLES RIVER SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-06-17,11:59:38,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CHARLES RIVER SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-06-18,11:27:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-06-19,23:04:48,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE:CRL",PRESS-RELEASE,DJ Global Press Release Wire,"Kessler Topaz Meltzer & Check, LLP: Deadline Reminder for Charles River Laboratories International, Inc. (CRL) Investors"
CRL,2023-06-20,22:36:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-06-21,22:49:47,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-06-23,12:48:30,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River issued a press release announcing its fourth quarter and full year 2022 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Charles River Laboratories International, Inc. (CRL) Investors and Encourages Investors to Contact the Firm Before July 18, 2023"
CRL,2023-06-23,14:41:02,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-06-23,14:41:02,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-06-23,22:27:50,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-06-24,12:00:03,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CHARLES RIVER SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-06-24,12:00:03,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CHARLES RIVER SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-06-25,11:27:44,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-06-26,00:39:18,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE:CRL",PRESS-RELEASE,DJ Global Press Release Wire,"CRL Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (CRL)"
CRL,2023-06-26,16:17:02,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-06-26,16:17:12,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-06-26,22:36:48,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-06-27,01:54:39,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action complaint has been filed against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,DJ Global Press Release Wire,"Grabar Law Office Investigates Claims on Behalf of Shareholders of Charles River Laboratories International, Inc. (CRL)"
CRL,2023-06-27,22:42:47,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-06-28,22:49:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-06-29,13:34:51,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE: CRL",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR REMINDER: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023"
CRL,2023-06-29,22:55:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-06-30,00:11:46,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Securities Fraud Class Action Lawsuit Filed Against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Charles River Laboratories International, Inc. and Encourages Investors to Contact the Firm"
CRL,2023-06-30,21:15:11,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River issued a press release announcing its fourth quarter and full year 2022 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Charles River Laboratories International, Inc. (CRL) Investors and Encourages Investors to Contact the Firm Before July 18, 2023"
CRL,2023-06-30,23:02:52,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-07-01,01:00:01,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class Action Lawsuits Have Been Filed Against Charles River, Virtu, Cutera",PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Charles River, Virtu, Cutera, and Luminar and Encourages Investors to Contact the Firm"
CRL,2023-07-01,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-07-01,12:00:12,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-07-02,11:27:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-07-02,15:00:44,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all Charles River Laboratories International, Inc. (CRL) Investors: Please contact Bronstein, Gewirtz & Grossman, LLC Today to Recover Your Losses"
CRL,2023-07-03,15:03:09,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all Charles River Laboratories International, Inc. (CRL) Investors: Please contact Bronstein, Gewirtz & Grossman, LLC Today to Recover Your Losses"
CRL,2023-07-03,22:21:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-07-04,15:01:52,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all Charles River Laboratories International, Inc. (CRL) Investors: Please contact Bronstein, Gewirtz & Grossman, LLC Today to Recover Your Losses"
CRL,2023-07-04,22:29:44,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-07-05,13:14:00,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Securities Fraud Class Action Against Charles River Laboratories International, Inc. (CRL)",PRESS-RELEASE,Business Wire,"Kessler Topaz Meltzer & Check, LLP Reminds CRL Investors of July 18, 2023 Deadline in Securities Fraud Class Action Against Charles River Laboratories International, Inc. (CRL)"
CRL,2023-07-05,15:01:19,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): lead plaintiff deadline is July 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today"
CRL,2023-07-05,20:10:27,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE: CRL",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE APPROACHING: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023"
CRL,2023-07-05,22:49:45,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-07-06,01:00:03,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class Action Lawsuits Have Been Filed Against Stem, Disney, Charles River",PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, Charles River, and Virtu and Encourages Investors to Contact the Firm"
CRL,2023-07-06,15:02:55,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): lead plaintiff deadline is July 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today"
CRL,2023-07-06,21:53:17,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Securities Fraud Class Action Lawsuit Filed Against Charles River Laboratories International, Inc. (CRL)",PRESS-RELEASE,DJ Global Press Release Wire,"CRL SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Charles River Laboratories International, Inc. (CRL)"
CRL,2023-07-06,22:55:49,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-07-07,15:00:43,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all Investors Charles River Laboratories International, Inc. (CRL): Lead Plaintiff Deadline is July 18, 2023 - Contact Bronstein, Gewirtz & Grossman, LLC Today"
CRL,2023-07-07,20:04:38,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE:CRL",PRESS-RELEASE,DJ Global Press Release Wire,"Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm"
CRL,2023-07-07,23:02:50,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-07-08,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-07-08,12:00:03,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-07-09,11:27:41,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-07-09,15:08:16,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): lead plaintiff deadline is July 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today"
CRL,2023-07-09,19:57:00,B13B68,Charles River Labs International Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against Charles River Laboratories International, Inc. (CRL)",PRESS-RELEASE,GlobeNewswire,"CRL CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Charles River Laboratories International, Inc. (CRL)"
CRL,2023-07-10,11:40:21,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Neutral From Buy by Citigroup
CRL,2023-07-10,11:40:21,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $225.00/Share From $260.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $225.00/Share From $260.00 by Citigroup
CRL,2023-07-10,13:19:03,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CRL INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on July 18, 2023 in Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc."
CRL,2023-07-10,13:19:03,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CRL INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on July 18, 2023 in Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc."
CRL,2023-07-10,14:03:17,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): lead plaintiff deadline is July 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today"
CRL,2023-07-10,18:31:28,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-07-10,19:53:03,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-07-10,19:53:03,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-07-10,22:13:41,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-07-11,14:22:45,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Neutral From Buy by Citigroup
CRL,2023-07-11,14:22:45,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $225.00/Share From $260.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $225.00/Share From $260.00 by Citigroup
CRL,2023-07-11,15:05:26,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): lead plaintiff deadline is July 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today"
CRL,2023-07-11,16:13:18,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE:CRL",PRESS-RELEASE,DJ Global Press Release Wire,"Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit"
CRL,2023-07-11,17:05:38,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-07-11,20:21:03,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-07-11,20:21:03,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-07-11,22:21:45,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-07-12,13:05:46,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE: CRL",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE APPROACHING: Berger Montague Advises Charles River Laboratories International, Inc. (CRL) Investors to Inquire About a Securities Fraud Action by July 18, 2023"
CRL,2023-07-12,15:01:27,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): lead plaintiff deadline is July 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today"
CRL,2023-07-12,17:02:18,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-07-12,22:29:45,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-07-13,04:00:30,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): lead plaintiff deadline is July 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today"
CRL,2023-07-13,22:36:45,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-07-14,01:09:26,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE:CRL",PRESS-RELEASE,DJ Global Press Release Wire,"Deadline in 5 Days for Charles River Laboratories International, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. (CRL) Investors of Filing Deadline in Class Action Lawsuit"
CRL,2023-07-14,15:01:15,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all Investors Charles River Laboratories International, Inc. (CRL): Lead Plaintiff Deadline is July 18, 2023 - Contact Bronstein, Gewirtz & Grossman, LLC Today"
CRL,2023-07-14,17:01:11,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-07-14,20:15:27,B13B68,Charles River Labs International Inc.,100,-0.64,legal,,"Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (CRL)",PRESS-RELEASE,DJ Global Press Release Wire,"Attention CRL Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc. (CRL) and Encourages Investors to Contact the Firm"
CRL,2023-07-14,22:44:44,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-07-14,23:14:04,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-07-14,23:14:04,B13B68,Charles River Labs International Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit"
CRL,2023-07-15,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,PR Newswire,"CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-07-15,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options"
CRL,2023-07-15,20:03:36,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Securities class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River"") (NYSE:CRL",PRESS-RELEASE,DJ Global Press Release Wire,"CRL DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Charles River Laboratories International, Inc. (CRL) Securities Fraud Class Action Lawsuit"
CRL,2023-07-16,12:33:43,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Notice
CRL,2023-07-16,15:00:29,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): lead plaintiff deadline is July 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today"
CRL,2023-07-16,19:00:12,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-07-17,01:30:41,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class Action Lawsuits Have Been Filed Against Stem, Disney, Charles River",PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, Charles River, and Virtu and Encourages Investors to Contact the Firm"
CRL,2023-07-17,15:01:00,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): lead plaintiff deadline is July 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today"
CRL,2023-07-17,17:01:18,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate"
CRL,2023-07-17,21:17:39,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Deadline Alert
CRL,2023-07-18,13:00:57,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Charles River Laboratories International, Inc. (CRL) Investors of Class Action and Last Few Hours to Actively Participate"
CRL,2023-07-18,15:00:51,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against Charles River Laboratories International, Inc. (""Charles River",PRESS-RELEASE,DJ Global Press Release Wire,"Calling all investors Charles River Laboratories International, Inc. (CRL): final deadline - contact Bronstein, Gewirtz & Grossman, LLC now!"
CRL,2023-07-18,21:24:42,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,Charles River Shareholder Action Reminder
CRL,2023-07-19,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
CRL,2023-07-19,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2023 financial results on Wednesday, August 9",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
CRL,2023-07-19,12:04:57,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
CRL,2023-07-19,12:04:57,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2023 financial results on Wednesday, August 9",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
CRL,2023-08-01,12:00:03,B13B68,Charles River Labs International Inc.,99,0.46,equity-actions,,Charles River's most recent investment in Seattle,PRESS-RELEASE,Business Wire,"Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets"
CRL,2023-08-01,12:02:20,B13B68,Charles River Labs International Inc.,99,0.46,equity-actions,,Charles River's most recent investment in Seattle,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets"
CRL,2023-08-09,11:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q EPS $1.89,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q EPS $1.89 >CRL
CRL,2023-08-09,11:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Adj EPS $2.69,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Adj EPS $2.69 >CRL
CRL,2023-08-09,11:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Net $97M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Net $97M >CRL
CRL,2023-08-09,11:00:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 2Q Rev $1.06B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Rev $1.06B >CRL
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Second-Quarter 2023 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For the quarter, revenue was $1.06 billion, an increase of 8.9%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Second-Quarter GAAP Earnings per Share of $1.89,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: GAAP earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $138.3 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $209.9 million in the second quarter of 2023,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,-0.65,revenues,down,Charles River Labs International Inc.: The GAAP operating margin decline,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2023 guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.30 -- $10.90,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 874,891 $782,827",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,92,0.0,revenues,,Charles River Labs International Inc.: Total revenue,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,92,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,772,381 $ 7,602,770",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,92,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,96,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,96,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,059,937 $973,131",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-08-09,11:00:01,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 8.9%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Second-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For the quarter, revenue was $1.06 billion, an increase of 8.9%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Second-Quarter GAAP Earnings per Share of $1.89,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: GAAP earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $138.3 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $209.9 million in the second quarter of 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,-0.65,revenues,down,Charles River Labs International Inc.: The GAAP operating margin decline,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2023 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.30 -- $10.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2023 Results
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 874,891 $782,827",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,92,0.0,revenues,,Charles River Labs International Inc.: Total revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,92,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,92,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,772,381 $ 7,602,770",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,92,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,96,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,96,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,059,937 $973,131",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-08-09,11:01:30,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 8.9%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-08-09,11:05:17,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Labs Narrows 2023 View To EPS $7.60,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Narrows 2023 View To EPS $7.60-EPS $8.20 >CRL
CRL,2023-08-09,11:05:43,B13B68,Charles River Labs International Inc.,100,0.0,earnings,unchanged,Charles River Labs Backs 2023 Adj EPS $10.30,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Backs 2023 Adj EPS $10.30-Adj EPS $10.90 >CRL
CRL,2023-08-09,11:06:33,B13B68,Charles River Labs International Inc.,100,-0.75,revenues,down,Charles River Labs Narrows 2023 Revenue Growth Outlook to 2.5%-4.5%,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Narrows 2023 Revenue Growth Outlook to 2.5%-4.5% >CRL
CRL,2023-08-09,11:19:33,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,Charles River Labs' revenue rose 8.9% to $1.06 billion,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Sales Rise as Research Demand Persists
CRL,2023-08-10,13:28:46,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by B of A Securities
CRL,2023-08-10,13:28:46,B13B68,Charles River Labs International Inc.,100,0.52,price-targets,upgrade,Charles River Labs Price Target Raised to $245.00/Share From $235.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $245.00/Share From $235.00 by B of A Securities
CRL,2023-08-10,16:44:37,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by JP Morgan
CRL,2023-08-10,16:44:37,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $250.00/Share From $225.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $250.00/Share From $225.00 by JP Morgan
CRL,2023-08-10,17:57:33,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 700 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 700 Of Charles River Labs Intl Inc >CRL
CRL,2023-08-10,19:00:26,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp Knell Registers 1,471 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Knell Registers 1,471 Of Charles River Labs Intl Inc >CRL"
CRL,2023-08-10,19:54:52,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp Barbo Registers 5,763 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Barbo Registers 5,763 Of Charles River Labs Intl Inc >CRL"
CRL,2023-08-14,20:12:29,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 700 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Sells 700 Of Charles River Labs Intl Inc >CRL
CRL,2023-08-14,20:15:36,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,"Chmn Foster Gifts 2,500 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Gifts 2,500 Of Charles River Labs Intl Inc >CRL"
CRL,2023-08-14,20:19:07,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp Barbo Sells 5,763 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Barbo Sells 5,763 Of Charles River Labs Intl Inc >CRL"
CRL,2023-08-14,20:19:24,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp Knell Sells 1,471 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Knell Sells 1,471 Of Charles River Labs Intl Inc >CRL"
CRL,2023-08-19,08:02:21,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 2Q 2023 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 2Q 2023 (CRL)"
CRL,2023-08-23,01:00:01,B13B68,Charles River Labs International Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against Charles River Laboratories International, Inc. (NYSE: CRL)",PRESS-RELEASE,Business Wire,"CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm"
CRL,2023-08-29,20:24:25,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Dir Wallman Buys 1,000 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Wallman Buys 1,000 Of Charles River Labs Intl Inc >CRL"
CRL,2023-09-11,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL,2023-09-11,12:01:20,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL,2023-09-13,17:00:39,B13B68,Charles River Labs International Inc.,100,0.01,analyst-ratings,neutral,Charles River Labs Initiated at Market Perform by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Initiated at Market Perform by TD Cowen
CRL,2023-09-13,17:00:39,B13B68,Charles River Labs International Inc.,100,0.0,price-targets,set,Charles River Labs Price Target Announced at $212.00/Share by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Announced at $212.00/Share by TD Cowen
CRL,2023-09-14,12:00:02,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Related Sciences Enter Multi-Program Collaboration,PRESS-RELEASE,Business Wire,Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
CRL,2023-09-14,12:03:27,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Related Sciences Enter Multi-Program Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
CRL,2023-09-22,13:25:22,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by Wells Fargo
CRL,2023-09-22,13:25:22,B13B68,Charles River Labs International Inc.,100,-0.34,price-targets,downgrade,Charles River Labs Price Target Cut to $275.00/Share From $280.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $275.00/Share From $280.00 by Wells Fargo
CRL,2023-09-22,15:50:02,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by Guggenheim,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by Guggenheim
CRL,2023-09-22,15:50:02,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $225.00/Share From $255.00 by Guggenheim,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $225.00/Share From $255.00 by Guggenheim
CRL,2023-09-22,16:54:32,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Baird
CRL,2023-09-22,16:54:32,B13B68,Charles River Labs International Inc.,100,-0.52,price-targets,downgrade,Charles River Labs Price Target Cut to $256.00/Share From $267.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $256.00/Share From $267.00 by Baird
CRL,2023-09-25,15:29:03,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Market Perform by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Market Perform by TD Cowen
CRL,2023-09-25,15:29:03,B13B68,Charles River Labs International Inc.,100,-0.28,price-targets,downgrade,Charles River Labs Price Target Cut to $209.00/Share From $212.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $209.00/Share From $212.00 by TD Cowen
CRL,2023-09-26,12:00:03,B13B68,Charles River Labs International Inc.,100,0.52,products-services,,Charles River Unveils Lentivation Platform to,PRESS-RELEASE,Business Wire,Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
CRL,2023-09-26,12:00:40,B13B68,Charles River Labs International Inc.,100,0.52,products-services,,"Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its lentiviral vector",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
CRL,2023-10-11,12:00:06,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Schneider Electric in partnership with the Pharmaceutical Supply Chain Initiative (PSCI), is a",PRESS-RELEASE,Business Wire,"Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals"
CRL,2023-10-11,12:02:00,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Schneider Electric in partnership with the Pharmaceutical Supply Chain Initiative (PSCI), is a",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals"
CRL,2023-10-16,12:30:01,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
CRL,2023-10-16,12:30:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2023 financial results on Wednesday, November 8",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
CRL,2023-10-16,12:44:43,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
CRL,2023-10-16,12:44:43,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2023 financial results on Wednesday, November 8",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
CRL,2023-10-24,12:34:10,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley
CRL,2023-10-24,12:34:10,B13B68,Charles River Labs International Inc.,100,-0.66,price-targets,downgrade,Charles River Labs Price Target Cut to $220.00/Share From $235.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $220.00/Share From $235.00 by Morgan Stanley
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Third-Quarter 2023 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For the quarter, revenue was $1.03 billion, an increase of 3.8%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Third-Quarter GAAP Earnings per Share of $1.69,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Third-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: GAAP earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $140.5 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Choose to partner with Charles River to,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $186.8 million in the third quarter of 2023,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,-0.68,revenues,down,Charles River Labs International Inc.: This was partially offset by lower revenue,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2023 guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.50 -- $10.70,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,96,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 869,759 $ 812,894",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,96,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,96,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,96,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,607,007 $ 7,602,770",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,96,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,91,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,91,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,026,623 $ 989,157",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 3.8 %",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q EPS $1.69,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q EPS $1.69 >CRL
CRL,2023-11-08,12:00:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q Adj EPS $2.72,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Adj EPS $2.72 >CRL
CRL,2023-11-08,12:00:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 3Q Net $87.4M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Net $87.4M >CRL
CRL,2023-11-08,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 3Q Rev $1.03B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 3Q Rev $1.03B >CRL
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Third-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For the quarter, revenue was $1.03 billion, an increase of 3.8%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Third-Quarter GAAP Earnings per Share of $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Third-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: GAAP earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $140.5 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Choose to partner with Charles River to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $186.8 million in the third quarter of 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,-0.68,revenues,down,Charles River Labs International Inc.: This was partially offset by lower revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2023 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $10.50 -- $10.70,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Third-Quarter 2023 Results
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,96,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 869,759 $ 812,894",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,96,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,96,0.0,earnings,,Charles River Labs International Inc.: Earnings per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,96,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,607,007 $ 7,602,770",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,96,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,91,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,91,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,026,623 $ 989,157",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-11-08,12:01:00,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 3.8 %",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2023-11-08,12:02:36,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,Charles River Labs Narrows 2023 View To Adj EPS $10.50,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Narrows 2023 View To Adj EPS $10.50-Adj EPS $10.70 >CRL
CRL,2023-11-08,12:04:24,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees 2023 EPS $7.30 >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees 2023 EPS $7.30 >CRL
CRL,2023-11-08,12:12:13,B13B68,Charles River Labs International Inc.,100,0.65,revenues,up,Charles River Laboratories' sales rose in the third quarter,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Revenue Rises Despite Softer Customer Spending
CRL,2023-11-08,12:12:13,B13B68,Charles River Labs International Inc.,100,0.48,equity-actions,down,Charles River is cutting costs,FULL-ARTICLE,Dow Jones Newswires,Charles River Labs Revenue Rises Despite Softer Customer Spending
CRL,2023-11-08,12:22:36,B13B68,Charles River Labs International Inc.,100,-0.74,earnings,down,"Charles River Labs Narrows Full-Year Earnings, Revenue Outlook",FULL-ARTICLE,Dow Jones Newswires,"Charles River Labs Narrows Full-Year Earnings, Revenue Outlook"
CRL,2023-11-08,12:22:36,B13B68,Charles River Labs International Inc.,100,-0.75,revenues,down,Charles River Laboratories International narrowed its full-year outlook for revenue,FULL-ARTICLE,Dow Jones Newswires,"Charles River Labs Narrows Full-Year Earnings, Revenue Outlook"
CRL,2023-11-08,12:22:36,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: the company expects full-year earnings of $10.50 to $10.70 a share,FULL-ARTICLE,Dow Jones Newswires,"Charles River Labs Narrows Full-Year Earnings, Revenue Outlook"
CRL,2023-11-09,13:00:05,B13B68,Charles River Labs International Inc.,99,0.0,products-services,,Charles River Labs International Inc.: Development of an ASO-based therapy,PRESS-RELEASE,Business Wire,Charles River Laboratories' Industry Experts to Present Advanced Modalities at Neuroscience 2023
CRL,2023-11-09,13:03:21,B13B68,Charles River Labs International Inc.,99,0.0,products-services,,Charles River Labs International Inc.: Development of an ASO-based therapy,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories' Industry Experts to Present Advanced Modalities at Neuroscience 2023
CRL,2023-11-09,17:18:31,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp LaPlume Registers 9,128 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP LaPlume Registers 9,128 Of Charles River Labs Intl Inc >CRL"
CRL,2023-11-09,19:59:50,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by UBS
CRL,2023-11-09,19:59:50,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $215.00/Share From $250.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $215.00/Share From $250.00 by UBS
CRL,2023-11-10,14:04:43,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley
CRL,2023-11-10,14:04:43,B13B68,Charles River Labs International Inc.,100,-0.68,price-targets,downgrade,Charles River Labs Price Target Cut to $205.00/Share From $220.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $205.00/Share From $220.00 by Morgan Stanley
CRL,2023-11-13,14:00:03,B13B68,Charles River Labs International Inc.,99,0.7,partnerships,,CGI Inc.: We are excited to join forces with Charles River,PRESS-RELEASE,Business Wire,Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
CRL,2023-11-13,14:04:02,B13B68,Charles River Labs International Inc.,99,0.7,partnerships,,CGI Inc.: We are excited to join forces with Charles River,PRESS-RELEASE,PR Newswire,(PR) Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
CRL,2023-11-13,14:04:02,B13B68,Charles River Labs International Inc.,99,0.7,partnerships,,CGI Inc.: We are excited to join forces with Charles River,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
CRL,2023-11-13,14:08:16,B13B68,Charles River Labs International Inc.,99,0.7,partnerships,,CGI Inc.: We are excited to join forces with Charles River,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
CRL,2023-11-13,21:13:53,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp LaPlume Sells 9,128 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Sells 9,128 Of Charles River Labs Intl Inc >CRL"
CRL,2023-11-15,14:27:35,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Chmn Foster Buys 5,620 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Foster Buys 5,620 Of Charles River Labs Intl Inc >CRL"
CRL,2023-11-19,08:43:29,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 3Q 2023 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 3Q 2023 (CRL)"
CRL,2023-11-21,22:11:02,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Coo Girshick Buys 1,322 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"COO Girshick Buys 1,322 Of Charles River Labs Intl Inc >CRL"
CRL,2023-11-27,13:30:00,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Evercore ISI Investor Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Evercore ISI Investor Conference
CRL,2023-11-27,13:32:22,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Evercore ISI Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Evercore ISI Investor Conference
CRL,2023-11-28,13:00:01,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration,PRESS-RELEASE,Business Wire,Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
CRL,2023-11-28,13:00:01,B13B68,Charles River Labs International Inc.,100,0.84,products-services,positive,Charles River Labs International Inc.: Company will perform plasmid DNA production in support of early phase trials,PRESS-RELEASE,Business Wire,Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
CRL,2023-11-28,13:01:31,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
CRL,2023-11-28,13:01:31,B13B68,Charles River Labs International Inc.,100,0.84,products-services,positive,Charles River Labs International Inc.: Company will perform plasmid DNA production in support of early phase trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
CRL,2023-11-28,13:03:35,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration,NEWS-FLASH,Dow Jones Newswires,Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
CRL,2023-11-30,17:39:32,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp LaPlume Registers 1,850 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP LaPlume Registers 1,850 Of Charles River Labs Intl Inc >CRL"
CRL,2023-12-01,21:13:35,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp LaPlume Sells 1,850 Of Charles River Labs Intl Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP LaPlume Sells 1,850 Of Charles River Labs Intl Inc >CRL"
CRL,2023-12-07,11:00:06,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Cdmo) collaboration with Charles River Laboratories International, Inc., for",PRESS-RELEASE,PR Newswire,Visgenx and Charles River Announce Expansion of Gene Therapy Manufacturing Alliance
CRL,2023-12-11,12:13:49,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Citigroup
CRL,2023-12-11,12:13:49,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $215.00/Share From $190.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $215.00/Share From $190.00 by Citigroup
CRL,2023-12-14,21:13:06,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp Creamer Registers 5,526 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP Creamer Registers 5,526 Of Charles River Labs Intl Inc >CRL"
CRL,2023-12-18,13:00:02,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration,PRESS-RELEASE,Business Wire,Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration
CRL,2023-12-18,13:00:20,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration
CRL,2023-12-18,13:02:50,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration,NEWS-FLASH,Dow Jones Newswires,Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration
CRL,2023-12-18,21:08:50,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp Creamer Sells 5,526 Of Charles River Labs Intl Inc",FULL-ARTICLE,Dow Jones Newswires,"VP Creamer Sells 5,526 Of Charles River Labs Intl Inc >CRL"
CRL,2023-12-20,20:07:05,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Overweight by JP Morgan
CRL,2023-12-20,20:07:05,B13B68,Charles River Labs International Inc.,100,0.8,price-targets,upgrade,Charles River Labs Price Target Raised to $270.00/Share From $210.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $270.00/Share From $210.00 by JP Morgan
CRL,2023-01-18,14:49:00,C7B470,Carel Industries S.p.A.,93,0.55,products-services,gain,Carel Industries aims to expand its presence in Turkish market,PRESS-RELEASE,Business Wire,"Global Air Humidifiers Market 2022 to 2031: Major Players Include Armstrong International, Boneco, Carel Industries and Crane USA Among Others - ResearchAndMarkets.com"
CRL,2025-01-13,13:00:00,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2025-01-13,13:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at J.P. Morgan Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL,2025-01-14,16:23:35,B13B68,Charles River Labs International Inc.,100,-0.68,revenues,down,Charles River Labs International Inc.: the company said it expects revenue to decline,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Stock Falls 6% on Dim FY25 Outlook
CRL,2025-01-14,16:23:35,B13B68,Charles River Labs International Inc.,100,0.47,equity-actions,,Charles River Labs International Inc.: the company said it will try to save money through restructuring initiatives,FULL-ARTICLE,Dow Jones Newswires,Charles River Laboratories Stock Falls 6% on Dim FY25 Outlook
CRL,2025-01-16,13:00:02,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Akron Bio Announce Collaboration to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
CRL,2025-01-16,13:00:02,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Akron Bio Announce Collaboration to,PRESS-RELEASE,Business Wire,Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
CRL,2025-01-16,13:00:55,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Akron Bio Announce Collaboration to,NEWS-FLASH,Dow Jones Newswires,Charles River and Akron Bio Announce Collaboration to Enhance Ops With Integration of CGMP Materials Into Cell Therapy Platform
CRL,2025-01-17,11:42:26,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Neutral From Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Neutral From Buy by UBS
CRL,2025-01-17,11:42:26,B13B68,Charles River Labs International Inc.,100,-0.84,price-targets,downgrade,Charles River Labs Price Target Cut to $185.00/Share From $250.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $185.00/Share From $250.00 by UBS
CRL,2025-01-22,11:35:18,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Market Perform From Outperform by William Blair,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Market Perform From Outperform by William Blair
CRL,2025-01-23,16:19:20,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Buy by Goldman Sachs
CRL,2025-01-23,16:19:20,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $190.00/Share From $220.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $190.00/Share From $220.00 by Goldman Sachs
CRL,2025-01-28,21:30:00,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
CRL,2025-01-28,21:30:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2024 financial results and provide 2025 guidance on Wednesday, February 19",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
CRL,2025-01-28,21:30:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2024 financial results and provide 2025 guidance on Wednesday, February 19",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
CRL,2025-01-28,21:31:40,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
CRL,2025-01-28,21:31:40,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2024 financial results and provide 2025 guidance on Wednesday, February 19",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
CRL,2025-01-28,21:31:40,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2024 financial results and provide 2025 guidance on Wednesday, February 19",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
CRL,2025-01-28,22:55:11,B13B68,Charles River Labs International Inc.,100,0.0,credit-ratings,stable,S&PGR Revises Charles River Laboratories Outlook To Stable,NEWS-FLASH,Dow Jones Newswires,S&PGR Revises Charles River Laboratories Outlook To Stable
CRL,2025-01-28,22:55:11,B13B68,Charles River Labs International Inc.,100,0.0,credit-ratings,stable,S&PGR Revises Charles River Laboratories Outlook To Stable,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Revises Charles River Laboratories Outlook To Stable
CRL,2025-02-03,18:52:25,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by JP Morgan
CRL,2025-02-03,18:52:25,B13B68,Charles River Labs International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $175.00/Share From $215.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $175.00/Share From $215.00 by JP Morgan
CRL,2025-02-03,21:23:53,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Coo Girshick Acquires 3,032 Of Charles River Labs Intl Inc >CRL",FULL-ARTICLE,Dow Jones Newswires,"COO Girshick Acquires 3,032 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-03,21:27:10,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp Creamer Acquires 1,677 Of Charles River Labs Intl Inc >CRL",FULL-ARTICLE,Dow Jones Newswires,"VP Creamer Acquires 1,677 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-03,21:29:41,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,Vp Knell Acquires 529 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,VP Knell Acquires 529 Of Charles River Labs Intl Inc >CRL
CRL,2025-02-03,21:31:49,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp Parisotto Acquires 1,287 Of Charles River Labs Intl Inc >CRL",FULL-ARTICLE,Dow Jones Newswires,"VP Parisotto Acquires 1,287 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-03,21:59:45,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Vp LaPlume Acquires 1,892 Of Charles River Labs Intl Inc >CRL",FULL-ARTICLE,Dow Jones Newswires,"VP LaPlume Acquires 1,892 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-03,22:04:37,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Chmn Foster Acquires 12,781 Of Charles River Labs Intl Inc >CRL",FULL-ARTICLE,Dow Jones Newswires,"Chmn Foster Acquires 12,781 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-03,22:18:18,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Cfo Pease Acquires 1,790 Of Charles River Labs Intl Inc >CRL",FULL-ARTICLE,Dow Jones Newswires,"CFO Pease Acquires 1,790 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-05,13:14:29,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley
CRL,2025-02-05,13:14:29,B13B68,Charles River Labs International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $184.00/Share From $220.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $184.00/Share From $220.00 by Morgan Stanley
CRL,2025-02-11,13:00:01,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Deciphex Extend Global Partnership to,PRESS-RELEASE,Business Wire,Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
CRL,2025-02-11,13:00:25,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Deciphex Extend Global Partnership to,NEWS-FLASH,Dow Jones Newswires,Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering With Exclusive Image Management Solutions
CRL,2025-02-13,13:01:34,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Conduit Pharmaceuticals partners with Charles River to,PRESS-RELEASE,GlobeNewswire,Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
CRL,2025-02-13,13:01:34,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Conduit Pharmaceuticals partners with Charles River to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
CRL,2025-02-18,13:18:29,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Barclays
CRL,2025-02-18,13:18:29,B13B68,Charles River Labs International Inc.,100,-0.82,price-targets,downgrade,Charles River Labs Price Target Cut to $166.00/Share From $205.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $166.00/Share From $205.00 by Barclays
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,-0.65,earnings,negative,Charles River Labs 4Q Loss/Shr $4.22,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Loss/Shr $4.22 >CRL
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,-0.65,earnings,negative,Charles River Labs 4Q Loss $214.5M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Loss $214.5M >CRL
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 4Q Rev $1B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 4Q Rev $1B >CRL
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Fourth-Quarter Segment Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Full-Year Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Fourth-Quarter Revenue of $1.00 Billion,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,-0.65,earnings,negative,Charles River Labs International Inc.: Fourth-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Full-Year GAAP Earnings per Share of $0.20,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Provides 2025 Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,,Charles River Labs International Inc.: Company Plans Stock Repurchases of Approximately $350 Million,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $136.6 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.64,earnings,up,Charles River Labs International Inc.: The increases in non-GAAP net income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $204.3 million in the fourth quarter of 2024,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,"Charles River Labs International Inc.: For 2024, DSA revenue was $2.45 billion",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,-0.65,revenues,down,Charles River Labs International Inc.: The GAAP operating margin decreased,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: The Company's 2025 guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.65,revenues,up,Charles River Labs International Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: GAAP EPS estimate $4.30 - $4.80,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.10 -- $9.60,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -2-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 811,913 $ 838,003",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.63,earnings,negative,Charles River Labs International Inc.: Operating income (loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.65,earnings,negative,Charles River Labs International Inc.: Net income (loss) (,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,528,345 $ 8,195,001",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,93,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,93,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,002,549 $1,013,476",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.65,earnings,negative,Charles River Labs International Inc.: Net income (loss),PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,dividends,,Charles River Labs International Inc.: Incremental dividends,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.67,earnings,down,Charles River Labs International Inc.: Gain) loss,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.65,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -6-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Fourth-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Full-Year Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Fourth-Quarter Revenue of $1.00 Billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,-0.65,earnings,negative,Charles River Labs International Inc.: Fourth-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Full-Year GAAP Earnings per Share of $0.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Provides 2025 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,,Charles River Labs International Inc.: Company Plans Stock Repurchases of Approximately $350 Million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $136.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.64,earnings,up,Charles River Labs International Inc.: The increases in non-GAAP net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $204.3 million in the fourth quarter of 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,"Charles River Labs International Inc.: For 2024, DSA revenue was $2.45 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,100,-0.65,revenues,down,Charles River Labs International Inc.: The GAAP operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: The Company's 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.65,revenues,up,Charles River Labs International Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: GAAP EPS estimate $4.30 - $4.80,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.10 -- $9.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -2-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 811,913 $ 838,003",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.63,earnings,negative,Charles River Labs International Inc.: Operating income (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.65,earnings,negative,Charles River Labs International Inc.: Net income (loss) (,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,528,345 $ 8,195,001",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,93,-0.65,earnings,negative,Charles River Labs International Inc.: Accumulated other comprehensive loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,93,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $1,002,549 $1,013,476",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.65,earnings,negative,Charles River Labs International Inc.: Net income (loss),PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.0,dividends,,Charles River Labs International Inc.: Incremental dividends,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,-0.67,earnings,down,Charles River Labs International Inc.: Gain) loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2025-02-19,12:00:02,B13B68,Charles River Labs International Inc.,99,0.65,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -6-
CRL,2025-02-19,12:03:26,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,,Charles River Labs Plans Stk Repurchases of About $350M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Plans Stk Repurchases of About $350M in 2025 >CRL
CRL,2025-02-19,12:04:06,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees FY25 EPS $4.30,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees FY25 EPS $4.30-EPS $4.80 >CRL
CRL,2025-02-19,12:04:11,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees FY25 Adj EPS $9.10,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees FY25 Adj EPS $9.10-Adj EPS $9.60 >CRL
CRL,2025-02-19,12:04:56,B13B68,Charles River Labs International Inc.,100,-0.27,revenues,down,Charles River Labs Sees FY25 Organic Rev Decrease 5.5% - 3.5%,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees FY25 Organic Rev Decrease 5.5% - 3.5% >CRL
CRL,2025-02-19,12:20:23,B13B68,Charles River Labs International Inc.,95,0.0,earnings,,"Charles River Laboratories International, Inc. issued a press release providing financial results for the fourth quarter",RNS-SEC8K,Dow Jones Newswires,Charles River Labs Files 8K - Operations And Financial Condition >CRL
CRL,2025-02-20,12:37:04,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Barclays
CRL,2025-02-20,12:37:04,B13B68,Charles River Labs International Inc.,100,-0.48,price-targets,downgrade,Charles River Labs Price Target Cut to $160.00/Share From $166.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $160.00/Share From $166.00 by Barclays
CRL,2025-02-20,12:52:54,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Baird
CRL,2025-02-20,12:52:54,B13B68,Charles River Labs International Inc.,100,-0.4,price-targets,downgrade,Charles River Labs Price Target Cut to $173.00/Share From $177.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $173.00/Share From $177.00 by Baird
CRL,2025-02-20,15:53:34,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by JP Morgan
CRL,2025-02-20,15:53:34,B13B68,Charles River Labs International Inc.,100,-0.62,price-targets,downgrade,Charles River Labs Price Target Cut to $165.00/Share From $175.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $165.00/Share From $175.00 by JP Morgan
CRL,2025-02-20,17:39:28,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,"Vp LaPlume Registers 4,400 Of Charles River Labs Intl Inc >CRL",RNS-SEC144,Dow Jones Newswires,"VP LaPlume Registers 4,400 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-21,21:31:04,B13B68,Charles River Labs International Inc.,99,0.22,acquisitions-mergers,,"Charles River Labs International Inc.: the ""Company"") purchased 6,075 shares of the Company's",RNS-SEC8K,Dow Jones Newswires,Charles River Labs Files 8K - Other Events >CRL
CRL,2025-02-21,21:41:44,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,"Vp LaPlume Sells 4,400 Of Charles River Labs Intl Inc",FULL-ARTICLE,Dow Jones Newswires,"VP LaPlume Sells 4,400 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-21,21:46:00,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Chmn Foster Buys 6,075 Of Charles River Labs Intl Inc >CRL",FULL-ARTICLE,Dow Jones Newswires,"Chmn Foster Buys 6,075 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-21,21:47:05,B13B68,Charles River Labs International Inc.,100,0.52,insider-trading,,"Coo Girshick Buys 1,514 Of Charles River Labs Intl Inc >CRL",TABULAR-MATERIAL,Dow Jones Newswires,"COO Girshick Buys 1,514 Of Charles River Labs Intl Inc >CRL"
CRL,2025-02-23,08:02:16,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 4Q 2024 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 4Q 2024 (CRL)"
CRL,2025-02-26,21:44:30,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Coo Girshick Gifts 430 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,COO Girshick Gifts 430 Of Charles River Labs Intl Inc >CRL
CRL,2025-03-04,09:05:00,B13B68,Charles River Labs International Inc.,100,0.58,acquisitions-mergers,,Fairjourney Biologics Acquires Charles River Laboratories South San Francisco Facility,PRESS-RELEASE,Business Wire,FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility
CRL,2025-03-04,11:17:31,B13B68,Charles River Labs International Inc.,100,0.62,analyst-ratings,positive,Charles River Labs Raised to Neutral From Sell by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raised to Neutral From Sell by Citigroup
CRL,2025-03-04,11:17:31,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $175.00/Share From $155.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $175.00/Share From $155.00 by Citigroup
CRL,2025-03-11,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Barclays 27(th) Annual Global Healthcare Conference on Wednesday, March 12",PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL,2025-03-11,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Barclays 27(th) Annual Global Healthcare Conference on Wednesday, March 12",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Barclays Global Healthcare Conference
CRL,2025-03-21,09:25:20,B13B68,Charles River Labs International Inc.,100,-0.58,analyst-ratings,negative,Charles River Labs Cut to Neutral From Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Cut to Neutral From Buy by Goldman Sachs
CRL,2025-03-21,09:25:20,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $170.00/Share From $190.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $170.00/Share From $190.00 by Goldman Sachs
CRL,2025-04-09,12:03:30,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Mizuho
CRL,2025-04-09,12:03:30,B13B68,Charles River Labs International Inc.,100,-0.8,price-targets,downgrade,Charles River Labs Price Target Cut to $155.00/Share From $175.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $155.00/Share From $175.00 by Mizuho
CRL,2025-04-10,14:21:01,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Barclays
CRL,2025-04-10,14:21:01,B13B68,Charles River Labs International Inc.,100,-0.78,price-targets,downgrade,Charles River Labs Price Target Cut to $145.00/Share From $160.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Cut to $145.00/Share From $160.00 by Barclays
CRL,2025-04-15,20:30:00,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
CRL,2025-04-15,20:30:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2025 financial results on Wednesday, May 7",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
CRL,2025-04-15,20:51:58,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
CRL,2025-04-15,20:51:58,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2025 financial results on Wednesday, May 7",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
CRL,2025-04-22,12:00:02,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Charles River recently collaborated with Revvity, Inc.",PRESS-RELEASE,Business Wire,Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
CRL,2025-04-22,12:00:02,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Charles River recently collaborated with Revvity, Inc.",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
CRL,2025-04-29,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: Lafana joined forces with Charles River to,PRESS-RELEASE,Business Wire,Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
CRL,2025-04-29,12:00:01,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: Lafana joined forces with Charles River to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
CRL,2025-05-05,21:47:13,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Cfo Pease Surrenders 889 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,CFO Pease Surrenders 889 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-07,11:00:05,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: Enters into Cooperation Agreement with Elliott Investment Management,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
CRL,2025-05-07,11:00:05,B13B68,Charles River Labs International Inc.,99,0.47,labor-issues,,Charles River Labs International Inc.: The Company also announced changes to its Board,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
CRL,2025-05-07,11:00:05,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: Enters into Cooperation Agreement with Elliott Investment Management,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
CRL,2025-05-07,11:00:05,B13B68,Charles River Labs International Inc.,99,0.47,labor-issues,,Charles River Labs International Inc.: The Company also announced changes to its Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q EPS 50c,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q EPS 50c >CRL
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q Net $25.5M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Net $25.5M >CRL
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 1Q Rev $984.2M >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Rev $984.2M >CRL
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Laboratories Announces First-Quarter 2025 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,-0.02,revenues,,Charles River Labs International Inc.: First-Quarter Revenue of $984.2 Million --,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: First-Quarter GAAP Earnings per Share of $0.50,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.7,earnings,up,Charles River Labs International Inc.: Increases 2025 Guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.7,earnings,up,Charles River Labs International Inc.: modestly increasing our financial guidance for 2025,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,,Charles River Labs International Inc.: Repurchased $350 Million of Common Stock in First Quarter of 2025,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $119.1 million",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.64,earnings,up,Charles River Labs International Inc.: The increases in non-GAAP net income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $213.1 million in the first quarter of 2025,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: The GAAP operating margin increase,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.62,revenues,up,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,approved,Charles River Labs International Inc.: Under its $1.0 billion stock repurchase authorization,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.30 -- $9.80,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 797,923 $ 816,862",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Earnings per common share Basic $ 0.50 $ 1.31,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,582,366 $ 7,528,345",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,91,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,91,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $ 984,168 $ 1,011,560",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2025-05-07,11:01:00,B13B68,Charles River Labs International Inc.,99,0.65,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: First-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,-0.02,revenues,,Charles River Labs International Inc.: First-Quarter Revenue of $984.2 Million --,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: First-Quarter GAAP Earnings per Share of $0.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.7,earnings,up,Charles River Labs International Inc.: Increases 2025 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.7,earnings,up,Charles River Labs International Inc.: modestly increasing our financial guidance for 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,,Charles River Labs International Inc.: Repurchased $350 Million of Common Stock in First Quarter of 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,"Charles River Labs International Inc.: On a non-GAAP basis, net income was $119.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: First-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.64,earnings,up,Charles River Labs International Inc.: The increases in non-GAAP net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $213.1 million in the first quarter of 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: The GAAP operating margin increase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.62,revenues,up,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.59,equity-actions,approved,Charles River Labs International Inc.: Under its $1.0 billion stock repurchase authorization,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.30 -- $9.80,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces First-Quarter 2025 Results
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 797,923 $ 816,862",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Earnings per common share Basic $ 0.50 $ 1.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,582,366 $ 7,528,345",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,91,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,91,0.0,revenues,,"Charles River Labs International Inc.: Total Revenue $ 984,168 $ 1,011,560",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2025-05-07,11:01:01,B13B68,Charles River Labs International Inc.,99,0.65,revenues,up,Charles River Labs International Inc.: Non-GAAP revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2025-05-07,11:06:17,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River Labs Enters Into Cooperation Agreement,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Enters Into Cooperation Agreement With Elliott Investment
CRL,2025-05-07,11:06:28,B13B68,Charles River Labs International Inc.,100,0.47,labor-issues,,Charles River Labs Names 4 New Directors,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Names 4 New Directors
CRL,2025-05-07,11:10:17,B13B68,Charles River Labs International Inc.,100,0.7,earnings,up,Charles River Labs Increases 2025 Guidance >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Increases 2025 Guidance >CRL
CRL,2025-05-07,11:11:00,B13B68,Charles River Labs International Inc.,100,0.7,earnings,up,Charles River Labs Raises FY25 View To EPS $4.35,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raises FY25 View To EPS $4.35-EPS $4.85
CRL,2025-05-07,11:16:17,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,"Charles River Labs International Inc.: Charles River Laboratories International, Inc. (the ""Company"") entered into a Cooperation",RNS-SEC8K,Dow Jones Newswires,Charles River Labs Files 8K - Entry Into Definitive Agreement >CRL
CRL,2025-05-07,11:16:17,B13B68,Charles River Labs International Inc.,99,0.47,labor-issues,,Charles River Labs International Inc.: the Company shall appoint a substitute director,RNS-SEC8K,Dow Jones Newswires,Charles River Labs Files 8K - Entry Into Definitive Agreement >CRL
CRL,2025-05-07,11:19:24,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 1Q Adj EPS $2.34,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 1Q Adj EPS $2.34 >CRL
CRL,2025-05-07,11:55:54,B13B68,Charles River Labs International Inc.,100,0.64,earnings,up,Charles River Labs 1Q Earnings Rise,FULL-ARTICLE,Dow Jones Newswires,"Charles River Labs 1Q Earnings Rise, Ups FY Outlook; Board Will Conduct Strategic Review of Business"
CRL,2025-05-07,11:55:54,B13B68,Charles River Labs International Inc.,100,0.39,products-services,,Charles River Labs International Inc.: The company also entered into an agreement with Elliott Investment Management,FULL-ARTICLE,Dow Jones Newswires,"Charles River Labs 1Q Earnings Rise, Ups FY Outlook; Board Will Conduct Strategic Review of Business"
CRL,2025-05-07,11:55:54,B13B68,Charles River Labs International Inc.,100,-0.68,revenues,down,Charles River said revenue fell,FULL-ARTICLE,Dow Jones Newswires,"Charles River Labs 1Q Earnings Rise, Ups FY Outlook; Board Will Conduct Strategic Review of Business"
CRL,2025-05-07,11:55:54,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River said it entered into a cooperation agreement with Elliott,FULL-ARTICLE,Dow Jones Newswires,"Charles River Labs 1Q Earnings Rise, Ups FY Outlook; Board Will Conduct Strategic Review of Business"
CRL,2025-05-07,16:17:43,B13B68,Charles River Labs International Inc.,99,-0.68,revenues,down,Charles River noted that revenue was down,FULL-ARTICLE,Dow Jones Newswires,Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help. -- Barrons.com
CRL,2025-05-07,16:17:43,B13B68,Charles River Labs International Inc.,99,0.39,products-services,,Charles River Labs International Inc.: The company said Wednesday that it had entered into an agreement with Elliott Investment Management,FULL-ARTICLE,Dow Jones Newswires,Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help. -- Barrons.com
CRL,2025-05-08,12:51:25,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Baird
CRL,2025-05-08,12:51:25,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $140.00/Share From $118.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $140.00/Share From $118.00 by Baird
CRL,2025-05-08,16:59:25,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Barclays
CRL,2025-05-08,16:59:25,B13B68,Charles River Labs International Inc.,100,0.66,price-targets,upgrade,Charles River Labs Price Target Raised to $155.00/Share From $145.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $155.00/Share From $145.00 by Barclays
CRL,2025-05-13,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Bank of America 2025 Health Care Conference on Wednesday, May 14",PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Bank of America Health Care Conference
CRL,2025-05-13,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Bank of America 2025 Health Care Conference on Wednesday, May 14",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Bank of America Health Care Conference
CRL,2025-05-13,19:36:29,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 500 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 500 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-14,20:27:56,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Dir Massaro Registers 280 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,Dir Massaro Registers 280 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-15,20:39:46,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 500 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Sells 500 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-15,20:44:40,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Dir Massaro Sells 140 Of Charles River Labs Intl Inc,FULL-ARTICLE,Dow Jones Newswires,Dir Massaro Sells 140 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-16,20:30:35,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Dir Massaro Sells 140 Of Charles River Labs Intl Inc,FULL-ARTICLE,Dow Jones Newswires,Dir Massaro Sells 140 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-22,07:01:23,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 1Q 2025 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 1Q 2025 (CRL)"
CRL,2025-05-23,12:04:09,B13B68,Charles River Labs International Inc.,100,0.94,analyst-ratings,positive,Charles River Labs Raised to Buy From Neutral by Redburn Atlantic,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raised to Buy From Neutral by Redburn Atlantic
CRL,2025-05-29,20:55:02,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 276 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Creamer Surrenders 276 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-29,21:00:28,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Coo Girshick Surrenders 640 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,COO Girshick Surrenders 640 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-29,21:02:37,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 112 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Surrenders 112 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-29,21:07:23,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 366 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Surrenders 366 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-29,21:09:07,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Parisotto Surrenders 213 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Parisotto Surrenders 213 Of Charles River Labs Intl Inc >CRL
CRL,2025-05-29,21:11:56,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Cfo Pease Surrenders 331 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,CFO Pease Surrenders 331 Of Charles River Labs Intl Inc >CRL
CRL,2025-06-02,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 45(th) Annual Growth Stock Conference on Tuesday, June 3",PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at William Blair and Jefferies Conferences
CRL,2025-06-02,12:00:02,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,"Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 45(th) Annual Growth Stock Conference on Tuesday, June 3",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at William Blair and Jefferies Conferences
CRL,2025-06-03,20:59:48,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Creamer Surrenders 120 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,VP Creamer Surrenders 120 Of Charles River Labs Intl Inc >CRL
CRL,2025-06-03,21:09:32,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Coo Girshick Surrenders 283 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,COO Girshick Surrenders 283 Of Charles River Labs Intl Inc >CRL
CRL,2025-06-03,21:09:37,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Knell Surrenders 273 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP Knell Surrenders 273 Of Charles River Labs Intl Inc >CRL
CRL,2025-06-03,21:09:52,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp LaPlume Surrenders 155 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,VP LaPlume Surrenders 155 Of Charles River Labs Intl Inc >CRL
CRL,2025-06-03,21:27:41,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp Parisotto Surrenders 105 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,VP Parisotto Surrenders 105 Of Charles River Labs Intl Inc >CRL
CRL,2025-06-03,21:37:03,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Cfo Pease Surrenders 185 Of Charles River Labs Intl Inc >CRL,FULL-ARTICLE,Dow Jones Newswires,CFO Pease Surrenders 185 Of Charles River Labs Intl Inc >CRL
CRL,2025-06-09,20:24:07,B13B68,Charles River Labs International Inc.,100,0.0,insider-trading,,Vp LaPlume Gifts 385 Of Charles River Labs Intl Inc >CRL,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Gifts 385 Of Charles River Labs Intl Inc >CRL
CRL,2025-06-17,16:43:12,B13B68,Charles River Labs International Inc.,100,-0.03,credit-ratings,stable,Fitch Affirms Charles River's IDR at 'BBB-'; Outlook Stable,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Charles River's IDR at 'BBB-'; Outlook Stable
CRL,2025-06-17,16:43:12,B13B68,Charles River Labs International Inc.,100,0.0,credit-ratings,affirmation,"Fitch Ratings has affirmed the Long-Term Issuer Default Ratings (IDRs) of Charles River Laboratories International, Inc.",PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Charles River's IDR at 'BBB-'; Outlook Stable
CRL,2025-06-17,16:43:12,B13B68,Charles River Labs International Inc.,100,-0.04,credit-ratings,set,"Fitch has also assigned a 'BBB-' IDR to Charles River Laboratories, Inc. (CRL)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Charles River's IDR at 'BBB-'; Outlook Stable
CRL,2025-06-17,16:43:22,B13B68,Charles River Labs International Inc.,100,-0.03,credit-ratings,stable,Fitch Affirms Charles River's IDR at 'BBB-'; Outlook Stable,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Charles River's IDR at 'BBB-'; Outlook Stable -2-
CRL,2025-07-09,12:27:50,B13B68,Charles River Labs International Inc.,100,0.94,analyst-ratings,positive,Charles River Labs Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raised to Buy From Neutral by Citigroup
CRL,2025-07-09,12:27:50,B13B68,Charles River Labs International Inc.,100,0.8,price-targets,upgrade,Charles River Labs Price Target Raised to $200.00/Share From $150.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $200.00/Share From $150.00 by Citigroup
CRL,2025-07-09,12:54:00,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Evercore ISI Group
CRL,2025-07-09,12:54:00,B13B68,Charles River Labs International Inc.,100,0.62,price-targets,upgrade,Charles River Labs Price Target Raised to $180.00/Share From $170.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $180.00/Share From $170.00 by Evercore ISI Group
CRL,2025-07-15,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
CRL,2025-07-15,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2025 financial results on Wednesday, August 6",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
CRL,2025-07-15,12:19:59,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
CRL,2025-07-15,12:19:59,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2025 financial results on Wednesday, August 6",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Laboratories Announces Second-Quarter 2025 Results,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For the quarter, revenue was $1,032.1 million, an increase of 0.6%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Second-Quarter GAAP Earnings per Share of $1.06,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,-0.24,revenues,down,"Charles River Labs International Inc.: Excluding this impact, revenue declined 0.5%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP net income was $154.0 million,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $213.3 million in the second quarter of 2025,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,-0.65,revenues,down,Charles River Labs International Inc.: The GAAP operating margin decline,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.62,revenues,up,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2025 guidance,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.90 -- $10.30,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q EPS $1.06,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q EPS $1.06 >CRL
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 840,836 $ 842,900",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Earnings per common share Basic $ 1.06 $ 1.75 $,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,560,545 $ 7,528,345",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -3-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Net $52.3M,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Net $52.3M >CRL
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,91,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -4-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs 2Q Rev $1.03B >CRL,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Rev $1.03B >CRL
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 0.6%",PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces -5-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Second-Quarter Segment Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.41,revenues,up,"Charles River Labs International Inc.: For the quarter, revenue was $1,032.1 million, an increase of 0.6%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Second-Quarter GAAP Earnings per Share of $1.06,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,-0.24,revenues,down,"Charles River Labs International Inc.: Excluding this impact, revenue declined 0.5%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP net income was $154.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: Second-quarter diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,revenues,,Charles River Labs International Inc.: Revenue for the RMS segment was $213.3 million in the second quarter of 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,-0.65,revenues,down,Charles River Labs International Inc.: The GAAP operating margin decline,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.62,revenues,up,Charles River Labs International Inc.: The non-GAAP operating margin increase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs International Inc.: The Company's 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs International Inc.: Non-GAAP EPS estimate $9.90 -- $10.30,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Second-Quarter 2025 Results
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,revenues,,"Charles River Labs International Inc.: Service revenue $ 840,836 $ 842,900",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.61,earnings,positive,Charles River Labs International Inc.: Earnings per common share Basic $ 1.06 $ 1.75 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,assets,,"Charles River Labs International Inc.: Total assets $ 7,560,545 $ 7,528,345",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -3-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,91,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -4-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.41,revenues,up,"Charles River Labs International Inc.: Revenue growth, reported 0.6%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2025-08-06,11:00:02,B13B68,Charles River Labs International Inc.,99,0.0,earnings,,Charles River Labs International Inc.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories -5-
CRL,2025-08-06,11:08:37,B13B68,Charles River Labs International Inc.,100,0.61,earnings,positive,Charles River Labs 2Q Adj EPS $3.12,NEWS-FLASH,Dow Jones Newswires,Charles River Labs 2Q Adj EPS $3.12 >CRL
CRL,2025-08-06,11:12:37,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,Charles River Labs Sees FY25 EPS $4.25,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Sees FY25 EPS $4.25-EPS $4.65 >CRL
CRL,2025-08-06,12:11:19,B13B68,Charles River Labs International Inc.,100,-0.67,earnings,down,Charles River 2Q Net Down,FULL-ARTICLE,Dow Jones Newswires,"Charles River 2Q Net Down, But Co. Boosts '25 Adj EPS View"
CRL,2025-08-06,12:11:19,B13B68,Charles River Labs International Inc.,100,-0.75,revenues,down,Charles River Labs International Inc.: The company now anticipates revenue falling,FULL-ARTICLE,Dow Jones Newswires,"Charles River 2Q Net Down, But Co. Boosts '25 Adj EPS View"
CRL,2025-08-07,13:23:06,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Equal-Weight by Barclays
CRL,2025-08-07,13:23:06,B13B68,Charles River Labs International Inc.,100,0.64,price-targets,upgrade,Charles River Labs Price Target Raised to $165.00/Share From $155.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $165.00/Share From $155.00 by Barclays
CRL,2025-08-07,19:00:35,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 400 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 400 Of Charles River Labs Intl Inc >CRL
CRL,2025-08-07,19:19:07,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by JP Morgan
CRL,2025-08-07,19:19:07,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $160.00/Share From $145.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $160.00/Share From $145.00 by JP Morgan
CRL,2025-08-08,12:37:39,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Evercore ISI Group
CRL,2025-08-08,12:37:39,B13B68,Charles River Labs International Inc.,100,0.6,price-targets,upgrade,Charles River Labs Price Target Raised to $190.00/Share From $180.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $190.00/Share From $180.00 by Evercore ISI Group
CRL,2025-08-08,20:19:57,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 400 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Sells 400 Of Charles River Labs Intl Inc >CRL
CRL,2025-08-18,17:30:26,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 800 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 800 Of Charles River Labs Intl Inc >CRL
CRL,2025-08-20,20:46:36,B13B68,Charles River Labs International Inc.,100,-0.49,insider-trading,,Vp LaPlume Sells 800 Of Charles River Labs Intl Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP LaPlume Sells 800 Of Charles River Labs Intl Inc >CRL
CRL,2025-08-22,07:01:23,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,"Charles River Laboratories Int, Inst Holders, 2Q 2025 (CRL)",RNS-SEC13F,Dow Jones Newswires,"Charles River Laboratories Int, Inst Holders, 2Q 2025 (CRL)"
CRL,2025-08-22,17:39:33,B13B68,Charles River Labs International Inc.,100,-0.48,insider-trading,,Vp LaPlume Registers 400 Of Charles River Labs Intl Inc >CRL,RNS-SEC144,Dow Jones Newswires,VP LaPlume Registers 400 Of Charles River Labs Intl Inc >CRL
CRL,2025-09-08,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences,PRESS-RELEASE,Business Wire,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL,2025-09-08,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,marketing,,Charles River Laboratories to Present at Baird and Morgan Stanley Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL,2025-09-09,11:00:21,B13B68,Charles River Labs International Inc.,100,0.94,analyst-ratings,positive,Charles River Labs Raised to Buy From Hold by Jefferies,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raised to Buy From Hold by Jefferies
CRL,2025-09-09,11:00:21,B13B68,Charles River Labs International Inc.,100,0.82,price-targets,upgrade,Charles River Labs Price Target Raised to $195.00/Share From $142.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $195.00/Share From $142.00 by Jefferies
CRL,2025-09-11,12:00:02,B13B68,Charles River Labs International Inc.,99,0.84,products-services,positive,Charles River Labs International Inc.: Supporting Phase I Clinical Trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer"
CRL,2025-09-11,12:00:02,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: We've partnered closely with CHLA to,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer"
CRL,2025-09-11,12:00:02,B13B68,Charles River Labs International Inc.,99,0.84,products-services,positive,Charles River Labs International Inc.: Supporting Phase I Clinical Trials,PRESS-RELEASE,Business Wire,"Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer"
CRL,2025-09-11,12:00:02,B13B68,Charles River Labs International Inc.,99,0.49,partnerships,,Charles River Labs International Inc.: We've partnered closely with CHLA to,PRESS-RELEASE,Business Wire,"Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer"
CRL,2025-09-16,11:05:01,B13B68,Charles River Labs International Inc.,100,0.53,labor-issues,,Charles River Laboratories Announces Chief Financial Officer Transition,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Chief Financial Officer Transition
CRL,2025-09-16,11:05:01,B13B68,Charles River Labs International Inc.,100,0.52,products-services,,Charles River Labs International Inc.: We have launched a comprehensive search to,PRESS-RELEASE,Business Wire,Charles River Laboratories Announces Chief Financial Officer Transition
CRL,2025-09-16,11:05:01,B13B68,Charles River Labs International Inc.,100,0.53,labor-issues,,Charles River Laboratories Announces Chief Financial Officer Transition,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Chief Financial Officer Transition
CRL,2025-09-16,11:05:01,B13B68,Charles River Labs International Inc.,100,0.52,products-services,,Charles River Labs International Inc.: We have launched a comprehensive search to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Announces Chief Financial Officer Transition
CRL,2025-09-16,11:06:54,B13B68,Charles River Labs International Inc.,100,-0.57,labor-issues,,Charles River Labs CFO Flavia Pease Has Resigned,NEWS-FLASH,Dow Jones Newswires,"Charles River Labs CFO Flavia Pease Has Resigned From Her Role, Effective Sept 29 >CRL"
CRL,2025-09-16,11:07:29,B13B68,Charles River Labs International Inc.,100,0.0,revenues,unchanged,Charles River Labs Reaffirms 2025 Rev and Non-GAAP EPS Guidance,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Reaffirms 2025 Rev and Non-GAAP EPS Guidance >CRL
CRL,2025-10-02,11:37:34,B13B68,Charles River Labs International Inc.,100,0.94,analyst-ratings,positive,Charles River Labs Raised to Overweight From Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raised to Overweight From Equal-Weight by Barclays
CRL,2025-10-02,11:37:34,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $195.00/Share From $165.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $195.00/Share From $165.00 by Barclays
CRL,2025-10-03,16:08:57,B13B68,Charles River Labs International Inc.,100,0.34,analyst-ratings,neutral,Charles River Labs Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Outperform by Evercore ISI Group
CRL,2025-10-03,16:08:57,B13B68,Charles River Labs International Inc.,100,0.6,price-targets,upgrade,Charles River Labs Price Target Raised to $200.00/Share From $190.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $200.00/Share From $190.00 by Evercore ISI Group
CRL,2025-10-06,15:37:53,B13B68,Charles River Labs International Inc.,100,0.94,analyst-ratings,positive,Charles River Labs Raised to Outperform From Market Perform by William Blair,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Raised to Outperform From Market Perform by William Blair
CRL,2025-10-08,12:00:02,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Toxys Announce Collaboration to,PRESS-RELEASE,Business Wire,Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
CRL,2025-10-08,12:11:48,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,Charles River and Toxys Announce Collaboration to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
CRL,2025-10-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call,PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
CRL,2025-10-14,12:00:01,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2025 financial results on Wednesday, November 5",PRESS-RELEASE,Business Wire,Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
CRL,2025-10-14,12:07:48,B13B68,Charles River Labs International Inc.,100,0.0,investor-relations,,Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
CRL,2025-10-14,12:07:48,B13B68,Charles River Labs International Inc.,100,0.0,earnings,,"Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2025 financial results on Wednesday, November 5",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
CRL,2025-10-17,13:28:11,B13B68,Charles River Labs International Inc.,100,0.0,analyst-ratings,neutral,Charles River Labs Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Is Maintained at Neutral by Mizuho
CRL,2025-10-17,13:28:11,B13B68,Charles River Labs International Inc.,100,0.78,price-targets,upgrade,Charles River Labs Price Target Raised to $174.00/Share From $155.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Charles River Labs Price Target Raised to $174.00/Share From $155.00 by Mizuho
CRL,2025-10-20,12:00:01,B13B68,Charles River Labs International Inc.,100,0.7,partnerships,,"Charles River Laboratories International, Inc. (NYSE:CRL) today announced a strategic collaboration with X-Chem, Inc.",PRESS-RELEASE,Business Wire,Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities
CRL,2025-10-20,12:00:04,B13B68,Charles River Labs International Inc.,100,0.7,partnerships,,"Charles River Laboratories International, Inc. (NYSE:CRL) today announced a strategic collaboration with X-Chem, Inc.",PRESS-RELEASE,Dow Jones Newswires,Press Release: Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities
CRL,2025-10-20,12:00:43,B13B68,Charles River Labs International Inc.,100,0.49,partnerships,,"Charles River, X-Chem Announce Strategic Collaboration",NEWS-FLASH,Dow Jones Newswires,"Charles River, X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities"
